Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer, January 2016

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1477 articles:
HTML format


 

Single Articles

  1. SHRIVASTAVA S, Mansure JJ, Almajed W, Cury F, et al
    The role of HMGB1 in radio-resistance of bladder cancer.
    Mol Cancer Ther. 2015 Dec 30. pii: molcanther.0581.2015.
    Abstract     Related articles   

  2. REZACOVA K, Canova K, Bezrouk A, Rudolf E, et al
    Selenite induces DNA damage and specific mitochondrial degeneration in human bladder cancer cells.
    Toxicol In Vitro. 2015 Dec 21. pii: S0887-2333(15)30034.
    Abstract     Related articles   

  3. ISKENDER B, Izgi K, Hizar E, Jauch J, et al
    Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.
    Tumour Biol. 2015.
    Abstract     Related articles   

  4. ZHENG SS, Gao JG, Liu ZJ, Zhang XH, et al
    Downregulation of fatty acid synthase complex suppresses cell migration by targeting phosphoAKT in bladder cancer.
    Mol Med Rep. 2015 Dec 30. doi: 10.3892/mmr.2015.4746.
    Abstract     Related articles   

  5. ZHU Z, Zhang J, Jiang W, Zhang X, et al
    Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis.
    Onco Targets Ther. 2015;8:3715-20.
    Abstract     Related articles   

  6. JIANG Y, Han Y, Sun C, Han C, et al
    Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
    Tumour Biol. 2015.
    Abstract     Related articles   

  7. FANG Z, Dai W, Wang X, Chen W, et al
    Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  8. SORIA F, Allasia M, Oderda M, Gontero P, et al
    Hyperthermia for non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2015.
    Abstract     Related articles   

  9. MIGLIETTA G, Gouda AS, Cogoi S, Pedersen EB, et al
    Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism.
    ACS Med Chem Lett. 2015;6:1179-83.
    Abstract     Related articles   

  10. HUGEN CM, Daneshmand S
    Lymph node dissection in bladder cancer: Where do we stand?
    World J Urol. 2015.
    Abstract     Related articles   

  11. MA T, Li J, Jiang Z, Wang W, et al
    [Narrow band imaging-assisted holmium laser resection reduces the residual tumor rate of primary non-muscle invasive bladder cancer: a comparison with the standard approach].
    Zhonghua Yi Xue Za Zhi. 2015;95:2775-8.
    Abstract     Related articles   

  12. SANKHWAR M, Sankhwar SN, Abhishek A, Gupta N, et al
    CYP1B1 gene polymorphisms correlate with an increased risk of urinary bladder cancer in India.
    Urol Oncol. 2015 Dec 18. pii: S1078-1439(15)00562.
    Abstract     Related articles   

  13. LEI CY, Wang W, Zhu YT, Fang WY, et al
    The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer.
    Urol Oncol. 2015 Dec 16. pii: S1078-1439(15)00563.
    Abstract     Related articles   

  14. BEARDO VILLAR P, Perez Perez AB, Castro Dorantes MJ, Jimenez Delgado SJ, et al
    [Effectiveness of a program of early instillation single chemotherapy in patients with bladder cancer].
    Rev Calid Asist. 2015 Dec 16. pii: S1134-282X(15)00168.
    Abstract     Related articles   

  15. BRUINS HM, Aben KK, Arends TJ, van der Heijden AG, et al
    The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Urol Oncol. 2015 Dec 15. pii: S1078-1439(15)00558.
    Abstract     Related articles   

  16. GRANTHAM JT, Howell DM, Bacaj PJ, Coad JE, et al
    Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2).
    W V Med J. 2015;111:34-6.
    Abstract     Related articles   

  17. KHADIM MT, Ahmed SA, Khan FA, Ikram A, et al
    Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
    J Pak Med Assoc. 2015;65:851-6.
    Abstract     Related articles   

  18. IACOVACCI V, Lucarini G, Ricotti L, Dario P, et al
    Untethered magnetic millirobot for targeted drug delivery.
    Biomed Microdevices. 2015;17:9962.
    Abstract     Related articles   

  19. SAJID MA, Khurshid H, Saeed M, Salahuddin O, et al
    Flexible cystoscopy a valuable diagnostic tool for lower urinary tract pathology.
    J Pak Med Assoc. 2015;65:253-5.
    Abstract     Related articles   

  20. WU Y, Enting D, Rudman S, Chowdhury S, et al
    Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond.
    Expert Rev Anticancer Ther. 2015;15:509-23.
    Abstract     Related articles   

  21. HU CY, Tsai YC, Wang SM, Huang CY, et al
    Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Biomed Res Int. 2015;2015:527976.
    Abstract     Related articles   

  22. REDONDO-GONZALEZ E, de Castro LN, Moreno-Sierra J, Maestro de las Casas ML, et al
    Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis.
    Biomed Res Int. 2015;2015:168682.
    Abstract     Related articles   

  23. DIAZ-DELGADO J, Sierra E, Arbelo M, Suarez-Bonnet A, et al
    Primary uterine T-cell lymphoma with metastasis in an Atlantic spotted dolphin (Stenella frontalis), Canary Islands, Spain.
    J Wildl Dis. 2015;51:538-41.
    Abstract     Related articles   

  24. HUANG H, Li X, Jin J
    Treatment of bladder transitional cell carcinoma in children: a single center experience from China.
    Arch Iran Med. 2015;18:250-2.
    Abstract     Related articles   

  25. HAYNE D
    Radical cystectomy in Australia.
    ANZ J Surg. 2015;85:101-2.
    Abstract     Related articles   

  26. NING YM, Maher VE
    Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: treatments in urologic oncology.
    Urol Oncol. 2015;33:137-42.
    Abstract     Related articles   

  27. SUN D, Sawada A, Nakashima M, Kobayashi T, et al
    MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
    Urol Oncol. 2015;33:111.
    Abstract     Related articles   

  28. YOUSSEF RF, Kapur P, Mosbah A, Abol-Enein H, et al
    Role of fibroblast growth factor in squamous cell carcinoma of the bladder: prognostic biomarker and potential therapeutic target.
    Urol Oncol. 2015;33:111.
    Abstract     Related articles   

  29. BROSS PF, Fan C, George B, Shannon K, et al
    Regulation of biologic oncology products in the FDAs Center for Biologics Evaluation and Research.
    Urol Oncol. 2015;33:133-6.
    Abstract     Related articles   

  30. CHEN J, Wang L, Tang Y, Gong G, et al
    Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    J Exp Clin Cancer Res. 2016;35:2.
    Abstract     Related articles   

  31. LIU X, Yao D, Liu C, Cao Y, et al
    Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
    Tumour Biol. 2016.
    Abstract     Related articles   

  32. FIGUEROA JD, Middlebrooks CD, Banday AR, Ye Y, et al
    Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.
    Hum Mol Genet. 2016.
    Abstract     Related articles   

  33. CHEN Z, Yu T, Zhou B, Wei J, et al
    Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo.
    Biomaterials. 2015;81:125-134.
    Abstract     Related articles   

  34. JIA ZM, Ai X, Teng JF, Wang YP, et al
    p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation.
    Tumour Biol. 2016.
    Abstract     Related articles   

  35. OHISHI T, Koga F, Migita T
    Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives.
    Int J Mol Sci. 2015;17.
    Abstract     Related articles   

  36. KUMONDAI M, Hosono H, Orikasa K, Arai Y, et al
    Genetic Polymorphisms of <i>CYP2A6</i> in a Case-Control Study on Bladder Cancer in Japanese Smokers.
    Biol Pharm Bull. 2016;39:84-9.
    Abstract     Related articles   

  37. LYONS MD, Smith AB
    Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer.
    Urol Oncol. 2015 Dec 24. pii: S1078-1439(15)00575.
    Abstract     Related articles   

  38. ZHANG J, Wang S, Han F, Li J, et al
    MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Gene. 2015 Dec 23. pii: S0378-1119(15)01546-2. doi: 10.1016/j.gene.2015.
    Abstract     Related articles   

  39. ZHOU XU, Qi L, Tong S, Cui YU, et al
    miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation.
    Oncol Lett. 2015;10:3183-3190.
    Abstract     Related articles   

  40. POYET C, Hermanns T, Zhong Q, Drescher E, et al
    Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.
    Oncol Lett. 2015;10:2753-2760.
    Abstract     Related articles   

  41. JIANG F, Ma S, Xue Y, Hou J, et al
    LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer.
    Biochem Biophys Res Commun. 2015 Dec 22. pii: S0006-291X(15)31083.
    Abstract     Related articles   

  42. WU P, Zhu G, Wei D, Liu S, et al
    Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis.
    J BUON. 2015;20:1229-38.
    Abstract     Related articles   

  43. GAJENDRA S, Sharma R, Sahoo MK
    Triple cancer: chronic lymphocytic leukemia with bladder and prostate carcinoma.
    Malays J Pathol. 2015;37:159-63.
    Abstract     Related articles   

  44. YANG M, Yu Q, Liu J, Fu W, et al
    T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
    J Surg Oncol. 2015;112:430-5.
    Abstract     Related articles   

  45. ALBA MA, Moreno-Palacios J, Beca S, Cid MC, et al
    Urologic and male genital manifestations of granulomatosis with polyangiitis.
    Autoimmun Rev. 2015;14:897-902.
    Abstract     Related articles   

  46. BAGCHI A, Dushaj K, Shrestha A, Leytin AL, et al
    Urinary bladder paraganglioma presenting as micturition-induced palpitations, dyspnea, and angina.
    Am J Case Rep. 2015;16:283-6.
    Abstract     Related articles   

  47. LEE JS, Kim HS, Jeong CW, Kwak C, et al
    The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
    Korean J Urol. 2015;56:295-304.
    Abstract     Related articles   

  48. GEORGIOS K, Evangelos B, Helai H, Ioannis G, et al
    Intravesical explosion during transurethral electrosurgery.
    Scott Med J. 2015;60:e25-6.
    Abstract     Related articles   

  49. WHITESIDE SA, Razvi H, Dave S, Reid G, et al
    The microbiome of the urinary tract--a role beyond infection.
    Nat Rev Urol. 2015;12:81-90.
    Abstract     Related articles   

  50. AHMADI N, Delprado WJ, Brooks AJ, Brenner PC, et al
    Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.
    ANZ J Surg. 2015;85:145-9.
    Abstract     Related articles   

  51. MARTINI T, Strobel P, Steidler A, Petrakopoulou N, et al
    [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].
    Urologe A. 2015;54:70-5.
    Abstract     Related articles   

  52. MARTINEZ-GIRON R, Martinez-Torre S, Mosquera-Martinez J
    Bladder aspergillosis detected by urine cytology.
    Diagn Cytopathol. 2015;43:403-6.
    Abstract     Related articles   

  53. BERRETTINI A, Castagnetti M, Salerno A, Nappo SG, et al
    Bladder urothelial neoplasms in pediatric age: experience at three tertiary centers.
    J Pediatr Urol. 2015;11:26.
    Abstract     Related articles   

  54. LIU B, Miyake H, Nishikawa M, Fujisawa M, et al
    Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Urol Oncol. 2015;33:110.
    Abstract     Related articles   

  55. NAMBIAR PR, Morton D, Dochterman LW, Houle C, et al
    Two-year carcinogenicity study in rats with a nonnucleoside reverse transcriptase inhibitor.
    Toxicol Pathol. 2015;43:354-65.
    Abstract     Related articles   


  56. Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
    Ann Acad Med Singapore. 2015;44:415-20.
    Abstract     Related articles   

  57. ROSENKRANTZ AB, Ego-Osuala IO, Khalef V, Deng FM, et al
    Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor After Transurethral Resection for Bladder Cancer.
    J Comput Assist Tomogr. 2016.
    Abstract     Related articles   

  58. AYARI C, Besancon M, Bergeron A, LaRue H, et al
    Poly(I:C) potentiates Bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Cancer Immunol Immunother. 2016.
    Abstract     Related articles   

  59. TOGNERI FS, Ward DG, Foster JM, Devall AJ, et al
    Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.
    Eur J Hum Genet. 2016 Jan 13. doi: 10.1038/ejhg.2015.
    Abstract     Related articles   

  60. SYED IS, Pedram A, Farhat WA
    Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis.
    Curr Urol Rep. 2016;17:11.
    Abstract     Related articles   

  61. DONAHUE TF, Cha EK, Bochner BH
    Rationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder Cancer.
    Curr Urol Rep. 2016;17:9.
    Abstract     Related articles   

  62. BYUN SJ, Kim JH, Oh YK, Kim BH, et al
    Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer.
    Radiat Oncol J. 2015;33:294-300.
    Abstract     Related articles   

  63. LI J, Wang L, Xiao R, Pan Q, et al
    High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  64. INOUE K, Matsuyama H, Fujimoto K, Hirao Y, et al
    The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
    Photodiagnosis Photodyn Ther. 2016 Jan 2. pii: S1572-1000(15)30062.
    Abstract     Related articles   

  65. LALOGLU E, Aksoy H, Aksoy YL, Ozkaya F, et al
    ANNALS EXPRESS: The Determination of Serum and Urinary Endocan Levels in Patients With Bladder Cancer.
    Ann Clin Biochem. 2016 Jan 8. pii: 0004563216629169.
    Abstract     Related articles   

  66. MUTO G, Collura D, Simone G, Muto GL, et al
    Stapled orthotopic ileal neobladder after radical cystectomy for bladder cancer: Functional results and complications over a 20-year period.
    Eur J Surg Oncol. 2015 Dec 2. pii: S0748-7983(15)00891.
    Abstract     Related articles   

  67. NIKAPOTA AD, Cresswell J, Appleyard S, Catt SL, et al
    Quality of Life after Bladder Cancer: A Prospective Study Comparing Patient-related Outcomes after Radical Surgery or Radical Radiotherapy for Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2015 Dec 30. pii: S0936-6555(15)00471.
    Abstract     Related articles   

  68. BLACK PC, Kassouf W
    Evolving concepts in muscle-invasive bladder cancer.
    World J Urol. 2016;34:1-2.
    Abstract     Related articles   

  69. LIU L, Liu Y, Zhang T, Wu H, et al
    Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
    J Exp Clin Cancer Res. 2016;35:3.
    Abstract     Related articles   

  70. ARIKAN O, Yyldyrym A, Ysbilen B, Canakci C, et al
    Clinical significance of serum and urinary HER2/neu protein levels in primary non-muscle invasive bladder cancer.
    Int Braz J Urol. 2015;41:1080-7.
    Abstract     Related articles   

  71. MATOUSKOVA M
    [Immunotherapy of Urothelial Carcinoma of the Bladder - from BCG Vaccines to Targeted Therapy].
    Klin Onkol. 2015;28 Suppl 4:4S95-102.
    Abstract     Related articles   

  72. SUKOSD F, Ivanyi B, Pajor L
    What can be more prognostic than the pTNM category assessed on radical cystectomy specimens?
    Virchows Arch. 2015;467:481-2.
    Abstract     Related articles   

  73. GAISA NT, Knuchel-Clarke R
    Response letter to "What can be more prognostic than the pTNM category assessed in radical cystectomy samples?" by Sukosd F, Ivanyi B and Pajor L.
    Virchows Arch. 2015;467:483-4.
    Abstract     Related articles   

  74. YU L, Wang Y, Shao S, Yang M, et al
    B7-H1/PD-1 blockade therapy in urological malignancies: current status and future prospects.
    Tumori. 2015;101:549-54.
    Abstract     Related articles   

  75. GALETTA D, Catino A, Misino A, De Ceglie A, et al
    Bladder and gastric metastases from lung adenocarcinoma harboring codon 13 KRAS mutation: a case report with unusual clinical outcome.
    Tumori. 2015;101:e138-40.
    Abstract     Related articles   

  76. KHORRAMDELAZAD H, Bagheri V, Hassanshahi G, Karami H, et al
    S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?
    Asian Pac J Cancer Prev. 2015;16:2725-9.
    Abstract     Related articles   

  77. SAPRE N, Hayes E, Bugeja P, Corcoran NM, et al
    Streamlining the assessment of haematuria: 3-year outcomes of a dedicated haematuria clinic.
    ANZ J Surg. 2015;85:334-8.
    Abstract     Related articles   

  78. ZENG LP, Hu ZM, Li K, Xia K, et al
    miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
    J Cell Mol Med. 2016 Jan 22. doi: 10.1111/jcmm.12760.
    Abstract     Related articles   

  79. ZHAN Y, Kapur N, Mir H, Singh N, et al
    Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Oncotarget. 2016 Jan 19. doi: 10.18632/oncotarget.6946.
    Abstract     Related articles   

  80. ZENG SX, Lu X, Xu WD, Zhang ZS, et al
    Segmental ureteroileal conduit resection for the treatment of distal upper urinary tract recurrence of bladder cancer following cystectomy.
    Chin J Cancer. 2016;35:15.
    Abstract     Related articles   

  81. DATTA NR, Eberle B, Puric E, Meister A, et al
    Is hyperthermia combined with radiotherapy adequate in elderly patients with muscle-invasive bladder cancers? Thermo-radiobiological implications from an audit of initial results.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  82. ABAIGAR-PEDRAZA I, Megias-Garrigos J, Sanchez-Paya J
    Quality-of-life survey for patients diagnosed with nonmuscle-invasive bladder cancer.
    Actas Urol Esp. 2016 Jan 12. pii: S0210-4806(15)00297.
    Abstract     Related articles   

  83. HAN E, Stein DM, Shi D, Miocinovic R, et al
    Concurrent Testicular and Bladder Cancer in a 57-year-old Man.
    Urol Case Rep. 2015;3:170-2.
    Abstract     Related articles   

  84. FACIO FN JR, Facio MF, Spessoto LC, Gatti M, et al
    Incidental Diagnosis of Bladder Cancer in a 17-year-old Patient.
    Urol Case Rep. 2015;3:96-7.
    Abstract     Related articles   

  85. IIDA K, Tomioka A, Maruyama Y, Otani T, et al
    [A Case of Muscle Invasive Bladder Cancer in a Patient with Systemic Lupus Erythematosus].
    Hinyokika Kiyo. 2015;61:499-503.
    Abstract     Related articles   

  86. ZHAO MJ, Song YF, Niu HT, Tian YX, et al
    Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.
    Oncotarget. 2016 Jan 13. doi: 10.18632/oncotarget.6909.
    Abstract     Related articles   

  87. NAM EY, Na SH, Kim SY, Yoon D, et al
    Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer.
    Infect Chemother. 2015;47:256-60.
    Abstract     Related articles   

  88. HARROP E, Kelly J, Griffiths G, Casbard A, et al
    Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy).
    Trials. 2016;17:35.
    Abstract     Related articles   

  89. DU C, Gao Y, Xu S, Jia J, et al
    KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.
    FEBS Lett. 2016 Jan 20. doi: 10.1002/1873-3468.12069.
    Abstract     Related articles   

  90. SAGER CC, Benamran DA, Wirth G, Iselin CE, et al
    [New approaches for the treatment of superficial bladder cancer].
    Rev Med Suisse. 2015;11:2281-4.
    Abstract     Related articles   

  91. SARDARI A, Thomas JV, Nix JW, Pietryga JA, et al
    Incidental Bladder Cancer Detected on Multiparametric Magnetic Resonance Imaging of the Prostate Gland.
    Case Rep Urol. 2015;2015:503154.
    Abstract     Related articles   

  92. SUN DK, Wang L, Wang JM, Zhang P, et al
    Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
    Genet Mol Res. 2015;14:18181-7.
    Abstract     Related articles   

  93. YANG DL, Xin MM, Wang JS, Xu HY, et al
    Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
    Genet Mol Res. 2015;14:17699-707.
    Abstract     Related articles   

  94. BERTZ S, Hartmann A, Knuchel-Clarke R, Gaisa NT, et al
    [Specific types of bladder cancer].
    Pathologe. 2016.
    Abstract     Related articles   

  95. SCHLACK K, Boegemann M, Steinestel J, Schrader AJ, et al
    The safety and efficacy of gemcitabine for the treatment of bladder cancer.
    Expert Rev Anticancer Ther. 2016.
    Abstract     Related articles   

  96. LU S, Xu L, Kang ET, Mahendran R, et al
    Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of Non-muscle-invasive bladder cancer.
    Eur J Pharm Sci. 2016 Jan 15. pii: S0928-0987(16)30014.
    Abstract     Related articles   

  97. WIRTZ RM, Fritz V, Stohr R, Hartmann A, et al
    [Molecular classification of bladder cancer : Possible similarities to breast cancer].
    Pathologe. 2016.
    Abstract     Related articles   

  98. CHUANG CH, Du YC, Wu TF, Chen CH, et al
    Immunosensor for the ultrasensitive and quantitative detection of bladder cancer in point of care testing.
    Biosens Bioelectron. 2015 Dec 30. pii: S0956-5663(15)30752.
    Abstract     Related articles   

  99. STEINBERG RL, Thomas LJ, Nepple KG
    Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guerin.
    Urol Oncol. 2016 Jan 14. pii: S1078-1439(15)00582.
    Abstract     Related articles   

  100. SUN X, Deng QF, Liang ZF, Zhang ZQ, et al
    Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells.
    Exp Toxicol Pathol. 2016 Jan 5. pii: S0940-2993(15)30037.
    Abstract     Related articles   

  101. MUKHERJI D, Jabbour MN, Saroufim M, Temraz S, et al
    Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?
    Clin Genitourin Cancer. 2015 Dec 17. pii: S1558-7673(15)00332.
    Abstract     Related articles   

  102. LEE MH, Thomas JL, Chang YC, Tsai YS, et al
    Electrochemical sensing of nuclear matrix protein 22 in urine with molecularly imprinted poly(ethylene-co-vinyl alcohol) coated zinc oxide nanorod arrays for clinical studies of bladder cancer diagnosis.
    Biosens Bioelectron. 2016;79:789-795.
    Abstract     Related articles   

  103. ZHOU J, Dai W, Song J
    miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT.
    Biochem Biophys Res Commun. 2016 Jan 6. pii: S0006-291X(16)30014.
    Abstract     Related articles   

  104. ZHANG L, Guo X, Min Y, Xu J, et al
    Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer.
    Int J Clin Exp Med. 2015;8:18528-32.
    Abstract     Related articles   

  105. SAKANO S, Inamoto T, Inoue R, Matsumoto H, et al
    Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
    Jpn J Clin Oncol. 2015;45:968-72.
    Abstract     Related articles   

  106. LEES AN
    Cutaneous metastasis of transitional cell carcinoma of the urinary bladder eight years after the primary: a case report.
    J Med Case Rep. 2015;9:102.
    Abstract     Related articles   

  107. MAO YQ, Zhu SX, Zhang W
    The iatrogenic injury of double vena cava due to misdiagnosis during the radical nephroureterectomy and cystectomy.
    World J Surg Oncol. 2015;13:41.
    Abstract     Related articles   

  108. LI X, Zhang TW, Tang JL, Fa PP, et al
    Loss of STAG2 causes aneuploidy in normal human bladder cells.
    Genet Mol Res. 2015;14:2638-46.
    Abstract     Related articles   

  109. COCHETTI G, Barillaro F, Boni A, Mearini E, et al
    Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer.
    Biomed Res Int. 2015;2015:154392.
    Abstract     Related articles   

  110. YANG H, Guo Y, Wang Z, Wang Z, et al
    [Value of detection of preoperative urinary soluble Fas expression in predicting the recurrence of non-muscle invasive bladder cancer].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41:24-9.
    Abstract     Related articles   

  111. YOSHIDA T, Kinoshita H, Yoshida K, Mishima T, et al
    Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Tumour Biol. 2016.
    Abstract     Related articles   

  112. GALOT R, Christian N, Bitar M, Seront E, et al
    Unusual presentation of bladder cancer resurgence and efficacy of radiotherapy.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  113. CUI J, Wang W, Chen S, Chen P, et al
    Combination of Intravesical Chemotherapy and Bacillus Calmette-Guerin Versus Bacillus Calmette-Guerin Monotherapy in Intermediate- and High-risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Medicine (Baltimore). 2016;95:e2572.
    Abstract     Related articles   

  114. YAMAMOTO K, Yamamoto K, Nakai G, Azuma H, et al
    Novel Software-Assisted Hemodynamic Evaluation of Pelvic Flow During Chemoperfusion of Pelvic Arteries for Bladder Cancer: Double- Versus Single-Balloon Technique.
    Cardiovasc Intervent Radiol. 2016.
    Abstract     Related articles   

  115. JAYARATNA IS, Navai N, Dinney CP
    Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer.
    Transl Androl Urol. 2015;4:273-82.
    Abstract     Related articles   

  116. MA T, Wang W, Jiang Z, Shao G, et al
    [Narrow band imaging-assisted holmium laser resection reduced the recurrence rate of non-muscle invasive bladder cancer: a prospective, randomized controlled study].
    Zhonghua Yi Xue Za Zhi. 2015;95:3032-5.
    Abstract     Related articles   

  117. SIDAWAY P
    Bladder Cancer: Novel chemotherapy triplet for advanced UC.
    Nat Rev Urol. 2016 Jan 27. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  118. TRENTA P, Calabro F, Cerbone L, Sternberg CN, et al
    Chemotherapy for Muscle-Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2016;17:6.
    Abstract     Related articles   

  119. WHYARD T, Waltzer WC, Waltzer D, Romanov V, et al
    Metabolic alterations in bladder cancer: applications for cancer imaging.
    Exp Cell Res. 2016 Jan 22. pii: S0014-4827(16)30005.
    Abstract     Related articles   

  120. LERNER SP, Dinney C, Kamat A, Bivalacqua TJ, et al
    Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG.
    Bl Cancer. 2015;1:29-30.
    Abstract     Related articles   

  121. YAN J, Shen P, Zheng J, Liu M, et al
    Clinical correlation between serum YKL-40 protein level and recurrence of non-muscle invasive bladder cancer.
    Ann Transl Med. 2015;3:354.
    Abstract     Related articles   

  122. LONG JD, Sullivan TB, Humphrey J, Logvinenko T, et al
    A non-invasive miRNA based assay to detect bladder cancer in cell-free urine.
    Am J Transl Res. 2015;7:2500-9.
    Abstract     Related articles   

  123. ZHAO X, He W, Li J, Huang S, et al
    MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
    Am J Transl Res. 2015;7:2346-54.
    Abstract     Related articles   

  124. WU CT, Chen WC, Chang YH, Lin WY, et al
    The role of PD-L1 in the radiation response and clinical outcome for bladder cancer.
    Sci Rep. 2016;6:19740.
    Abstract     Related articles   

  125. TAO S, Long Z, Zhang XJ, Chen SS, et al
    Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis.
    Int J Surg. 2016 Jan 20. pii: S1743-9191(16)00053.
    Abstract     Related articles   

  126. PENG M, Su Q, Zeng Q, Li L, et al
    High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.
    Oncotarget. 2016 Jan 18. doi: 10.18632/oncotarget.6933.
    Abstract     Related articles   

  127. CAI Y, Li HZ, Zhang YS
    Successful Treatment of Coexisting Paraganglioma of the Retroperitoneum and Urinary Bladder by Intermediate-Dose 131I-MIBG Therapy: A Case Report.
    Medicine (Baltimore). 2015;94:e1686.
    Abstract     Related articles   

  128. SAMPSON JN, Wheeler WA, Yeager M, Panagiotou O, et al
    Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
    J Natl Cancer Inst. 2015;107:djv279.
    Abstract     Related articles   

  129. GIUBELLINO A, Lara K, Martucci V, Huynh T, et al
    Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.
    Am J Surg Pathol. 2015;39:1488-92.
    Abstract     Related articles   

  130. HUANG HN, Rajanbabu V, Pan CY, Chan YL, et al
    Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice.
    Mar Drugs. 2015;13:3241-58.
    Abstract     Related articles   

  131. DOZIER J, Jameel Z, McCain DA, Hassoun P, et al
    Massive malignant solitary fibrous tumor arising from the bladder serosa: a case report.
    J Med Case Rep. 2015;9:46.
    Abstract     Related articles   

  132. ZHANG T, Fan X, Song L, Ren L, et al
    c-Fos is involved in inhibition of human bladder carcinoma T24 cells by brazilin.
    IUBMB Life. 2015;67:175-81.
    Abstract     Related articles   

  133. MURALIDARAN C, Dey P, Nijhawan R, Kakkar N, et al
    Artificial neural network in diagnosis of urothelial cell carcinoma in urine cytology.
    Diagn Cytopathol. 2015;43:443-9.
    Abstract     Related articles   

  134. SOUBRA A, Zabell JR, Adejoro O, Konety BR, et al
    Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Clin Genitourin Cancer. 2015;13:e173-81.
    Abstract     Related articles   

  135. ROUANNE M, Perreaud A, Letang N, Yonneau L, et al
    Trends in renal function after radical cystectomy and ileal conduit diversion: new insights regarding estimated glomerular filtration rate variations.
    Clin Genitourin Cancer. 2015;13:e139-44.
    Abstract     Related articles   

  136. BEN FRADJ MK, Gargouri MM, Hammami MB, Ben Rhouma S, et al
    Bladder cancer is associated with low plasma 25-hydroxyvitamin D concentrations in Tunisian population.
    Nutr Cancer. 2016.
    Abstract     Related articles   

  137. SOUBRA A, Hayward D, Dahm P, Goldfarb R, et al
    The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
    World J Urol. 2016.
    Abstract     Related articles   

  138. XU X, Zhu Y, Liang Z, Li S, et al
    c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3beta/Snail signaling.
    Cell Death Dis. 2016;7:e2088.
    Abstract     Related articles   

  139. DI LORENZO G, Pagliuca M, Perillo T, Zarrella A, et al
    Complete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case Report.
    Medicine (Baltimore). 2016;95:e2598.
    Abstract     Related articles   

  140. BOGOEVA V, Siksjo M, Saeterbo KG, Melo TB, et al
    Ruthenium porphyrin-induced photodamage in bladder cancer cells.
    Photodiagnosis Photodyn Ther. 2016 Feb 1. pii: S1572-1000(16)30012.
    Abstract     Related articles   

  141. MASSARI F, Ciccarese C, Vau N, Santoni M, et al
    EMERGING IMMUNOTARGETS IN BLADDER CANCER.
    Curr Drug Targets. 2016.
    Abstract     Related articles   

  142. CHEN NC, Chyau CC, Lee YJ, Tseng HC, et al
    Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells.
    Sci Rep. 2016;6:20417.
    Abstract     Related articles   

  143. MAHDAVIFAR N, Ghoncheh M, Pakzad R, Momenimovahed Z, et al
    Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World.
    Asian Pac J Cancer Prev. 2016;17:381-6.
    Abstract     Related articles   

  144. OZER K, Horsanali MO, Gorgel SN, Ozbek E, et al
    Diabetes is an Important Risk Factor for Metastasis in Non- Muscle-Invasive Bladder Cancer.
    Asian Pac J Cancer Prev. 2016;17:105-8.
    Abstract     Related articles   

  145. QIAO Y, Zhu X, Li A, Yang S, et al
    Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  146. EGAWA H, Jingushi K, Hirono T, Ueda Y, et al
    The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.
    Sci Rep. 2016;6:20574.
    Abstract     Related articles   

  147. LU CC, Shen CH, Chang CB, Hsieh HY, et al
    Guizhi Fuling Wan as a novel agent for intravesical treatment for bladder cancer in mouse model.
    Mol Med. 2016 Jan 13. doi: 10.2119/molmed.2015.00085.
    Abstract     Related articles   

  148. SANKIEWICZ A, Guszcz T, Mena-Hortelano R, Zukowski K, et al
    Podoplanin serum and urine concentration in transitional bladder cancer.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  149. SWALLOW TW, Mabbutt S, Bell CR
    Muscle invasive bladder cancer culminating with leptomeningeal carcinomatosis.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  150. PACKIAM VT, Pearce SM, Steinberg GD
    The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guerin failures for non-muscle-invasive bladder cancer.
    Ther Adv Urol. 2016;8:29-37.
    Abstract     Related articles   

  151. HASHINE K, Ide T, Nakashima T, Hosokawa T, et al
    Results of second transurethral resection for high-grade T1 bladder cancer.
    Urol Ann. 2016;8:10-5.
    Abstract     Related articles   

  152. FENNER A
    Bladder cancer: To be or NOTCH2 be?
    Nat Rev Urol. 2016 Feb 2. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  153. SHIMIZU Y, Furuya H, Bryant Greenwood P, Chan O, et al
    A multiplex immunoassay for the non-invasive detection of bladder cancer.
    J Transl Med. 2016;14:31.
    Abstract     Related articles   

  154. PARODI A, Traverso P, Kalli F, Conteduca G, et al
    Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.
    Oncotarget. 2016 Jan 25. doi: 10.18632/oncotarget.7024.
    Abstract     Related articles   

  155. MU DW, Guo HQ, Zhou GB, Li JY, et al
    Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.
    Int J Clin Exp Pathol. 2015;8:13864-70.
    Abstract     Related articles   

  156. ZHAO Y, Chen C, Pan W, Gao M, et al
    Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis.
    Nutrition. 2015 Dec 19. pii: S0899-9007(15)00475.
    Abstract     Related articles   

  157. CARVALHO DR
    Improving Access to Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer in a Community Hospital.
    Urol Nurs. 2015;35:287-91.
    Abstract     Related articles   

  158. BUCKLE SANDY
    Use in paediatric care.
    Br J Nurs. 2015;24.
    Abstract     Related articles   

  159. YE HY, Xu QQ, Huang XB, Ma K, et al
    [Tuberculous prostatic abscess following intravesical bacillus Calmette-Guerin immunotherapy: a case report].
    Beijing Da Xue Xue Bao. 2015;47:1039-41.
    Abstract     Related articles   

  160. GAO L, Fan Y, Zhang ZL
    [Clinical analysis of 31 ankylosing spondylitis patients with malignancies].
    Beijing Da Xue Xue Bao. 2015;47:962-5.
    Abstract     Related articles   

  161. SAJJAN RS, Gavra M, Agrawal K, Syed R, et al
    68Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  162. ERIKSSON P, Aine M, Veerla S, Liedberg F, et al
    Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
    BMC Med Genomics. 2015;8:25.
    Abstract     Related articles   

  163. HEUBACH J, Monsior J, Deenen R, Niegisch G, et al
    The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.
    Mol Cancer. 2015;14:108.
    Abstract     Related articles   

  164. ROWBOTTOM L, Stinson J, McDonald R, Emmenegger U, et al
    Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.
    Ann Palliat Med. 2015;4:70-7.
    Abstract     Related articles   

  165. LILLEY EJ, Bader AM, Cooper Z
    A values-based conceptual framework for surgical appropriateness: an illustrative case report.
    Ann Palliat Med. 2015;4:54-7.
    Abstract     Related articles   

  166. CAKIR A, Akgun Z, Fayda M, Agaoglu F, et al
    Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.
    Asian Pac J Cancer Prev. 2015;16:3365-70.
    Abstract     Related articles   

  167. MAXWELL JP, Wang C, Wiebe N, Yilmaz A, et al
    Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
    Diagn Pathol. 2015;10:3.
    Abstract     Related articles   

  168. DAVIS FM, Miller DJ, Newton D, Arya S, et al
    Successful treatment of a mycotic multifocal thoracoabdominal aortic aneurysm as a late sequelae of intravesical bacillus Calmette-Guerin therapy: case report and literature review.
    Ann Vasc Surg. 2015;29:840.
    Abstract     Related articles   

  169. LIEBERMAN P
    Anaphylaxis after cystoscopy.
    J Allergy Clin Immunol Pract. 2015;3:469-70.
    Abstract     Related articles   

  170. BAI Y, Wang X, Li X, Pu C, et al
    Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery.
    J Endourol. 2015;29:640-9.
    Abstract     Related articles   

  171. DEDEUGD C, Miyake M, Palacios DA, Rosser CJ, et al
    The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.
    J Racial Ethn Health Disparities. 2015;2:124-31.
    Abstract     Related articles   

  172. JOZWICKI W, Brozyna AA, Siekiera J, Slominski AT, et al
    Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.
    Oncotarget. 2016 Feb 5. doi: 10.18632/oncotarget.7199.
    Abstract     Related articles   

  173. BLANCA A, Requena MJ, Alvarez J, Cheng L, et al
    FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
    Biomark Med. 2016.
    Abstract     Related articles   

  174. SMITH SG, Zaharoff DA
    Future directions in bladder cancer immunotherapy: towards adaptive immunity.
    Immunotherapy. 2016.
    Abstract     Related articles   

  175. FIGUEROA JD, Prokunina-Olsson L, Koutros S, Garcia-Closas M, et al
    Response.
    J Natl Cancer Inst. 2016;108.
    Abstract     Related articles   

  176. SELINSKI S, Krech E, Ovsiannikov D, Blaszkewicz M, et al
    RE: Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
    J Natl Cancer Inst. 2016;108.
    Abstract     Related articles   

  177. FENNER A
    Bladder cancer: Could chemohyperthermia finally set the NMIBC world on fire?
    Nat Rev Urol. 2016 Feb 9. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  178. DI MATTINA AJ, Fazelat A, Santaro A
    Exudative Retinal Detachment Reveals Metastatic Bladder Cancer.
    Optom Vis Sci. 2016.
    Abstract     Related articles   

  179. ANTONOVA O, Toncheva D, Grigorov E
    Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes.
    J BUON. 2015;20:1397-406.
    Abstract     Related articles   

  180. MOSCHINI M, Bianchi M, Rossi MS, DellOglio P, et al
    Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
    Urol Oncol. 2016 Feb 2. pii: S1078-1439(15)00612.
    Abstract     Related articles   

  181. WEINGARTEN TN, Taccolini AM, Ahle ST, Dietz KR, et al
    Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study.
    Can J Anaesth. 2016.
    Abstract     Related articles   

  182. ZHANG XK, Zhang ZL, Yang P, Cai MY, et al
    Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Jpn J Clin Oncol. 2015;45:1069-75.
    Abstract     Related articles   

  183. LOJANAPIWAT B
    Urologic cancer in Thailand.
    Jpn J Clin Oncol. 2015;45:1007-15.
    Abstract     Related articles   

  184. CASTILLO OA, Vidal-Mora I, Rodriguez-Carlin A, Silva A, et al
    First Report: Robot-Assisted Total Pelvic Exenteration for Locally Advanced Prostate Cancer.
    J Laparoendosc Adv Surg Tech A. 2015;25:592-4.
    Abstract     Related articles   

  185. KNAPP DW, Dhawan D, Ostrander E
    "Lassie," "Toto," and fellow pet dogs: poised to lead the way for advances in cancer prevention.
    Am Soc Clin Oncol Educ Book. 2015:e667-72. doi: 10.14694/EdBook_AM.2015.
    Abstract     Related articles   

  186. YANG C, Zhou Y, Zhang L, Jin C, et al
    Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Int J Clin Exp Pathol. 2015;8:1768-75.
    Abstract     Related articles   

  187. SAG D, Cekic C, Wu R, Linden J, et al
    The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity.
    Nat Commun. 2015;6:6354.
    Abstract     Related articles   

  188. GAYED BA, Bagrodia A, Gaitonde M, Krabbe LM, et al
    Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary results.
    Urol Oncol. 2015;33:18.
    Abstract     Related articles   

  189. SOSNOWSKI R, Przewozniak K
    The role of the urologist in smoking cessation: why is it important?
    Urol Oncol. 2015;33:30-9.
    Abstract     Related articles   

  190. RICE KR, Koch MO, Kao CS, Pedrosa JA, et al
    Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology.
    Urol Oncol. 2015;33:20.
    Abstract     Related articles   

  191. ZHANG P, Wang X
    Suppression of SIPA-1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E-cadherin and ZO-1.
    Exp Ther Med. 2016;11:213-217.
    Abstract     Related articles   

  192. WANG X, Chen E, Tang M, Yang X, et al
    The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.
    Tumour Biol. 2016.
    Abstract     Related articles   

  193. STEWART-MERRILL SB, Alahdab F, Benkhadra K, Wang Z, et al
    Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis.
    Urol Oncol. 2016 Feb 9. pii: S1078-1439(15)00577.
    Abstract     Related articles   

  194. IZUMI K, Ito Y, Miyamoto H, Miyoshi Y, et al
    Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
    Oncotarget. 2016 Feb 12. doi: 10.18632/oncotarget.7358.
    Abstract     Related articles   

  195. QI D, Li J, Jiang M, Liu C, et al
    The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis.
    Int J Clin Exp Med. 2015;8:20701-11.
    Abstract     Related articles   

  196. TANG J, Li X, Jiang X, Xu W, et al
    The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.
    Int J Clin Exp Med. 2015;8:20236-44.
    Abstract     Related articles   

  197. SASIKUMAR S, Wijayarathna KS, Karunaratne KA, Gobi U, et al
    Pathological Characteristics of Primary Bladder Carcinoma Treated at a Tertiary Care Hospital and Changing Demographics of Bladder Cancer in Sri Lanka.
    Adv Urol. 2016;2016:5751647.
    Abstract     Related articles   

  198. SUGIYAMA K, Sugawara Y, Tomata Y, Nishino Y, et al
    The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi Cohort Study and Ohsaki Cohort Study.
    Eur J Cancer Prev. 2016.
    Abstract     Related articles   

  199. DEMIRCI U, Dizdar O, Cetindag MF, Altinova S, et al
    Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle invasive bladder cancer.
    J Cancer Res Ther. 2015;11:704-7.
    Abstract     Related articles   

  200. KIM HS, Ku JH
    Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer.
    Dis Markers. 2016;2016:8345286.
    Abstract     Related articles   

  201. BARDOLI AD, Afshar M, Viney R, Foster M, et al
    The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target.
    Future Oncol. 2016.
    Abstract     Related articles   

  202. KELSEY R
    Bladder cancer: Urinary microRNA profiling for predicting UCB recurrence.
    Nat Rev Urol. 2016 Feb 16. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  203. SOLOWAY MS
    Bladder cancer: Active surveillance for low-grade Ta bladder tumours.
    Nat Rev Urol. 2016 Feb 16. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  204. GIUNCHI F, Panzacchi R, Capizzi E, Schiavina R, et al
    Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer.
    Clin Genitourin Cancer. 2016 Jan 22. pii: S1558-7673(16)30002.
    Abstract     Related articles   

  205. HAN E, Jang SY, Kim G, Lee YH, et al
    Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.
    Medicine (Baltimore). 2016;95:e2786.
    Abstract     Related articles   

  206. BAKRY R, El-Sayed MI, Hamza HM, Hassan KH, et al
    Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients.
    Oncol Lett. 2016;11:823-830.
    Abstract     Related articles   

  207. LIU N, Fei X, Shen Y, Shi W, et al
    Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis.
    Onco Targets Ther. 2016;9:579-86.
    Abstract     Related articles   

  208. MORALES A, Cohen Z
    Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin.
    Expert Opin Biol Ther. 2016;16:273-83.
    Abstract     Related articles   

  209. YU DS, Wu CL, Ping SY, Keng C, et al
    Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Kaohsiung J Med Sci. 2015;31:391-7.
    Abstract     Related articles   

  210. HSU JS, Lin CC, Chen YT, Lee YC, et al
    Primary mucosa-associated lymphoid tissue lymphoma of the urinary bladder.
    Kaohsiung J Med Sci. 2015;31:388-9.
    Abstract     Related articles   

  211. DE LUCA AC, Dholakia K, Mazilu M
    Modulated Raman Spectroscopy for Enhanced Cancer Diagnosis at the Cellular Level.
    Sensors (Basel). 2015;15:13680-704.
    Abstract     Related articles   

  212. COTA JB, Peleteiro MC, Petti L, Tavares L, et al
    Detection and quantification of bovine papillomavirus type 2 in urinary bladders and lymph nodes in cases of Bovine Enzootic Hematuria from the endemic region of Azores.
    Vet Microbiol. 2015;178.
    Abstract     Related articles   

  213. BRANCATO SJ, Lewi K, Agarwal PK
    Evolving immunotherapy strategies in urothelial cancer.
    Am Soc Clin Oncol Educ Book. 2015:e284-90. doi: 10.14694/EdBook_AM.2015.
    Abstract     Related articles   

  214. LIU J, Zhang WY, Ding DG
    Expression of aquaporin 1 in bladder uroepithelial cell carcinoma and its relevance to recurrence.
    Asian Pac J Cancer Prev. 2015;16:3973-6.
    Abstract     Related articles   

  215. DIORIO GJ, Canter DJ
    Adjunctive use of narrow band imaging during transurethral resection/vaporization of bladder tumors to aid In identifying mucosal and sub-mucosal hypervascularity.
    Can J Urol. 2015;22:7763-6.
    Abstract     Related articles   

  216. NORBERG SM, Oros M, Manucha V, Eun D, et al
    Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasis.
    Can J Urol. 2015;22:7755-7.
    Abstract     Related articles   

  217. PEDERSEN SB, Nielsen JC, Botker HE, Farkas DK, et al
    Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.
    Europace. 2015;17:902-8.
    Abstract     Related articles   

  218. MARTIN-FUENTES A, Sanchez-Herreros C, Cuevas-Santos J, De Eusebio-Murillo E, et al
    Extramammary Paget disease secondary to a transitional cell carcinoma of the bladder.
    Indian J Dermatol Venereol Leprol. 2015;81:318-20.
    Abstract     Related articles   


  219. SIU newsletter - March 2015.
    World J Urol. 2015;33:445-56.
    Abstract     Related articles   

  220. GANDRUP KL, Logager VB, Bretlau T, Nordling J, et al
    Diagnosis of bladder tumours in patients with macroscopic haematuria: a prospective comparison of split-bolus computed tomography urography, magnetic resonance urography and flexible cystoscopy.
    Scand J Urol. 2015;49:224-9.
    Abstract     Related articles   

  221. ZHANG A, Shang D, Zhang J, Zhang L, et al
    A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.
    World J Urol. 2015;33:713-7.
    Abstract     Related articles   

  222. HORN T, Schmid SC, Seitz AK, Grab J, et al
    Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent.
    World J Urol. 2015;33:813-9.
    Abstract     Related articles   

  223. REIS LO, Ferrari K, Zamuner M, Rocha GZ, et al
    Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model.
    World J Urol. 2015;33:413-9.
    Abstract     Related articles   

  224. KIM HS, Moon KC, Jeong CW, Kwak C, et al
    The clinical significance of intra-operative ureteral frozen section analysis at radical cystectomy for urothelial carcinoma of the bladder.
    World J Urol. 2015;33:359-65.
    Abstract     Related articles   

  225. MAY M, Aziz A, Brookman-May S, Roghmann F, et al
    Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
    World J Urol. 2015;33:343-50.
    Abstract     Related articles   

  226. AL-AHMADIE HA, Iyer G, Lee BH, Scott SN, et al
    Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
    Nat Genet. 2016 Feb 22. doi: 10.1038/ng.3503.
    Abstract     Related articles   

  227. NOWAK-SADZIKOWSKA J, Skora T, Szyszka-Charewicz B, Jakubowicz J, et al
    Muscle-invasive bladder cancer treated with TURB followed by concomitant boost with small reduction of radiotherapy field with or without of chemotherapy.
    Rep Pract Oncol Radiother. 2016;21:31-6.
    Abstract     Related articles   

  228. CHAPPIDI MR, Kates M, Patel HD, Tosoian JJ, et al
    Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2016 Feb 15. pii: S1078-1439(15)00606.
    Abstract     Related articles   

  229. KEKEEVA T, Tanas A, Kanygina A, Alexeev D, et al
    Novel fusion transcripts in bladder cancer identified by RNA-seq.
    Cancer Lett. 2016 Feb 16. pii: S0304-3835(16)30064.
    Abstract     Related articles   

  230. HO ME, Quek SI, True LD, Seiler R, et al
    Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2.
    Oncotarget. 2016 Feb 15. doi: 10.18632/oncotarget.7400.
    Abstract     Related articles   

  231. MACKENZIE TA, Zaha R, Smith J, Karagas MR, et al
    Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study.
    Diabetes Ther. 2016.
    Abstract     Related articles   

  232. LIU Z, Tian Q, Xia S, Yin H, et al
    Evaluation of the improved tubeless cutaneous ureterostomy technique following radical cystectomy in cases of invasive bladder cancer complicated by peritoneal metastasis.
    Oncol Lett. 2016;11:1401-1405.
    Abstract     Related articles   

  233. ZHOU Q, Chang H, Yang L, Zhang J, et al
    Arteriovenous Malformation Masquerading as a Bladder Tumor. A Case Report.
    Anal Quant Cytopathol Histpathol. 2015;37:322-5.
    Abstract     Related articles   

  234. LIU Q, Shin Y, Kee JS, Kim KW, et al
    Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimens.
    Biosens Bioelectron. 2015;71:365-72.
    Abstract     Related articles   

  235. KITCHEN MO, Bryan RT, Emes RD, Glossop JR, et al
    Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
    Epigenetics. 2016.
    Abstract     Related articles   

  236. MOSCHINI M, Karnes RJ, Sharma V, Gandaglia G, et al
    Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
    Eur J Surg Oncol. 2016 Feb 18. pii: S0748-7983(16)00105.
    Abstract     Related articles   

  237. KOZAKOWSKA M, Dobrowolska-Glazar B, Okon K, Jozkowicz A, et al
    Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder Cancer.
    J Clin Med. 2016;5.
    Abstract     Related articles   

  238. JOZWICKI W, Brozyna AA, Siekiera J, Slominski AT, et al
    Changes in Immunogenicity during the Development of Urinary Bladder Cancer: A Preliminary Study.
    Int J Mol Sci. 2016;17.
    Abstract     Related articles   

  239. NAGATA M, Muto S, Horie S
    Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.
    Dis Markers. 2016;2016:8205836.
    Abstract     Related articles   

  240. FRIEDLANDER E, Martinez Pascual P, Montilla de Mora P, Scola Yurrita B, et al
    Bilateral parotid glands infection caused by Calmette-Guerin Bacillus after intravesical therapy for recurrent bladder cancer: a case report.
    Braz J Otorhinolaryngol. 2016 Feb 6. pii: S1808-8694(16)00008.
    Abstract     Related articles   

  241. COLLAZO-LORDUY A, Galsky MD
    Systemic therapy for metastatic bladder cancer in 2016 and beyond.
    Future Oncol. 2016.
    Abstract     Related articles   

  242. BANSAL N, Gupta AK, Gupta A, Sankhwar SN, et al
    Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation.
    J Pharm Biomed Anal. 2016;124:22-25.
    Abstract     Related articles   

  243. LIU Z, Yokoyama NN, Blair CA, Li X, et al
    High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with approximately 240-Fold Higher Drug Concentration in Urine than Serum.
    Mol Cancer Ther. 2016.
    Abstract     Related articles   

  244. VANDEVEER AJ, Fallon JK, Tighe R, Sabzevari H, et al
    Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.
    Cancer Immunol Res. 2016 Feb 26. pii: canimm.0176.2015.
    Abstract     Related articles   

  245. CARRASCO HERNANDEZ L, Castano Nunez AL, Rodriguez Portal JA
    Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer.
    Arch Bronconeumol. 2016 Feb 23. pii: S0300-2896(16)00035.
    Abstract     Related articles   

  246. IIDA K, Naiki T, Kawai N, Etani T, et al
    Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.
    BMC Urol. 2016;16:8.
    Abstract     Related articles   

  247. AMIRA AT, Mejri S, Belhaj R, Karkni W, et al
    Prognostic Value of Immunohistochemical Expression Profile of Epidermal Growth Factor Receptor in Urothelial Bladder Cancer.
    J Immunoassay Immunochem. 2016.
    Abstract     Related articles   

  248. MOTAWI TK, Rizk SM, Ibrahim TM, Ibrahim IA, et al
    Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
    Cell Biochem Funct. 2016 Feb 24. doi: 10.1002/cbf.3171.
    Abstract     Related articles   

  249. SOUSA A, Pineiro I, Rodriguez S, Aparici V, et al
    Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  250. DE GROOTE R, Gandaglia G, Geurts N, Goossens M, et al
    Robot-assisted Radical Cystectomy for Bladder Cancer in Octogenarians.
    J Endourol. 2016.
    Abstract     Related articles   

  251. TODENHOFER T, Hennenlotter J, Dorner N, Kuhs U, et al
    Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    J Cancer Res Clin Oncol. 2016.
    Abstract     Related articles   

  252. CZERNIAK B, Dinney C, McConkey D
    Origins of Bladder Cancer.
    Annu Rev Pathol. 2016.
    Abstract     Related articles   

  253. BELL MD, Yafi FA, Brimo F, Steinberg J, et al
    Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.
    World J Urol. 2016.
    Abstract     Related articles   

  254. VAN VALENBERG H, Colombo R, Witjes F
    Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  255. CHEN M, Ye Y, Zou B, Guo S, et al
    C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.
    J Transl Med. 2016;14:55.
    Abstract     Related articles   

  256. ZHANG KX, Matsui Y, Lee C, Osamu O, et al
    Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs.
    Gene Ther. 2016 Feb 23. doi: 10.1038/gt.2016.
    Abstract     Related articles   

  257. GOYAL NK, Goel A, Singh V, Sankhwar SN, et al
    Bladder cancer presenting with spontaneous subcapsular urinoma of kidney.
    Indian J Cancer. 2015;52:473-4.
    Abstract     Related articles   

  258. MARTOV AG, Solomatnikov IA, Baykov NA, Andronov AS, et al
    [NARROWED SPECTRUM DIAGNOSTICS AND COMPUTER CHROMOENDOSCOPY IN THE DIAGNOSIS OF EPITHELIAL NEOPLASMS OF THE LOWER AND UPPER URINARY TRACT].
    Urologiia. 2015;:55-9.
    Abstract     Related articles   

  259. PAVLOV VN, Pushkarev AM, Kondratenko YV, Safiullin RI, et al
    [MARKERS OF KIDNEY DAMAGE AND NEPHROPROTECTIVE THERAPY IN RADICAL CYSTECTOMY].
    Urologiia. 2015;:27-30.
    Abstract     Related articles   

  260. ROY P, Lee JK, Sheikh A, Lin W, et al
    Quantitative Comparison of Misregistration in Abdominal and Pelvic Organs Between PET/MRI and PET/CT: Effect of Mode of Acquisition and Type of Sequence on Different Organs.
    AJR Am J Roentgenol. 2015;205:1295-305.
    Abstract     Related articles   

  261. MCCROSKEY Z, Pambuccian SE, Kleitherms S, Antic T, et al
    Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens.
    Am J Clin Pathol. 2015;144:902-8.
    Abstract     Related articles   

  262. YEE CH, Ng CF
    Urological malignancy in Hong Kong: the trend and the practice.
    Jpn J Clin Oncol. 2015;45:1103-6.
    Abstract     Related articles   

  263. WU P, Liu S, Zhang W, Zhang Y, et al
    Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Jpn J Clin Oncol. 2015;45:1175-81.
    Abstract     Related articles   

  264. TIAN W, Epstein JI
    Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases.
    Hum Pathol. 2015;46:1836-41.
    Abstract     Related articles   

  265. DHILLON J, Liang Y, Kamat AM, Siefker-Radtke A, et al
    Urachal carcinoma: a pathologic and clinical study of 46 cases.
    Hum Pathol. 2015;46:1808-14.
    Abstract     Related articles   

  266. LI CF, Wu WJ, Wu WR, Liao YJ, et al
    The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
    Oncotarget. 2015;6:9220-39.
    Abstract     Related articles   

  267. LOTAN Y
    Promises and challenges of fluorescence cystoscopy.
    Urol Oncol. 2015;33:261-4.
    Abstract     Related articles   

  268. VEMANA G, Vetter J, Chen L, Sandhu G, et al
    Sources of variation in follow-up expenditure after radical cystectomy.
    Urol Oncol. 2015;33:267.
    Abstract     Related articles   

  269. BUTROS SR, McCarthy CJ, Karaosmanoglu AD, Shenoy-Bhangle AS, et al
    Feasibility and effectiveness of image-guided percutaneous biopsy of the urinary bladder.
    Abdom Imaging. 2015;40:1838-42.
    Abstract     Related articles   

  270. XUE D, Zhang X, Zhang X, Liu J, et al
    Clinical significance and biological roles of TRIM24 in human bladder carcinoma.
    Tumour Biol. 2015;36:6849-55.
    Abstract     Related articles   

  271. WU M, Seto E, Zhang J
    E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
    Oncotarget. 2015;6:11252-63.
    Abstract     Related articles   

  272. BELLMUNT J, Werner L, Bamias A, Fay AP, et al
    HER2 as a target in invasive urothelial carcinoma.
    Cancer Med. 2015;4:844-52.
    Abstract     Related articles   

  273. LIU W, Qi L, Zu X, Li Y, et al
    A preoperative marker panel for the prediction of residual tumor and the decision making for repeat transurethral resection.
    Urol Oncol. 2015;33:165.
    Abstract     Related articles   

  274. MARTUCCI VL, Lorenzo ZG, Weintraub M, del Rivero J, et al
    Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.
    Urol Oncol. 2015;33:167.
    Abstract     Related articles   

  275. MAI KT, Ball CG, Swift J, A Flood T, et al
    Novel technique of sampling the urinary bladder for urothelial carcinoma specimens.
    Int J Surg Pathol. 2015;23:202-6.
    Abstract     Related articles   

  276. NISHIKAWA M, Miyake H, Behnsawy HM, Fujisawa M, et al
    Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
    Urol Oncol. 2015;33:166.
    Abstract     Related articles   

  277. LARSEN BT, Smith ML, Grys TE, Vikram HR, et al
    Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
    Int J Surg Pathol. 2015;23:189-95.
    Abstract     Related articles   

  278. KISS B, Skuginna V, Fleischmann A, Bell RH, et al
    Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder.
    Urol Oncol. 2015;33:166.
    Abstract     Related articles   

  279. DOHN LH, Illemann M, Hoyer-Hansen G, Christensen IJ, et al
    Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Urol Oncol. 2015;33:165.
    Abstract     Related articles   

  280. SAEKI K, Fujita A, Fujita N, Nakagawa T, et al
    Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005-2011).
    Can Vet J. 2015;56:73-80.
    Abstract     Related articles   

  281. IGCI M, Arslan A, Erturhan S, Igci YZ, et al
    Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.
    Mol Biol Rep. 2015;42:507-16.
    Abstract     Related articles   

  282. BURGESS EF
    Individualized management of advanced bladder cancer: Where do we stand?
    Urol Oncol. 2015;33:187-95.
    Abstract     Related articles   

  283. KIM SH, Ho JN, Jin H, Lee SC, et al
    Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
    Investig Clin Urol. 2016;57:63-72.
    Abstract     Related articles   

  284. WANG Y, Li Z, Meng X, Hu X, et al
    Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.
    Medicine (Baltimore). 2016;95:e2951.
    Abstract     Related articles   

  285. YASAR O, Akcay T, Obek C, Turegun FA, et al
    Diagnostic potential of YKL-40 in bladder cancer.
    Urol Oncol. 2016 Mar 5. pii: S1078-1439(16)00036.
    Abstract     Related articles   

  286. ROBINSON AG, Wei X, Mackillop WJ, Peng Y, et al
    Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice.
    J Natl Compr Canc Netw. 2016;14:291-8.
    Abstract     Related articles   

  287. CELIK O, Akand M, Keskin MZ, Yoldas M, et al
    Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm.
    Eur Rev Med Pharmacol Sci. 2016;20:652-6.
    Abstract     Related articles   

  288. PANNEERSELVAM J, Xie G, Che R, Su M, et al
    Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor Suppressor Signaling Pathway.
    J Proteome Res. 2016.
    Abstract     Related articles   

  289. NISHIYAMA H
    [III. Diagnosis and treatment for bladder cancer--recent topics].
    Gan To Kagaku Ryoho. 2016;43:54-8.
    Abstract     Related articles   

  290. XIAO S, Wang J, Xiao N
    MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
    Int J Biol Markers. 2016 Feb 29:0. doi: 10.5301/jbm.5000199.
    Abstract     Related articles   

  291. BERNARDO C, Cunha MC, Santos JH, da Costa JM, et al
    Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.
    Tumour Biol. 2016.
    Abstract     Related articles   

  292. ZHANG M, Wu X, Lu W, Ge Y, et al
    Rs401681 polymorphism in TERT-CLPTM1L was associated with bladder cancer risk: A meta-analysis.
    Iran J Basic Med Sci. 2015;18:1130-6.
    Abstract     Related articles   

  293. OLIVIERI M, Ferro M, Terreri S, Durso M, et al
    Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.
    Oncotarget. 2016 Mar 1. doi: 10.18632/oncotarget.7833.
    Abstract     Related articles   

  294. EL-TAJI OM, Alam S, Hussain SA
    Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers.
    Curr Treat Options Oncol. 2016;17:15.
    Abstract     Related articles   

  295. GHADIMI T, Gheitasi B, Nili S, Karimi M, et al
    Occupation, smoking, opium, and bladder cancer: A case-control study.
    South Asian J Cancer. 2015;4:111-4.
    Abstract     Related articles   

  296. CATA JP, Lasala J, Pratt G, Feng L, et al
    Association between Perioperative Blood Transfusions and Clinical Outcomes in Patients Undergoing Bladder Cancer Surgery: A Systematic Review and Meta-Analysis Study.
    J Blood Transfus. 2016;2016:9876394.
    Abstract     Related articles   

  297. KIM CY, Lee SW, Choi SH, Son SH, et al
    Granulomatous Prostatitis After Intravesical Bacillus Calmette-Guerin Instillation Therapy: A Potential Cause of Incidental F-18 FDG Uptake in the Prostate Gland on F-18 FDG PET/CT in Patients with Bladder Cancer.
    Nucl Med Mol Imaging. 2016;50:31-7.
    Abstract     Related articles   

  298. MASAOKA H, Matsuo K, Ito H, Wakai K, et al
    Cigarette smoking and bladder cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population.
    Jpn J Clin Oncol. 2016;46:273-83.
    Abstract     Related articles   


  299. Plasmacytoid Variant Bladder Cancers Harbor CDH1 Mutations.
    Cancer Discov. 2016.
    Abstract     Related articles   

  300. WU X, Liu D, Tao D, Xiang W, et al
    BRD4 regulates EZH2 transcription through up-regulation of C-MYC and represents a novel therapeutic target in bladder cancer.
    Mol Cancer Ther. 2016 Mar 3. pii: molcanther.0750.2015.
    Abstract     Related articles   

  301. VAN BRUWAENE S, Costello AJ, VAN Poppel H
    Prognosis of node-positive bladder cancer in 2015.
    Minerva Urol Nefrol. 2016.
    Abstract     Related articles   


  302. The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer.
    J Wound Ostomy Continence Nurs. 2016;43:E1.
    Abstract     Related articles   

  303. HARPER BT, Klaassen Z, DiBianco JM, Yaguchi G, et al
    Suicide Risk in Patients With Bladder Cancer: A Call to Action.
    J Wound Ostomy Continence Nurs. 2016;43:170-1.
    Abstract     Related articles   

  304. YU R, Yu BX, Chen JF, Lv XY, et al
    Anti-tumor effects of Atractylenolide I on bladder cancer cells.
    J Exp Clin Cancer Res. 2016;35:40.
    Abstract     Related articles   

  305. SCHREINER M, Schneider B, Pauls S
    [Cardiac metastasis of a recurrent urothelial carcinoma of the bladder].
    Rofo. 2015;187:1124-6.
    Abstract     Related articles   

  306. SONG W, Jeon HG
    Incidence of kidney, bladder, and prostate cancers in Korea: An update.
    Korean J Urol. 2015;56:422-8.
    Abstract     Related articles   

  307. FATIMA N, Canter DJ, Carthon BC, Kucuk O, et al
    Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
    Can J Urol. 2015;22:7783-7.
    Abstract     Related articles   

  308. TAJIMA S, Koda K
    Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
    Int J Clin Exp Pathol. 2015;8:3288-93.
    Abstract     Related articles   

  309. KIM HS, Moon KC, Jeong CW, Kwak C, et al
    Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.
    Sci Rep. 2015;5:9626.
    Abstract     Related articles   

  310. HUANG H, Sun M, Li X, Jin J, et al
    Urothelial carcinoma of the bladder in patients aged 30 years or younger: clinicopathological analysis and expression of fibroblast growth factor receptor 3 (FGFR3) of 45 cases.
    Med Oncol. 2015;32:137.
    Abstract     Related articles   

  311. REDER NP, Maxwell SP, Pambuccian SE, Barkan GA, et al
    Diagnostic accuracy of intraoperative frozen sections during radical cystectomy does not affect disease-free or overall survival: a study of 364 patients with urothelial carcinoma of the urinary bladder.
    Ann Diagn Pathol. 2015;19:107-12.
    Abstract     Related articles   

  312. GAKIS G, Ali-El-Dein B, Babjuk M, Hrbacek J, et al
    Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional study.
    Urol Oncol. 2015;33:204.
    Abstract     Related articles   

  313. NAYA Y, Oishi M, Yamada Y, Ueda T, et al
    Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion.
    Int J Clin Oncol. 2015;20:593-7.
    Abstract     Related articles   

  314. PAN LT, Sheung Y, Guo WP, Rong ZB, et al
    Hedyotis diffusa plus Scutellaria barbata Induce Bladder Cancer Cell Apoptosis by Inhibiting Akt Signaling Pathway through Downregulating miR-155 Expression.
    Evid Based Complement Alternat Med. 2016;2016:9174903.
    Abstract     Related articles   

  315. GUPTA S, Hau AM, Al-Ahmadie HA, Harwalkar J, et al
    Transforming Growth Factor-beta Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion.
    Am J Pathol. 2016 Mar 14. pii: S0002-9440(16)00095.
    Abstract     Related articles   

  316. TAN ST, Liu SY, Wu B
    TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells Through NF-kappaB Signaling.
    Cancer Res Treat. 2016 Mar 11. doi: 10.4143/crt.2015.
    Abstract     Related articles   


  317. Retraction notice to "Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers" [Biochem. Pharmacol. 79 (2010) 218-228].
    Biochem Pharmacol. 2016;102:145.
    Abstract     Related articles   

  318. ROSE TL, Milowsky MI
    Improving Systemic Chemotherapy for Bladder Cancer.
    Curr Oncol Rep. 2016;18:27.
    Abstract     Related articles   

  319. BRAUSI M, Morselli S
    The treatment of Ta-T1 bladder cancer in the era of worldwide BCG shortage.
    Minerva Urol Nefrol. 2016.
    Abstract     Related articles   

  320. SILVERS CR, Liu YR, Wu CH, Miyamoto H, et al
    Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.
    Oncotarget. 2016 Mar 10. doi: 10.18632/oncotarget.8024.
    Abstract     Related articles   

  321. KIM YH, Yan C, Lee IS, Piao XM, et al
    Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Investig Clin Urol. 2016;57:106-12.
    Abstract     Related articles   

  322. HONG SK
    Biomarkers for bladder cancer: The search continues!
    Investig Clin Urol. 2016;57:73-4.
    Abstract     Related articles   

  323. SUN CM, Xiong DB, Yan Y, Geng J, et al
    Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.
    Int J Biol Markers. 2016 Mar 15:0. doi: 10.5301/jbm.5000189.
    Abstract     Related articles   

  324. SCARPATO KR, Tyson MD, Clark PE
    Natural biology and management of nonmuscle invasive bladder cancer.
    Curr Opin Oncol. 2016.
    Abstract     Related articles   

  325. JOKISCH JF, Ganswindt U, Hentrich M, Stief C, et al
    [Diagnosis and therapy of bladder cancer].
    MMW Fortschr Med. 2015;157:42-5.
    Abstract     Related articles   

  326. KASSOUF W, Aprikian A, Black P, Kulkarni G, et al
    Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 20
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  327. GOTTO GT, Shea-Budgell MA, Dean Ruether J
    Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  328. BOOTH CM
    Perioperative chemotherapy for muscle-invasive bladder cancer: Closing the gap between evidence and practice.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  329. NAYAN M, Bhindi B, Yu JL, Mamdani M, et al
    The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  330. WARRICK JI, Raman JD, Kaag M, Bruggeman T, et al
    Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer.
    Urol Oncol. 2016 Mar 11. pii: S1078-1439(16)00044.
    Abstract     Related articles   

  331. REZAKAHN KHAJEH N, Khoyilar C, Wu Y, Spradling K, et al
    Chemoprevention of Bladder Cancer: A Mini Review.
    Mini Rev Med Chem. 2016.
    Abstract     Related articles   

  332. DEGENER S, Mata DA, Youssef R, Godde D, et al
    A review of molecular predictors of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Mini Rev Med Chem. 2016.
    Abstract     Related articles   

  333. SPRADLING K, Youssef RF
    Controversies Related to Diabetes and Risk of Bladder Cancer.
    Mini Rev Med Chem. 2016.
    Abstract     Related articles   

  334. DANSK V, Malmstrom PU, Blackberg M, Malmenas M, et al
    Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.
    Future Oncol. 2016.
    Abstract     Related articles   

  335. MASSARI F, Ciccarese C, Santoni M, Iacovelli R, et al
    Metabolic phenotype of bladder cancer.
    Cancer Treat Rev. 2016;45:46-57.
    Abstract     Related articles   

  336. ORDING AG, Nielsen ME, Smith AB, Horvath-Puho E, et al
    Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011.
    Urol Oncol. 2016 Mar 9. pii: S1078-1439(16)00047.
    Abstract     Related articles   

  337. VELAER KN, Steinberg RL, Thomas LJ, O'Donnell MA, et al
    Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer.
    Curr Urol Rep. 2016;17:38.
    Abstract     Related articles   

  338. LITWIN MS, Tan HJ
    Cancer surgeons and health system innovation: incentivizing change.
    J Natl Cancer Inst. 2015;108.
    Abstract     Related articles   

  339. O'NEIL B, Graves AJ, Barocas DA, Chang SS, et al
    Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
    J Natl Cancer Inst. 2015;108.
    Abstract     Related articles   

  340. SALAS LA, Bustamante M, Gonzalez JR, Gracia-Lavedan E, et al
    DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.
    Epigenetics. 2015;10:650-61.
    Abstract     Related articles   

  341. KENZAKA T
    Purple urine bag syndrome in a patient with a urethral balloon catheter and a history of ileal conduit urinary diversion.
    Korean J Intern Med. 2015;30:420.
    Abstract     Related articles   

  342. BREEN V, Kasabov N, Kamat AM, Jacobson E, et al
    A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion(R) FISH, NMP22(R) and cytology based on imputation of multiple datasets.
    BMC Med Res Methodol. 2015;15:45.
    Abstract     Related articles   

  343. XUE M, Li X, Chen W
    Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein alpha by hypoxia inducible factor-1alpha in bladder transitional carcinoma cells.
    Mol Med Rep. 2015;12:2121-7.
    Abstract     Related articles   

  344. ZHU H, Tang Y, Zhang X, Jiang X, et al
    Downregulation of UPK1A suppresses proliferation and enhances apoptosis of bladder transitional cell carcinoma cells.
    Med Oncol. 2015;32:84.
    Abstract     Related articles   

  345. NAKANISHI Y, Akiyama N, Tsukaguchi T, Fujii T, et al
    Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1.
    Mol Cancer Ther. 2015;14:704-12.
    Abstract     Related articles   

  346. CHOI E, Williamson SR, Montironi R, Zhang S, et al
    Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Histopathology. 2015;67:20-38.
    Abstract     Related articles   

  347. DAVIS M, Bunin DI, Samuelsson SJ, Altera KP, et al
    Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats.
    Toxicol Pathol. 2015;43:519-29.
    Abstract     Related articles   

  348. LI J, Zhuang C, Liu Y, Chen M, et al
    shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.
    Oncotarget. 2016 Mar 22. doi: 10.18632/oncotarget.8259.
    Abstract     Related articles   

  349. BOTELHO MC, Alves H, Richter J
    Estrogen metabolites for the diagnosis of schistosomiasis associated urinary bladder cancer.
    SM Trop Med J. 2016;1.
    Abstract     Related articles   

  350. GOFRIT ON, Yutkin V, Shapiro A, Pizov G, et al
    The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer.
    Front Oncol. 2016;6:43.
    Abstract     Related articles   

  351. CHALFIN HJ, Liu JJ, Gandhi N, Feng Z, et al
    Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  352. WANG C, Ge Q, Zhang Q, Chen Z, et al
    Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
    J Exp Clin Cancer Res. 2016;35:53.
    Abstract     Related articles   

  353. NTZEROS K, Stamatakos M, Stokidis S, Louka G, et al
    Bladder Cancer: The Hormonal Dependence Enigma and a New Hormonal Player.
    Indian J Surg. 2015;77.
    Abstract     Related articles   

  354. KOUKOURAKIS MI, Kakouratos C, Kalamida D, Bampali Z, et al
    Hypoxia-inducible proteins HIF1alpha and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
    Int J Radiat Biol. 2016.
    Abstract     Related articles   

  355. BAMIAS A, Tsantoulis P, Zilli T, Papatsoris A, et al
    Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis.
    Cancer Med. 2016 Mar 22. doi: 10.1002.
    Abstract     Related articles   

  356. JAHED M, Ebadi N, Mivehchi M, Majidizadeh T, et al
    MGMT hypermethylation and BCL-2 overexpression associated with superficial bladder cancer and recurrence.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  357. THORSTENSON A, Hagberg O, Ljungberg B, Liedberg F, et al
    Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer.
    Scand J Urol. 2016.
    Abstract     Related articles   

  358. GOPALAKRISHNA A, Longo TA, Fantony JJ, Van Noord M, et al
    Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review.
    J Cancer Surviv. 2016.
    Abstract     Related articles   

  359. SIDAWAY P
    Bladder cancer: Atezolizumab effective against advanced-stage disease.
    Nat Rev Urol. 2016 Mar 22. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  360. AL-ZALABANI AH, Stewart KF, Wesselius A, Schols AM, et al
    Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses.
    Eur J Epidemiol. 2016.
    Abstract     Related articles   

  361. REXER H
    [A study of non-muscle-invasive bladder cancer therapy : Treatment of high-grade non-muscle-invasive urothelial carcinoma of the bladder with the standard number and dosage of intravesical BCG instillations versus a reduced number intravesical BCG ins
    Urologe A. 2016.
    Abstract     Related articles   

  362. WHITE-GILBERTSON S, Davis M, Voelkel-Johnson C, Kasman LM, et al
    Sex differences in the MB49 syngeneic, murine model of bladder cancer.
    Bladder (San Franc). 2016;3.
    Abstract     Related articles   

  363. ZENG FC, Cen S, Tang ZY, Kang XL, et al
    Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.
    Oncol Lett. 2016;11:2213-2222.
    Abstract     Related articles   

  364. WANG Z, Xiong W, Pan C, Zhu L, et al
    Aggressive muscle-invasive bladder cancer with sarcomatoid differentiation in a 10-year-old girl: A case report.
    Exp Ther Med. 2016;11:985-987.
    Abstract     Related articles   

  365. FAIENA I, Dombrovskiy VY, Sultan RC, Salmasi AH, et al
    Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study.
    Clin Genitourin Cancer. 2016 Feb 23. pii: S1558-7673(16)30032.
    Abstract     Related articles   

  366. LUTKENHAUS LJ, van Os RM, Bel A, Hulshof MC, et al
    Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.
    Radiat Oncol. 2016;11:45.
    Abstract     Related articles   

  367. KOSLINSKI P, Daghir-Wojtkowiak E, Szatkowska-Wandas P, Markuszewski M, et al
    The metabolic profiles of pterin compounds as potential biomarkers of bladder cancer-Integration of analytical-based approach with biostatistical methodology.
    J Pharm Biomed Anal. 2016 Feb 28. pii: S0731-7085(16)30100.
    Abstract     Related articles   

  368. LUCCA I, Klatte T, Fajkovic H, de Martino M, et al
    Gender differences in incidence and outcomes of urothelial and kidney cancer.
    Nat Rev Urol. 2015;12:585-92.
    Abstract     Related articles   

  369. DUNLOP A, McQuaid D, Nill S, Murray J, et al
    Comparison of CT number calibration techniques for CBCT-based dose calculation.
    Strahlenther Onkol. 2015;191:970-8.
    Abstract     Related articles   

  370. ZHUANG Y, Zhang M, Chen B, Duan R, et al
    Quencher group induced high specificity detection of telomerase in clear and bloody urines by AIEgens.
    Anal Chem. 2015;87:9487-93.
    Abstract     Related articles   

  371. MARCHALIK D, Krishnan J, Verghese M, Venkatesan K, et al
    Clear cell adenocarcinoma of the bladder with intravesical cervical invasion.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  372. ZAKARIA MB, Belik AA, Liu CH, Hsieh HY, et al
    Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.
    Chem Asian J. 2015;10:1457-62.
    Abstract     Related articles   

  373. ATMACA AF, Canda AE, Gok B, Akbulut Z, et al
    Open versus robotic radical cystectomy with intracorporeal Studer diversion.
    JSLS. 2015;19:e2014.
    Abstract     Related articles   

  374. POLETAJEW S, Wilczek E, Wasiutynski A, Gornicka B, et al
    Antigenic profile of muscularis mucosae and muscularis propria of the urinary bladder.
    Iran J Immunol. 2015;12:50-63.
    Abstract     Related articles   

  375. HANAZONO K, Fukumoto S, Kawamura Y, Endo Y, et al
    Epidermal growth factor receptor expression in canine transitional cell carcinoma.
    J Vet Med Sci. 2015;77:1-6.
    Abstract     Related articles   

  376. TSUI TY, Heumann A, Vashist YK, Izbicki JR, et al
    How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant.
    Langenbecks Arch Surg. 2016.
    Abstract     Related articles   

  377. TUCCORI M, Filion KB, Yin H, Yu OH, et al
    Pioglitazone use and risk of bladder cancer: population based cohort study.
    BMJ. 2016;352:i1541.
    Abstract     Related articles   

  378. CHEN CH, Liu YM, Pan SL, Liu YR, et al
    Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo.
    Oncotarget. 2016 Mar 25. doi: 10.18632/oncotarget.8380.
    Abstract     Related articles   

  379. JACKSON SS, George DM, Loffredo CA, Amr S, et al
    Non-occupational Exposure to Agricultural Work and Risk of Urinary Bladder Cancer Among Egyptian Women.
    Arch Environ Occup Health. 2016.
    Abstract     Related articles   

  380. CHRISTODOULEAS JP, Hwang WT, Baumann BC
    Adjuvant Radiation for Locally Advanced Bladder Cancer? A Question Worth Asking.
    Int J Radiat Oncol Biol Phys. 2016;94:1040-2.
    Abstract     Related articles   

  381. REDDY AV, Pariser JJ, Pearce SM, Weichselbaum RR, et al
    Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;94:1031-9.
    Abstract     Related articles   

  382. HAFEEZ S, Warren-Oseni K, McNair HA, Hansen VN, et al
    Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (</=70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:1022-30.
    Abstract     Related articles   

  383. SHA N, Xu H, Chen T, Tian DW, et al
    The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.
    Onco Targets Ther. 2016;9:1175-9.
    Abstract     Related articles   

  384. LIANG C, Chi R, Huang L, Wang J, et al
    Upper Tract Urothelial Carcinomas Accompanied by Previous or Synchronous Nonmuscle-Invasive Bladder Cancer and Preoperative Hydronephrosis Might Have Worse Oncologic Outcomes After Radical Nephroureterectomy.
    Clin Genitourin Cancer. 2016 Feb 21. pii: S1558-7673(16)30036.
    Abstract     Related articles   

  385. BAUMANN BC, He J, Hwang WT, Tucker KN, et al
    Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Jan 23. pii: S0360-3016(16)00055.
    Abstract     Related articles   

  386. CHEN M, Zhuang C, Liu Y, Li J, et al
    Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Cancer Lett. 2016 Mar 24. pii: S0304-3835(16)30197.
    Abstract     Related articles   

  387. WU CL, Ho JY, Chou SC, Yu DS, et al
    MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Oncotarget. 2016 Apr 2. doi: 10.18632/oncotarget.8557.
    Abstract     Related articles   

  388. LIU Q, Yuan W, Tong D, Liu G, et al
    Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.
    Oncotarget. 2016 Apr 5. doi: 10.18632/oncotarget.8595.
    Abstract     Related articles   

  389. LI X, Zhang Y, Gao H, Sun X, et al
    The Value of Extended Nursing Services on Patients with Bladder Cancer after Endoscopic Bladder Resection.
    Iran J Public Health. 2016;45:48-53.
    Abstract     Related articles   

  390. CHOI S, Shin JH, Lee YR, Joo HK, et al
    Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Dis Markers. 2016;2016:7276502.
    Abstract     Related articles   

  391. LIEM EI, Crezee H, de la Rosette JJ, de Reijke TM, et al
    Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  392. CHEN Y, Yu X, Li T, Yan H, et al
    Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
    Int J Biol Markers. 2016 Apr 7:0. doi: 10.5301/jbm.5000204.
    Abstract     Related articles   

  393. KIM TH, Sung HH, Jeon HG, Seo SI, et al
    Oncological outcomes in patients treated with radical cystectomy for bladder cancer: Comparison between open, laparoscopic, and robot-assisted approaches.
    J Endourol. 2016.
    Abstract     Related articles   

  394. GE JJ, Wang CH, Chen Z, Zhang QS, et al
    [Effect of synthetic small double-stranded RNA on the development of bladder cancer by activating P21 expression].
    Zhonghua Yi Xue Za Zhi. 2016;96:812-816.
    Abstract     Related articles   

  395. POLOM W, Markuszewski M, Cytawa W, Lass P, et al
    Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  396. YIN M, Joshi M, Meijer RP, Glantz M, et al
    Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systemic Review and Two-Step Meta-Analysis.
    Oncologist. 2016 Apr 6. pii: theoncologist.2015-0440.
    Abstract     Related articles   

  397. SFETSAS K, Mitropoulos D
    Reducing understaging of bladder cancer with the aid of photodynamic cystoscopy.
    J Egypt Natl Canc Inst. 2016 Apr 1. pii: S1110-0362(16)30005.
    Abstract     Related articles   

  398. MULTHOFF G, Habl G, Combs SE
    Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  399. XU T, Qin L, Zhu Z, Wang X, et al
    MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin alpha5.
    Oncotarget. 2016 Mar 30. doi: 10.18632/oncotarget.8479.
    Abstract     Related articles   

  400. MAKHDOOMI R, Bashir N, Bhat N, Bashir S, et al
    Clinicopathological Spectrum Of Gall Bladder Cancer In Kashmir - An Institutional Study.
    Gulf J Oncolog. 2016;1:79-85.
    Abstract     Related articles   

  401. BOS D, Allard CB, Dason S, Ruzhynsky V, et al
    Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes.
    Scand J Urol. 2016.
    Abstract     Related articles   

  402. PUNTONI M, Petrera M, Campora S, Garrone E, et al
    PROGNOSTIC SIGNIFICANCE OF VEGF AFTER TWENTY YEAR FOLLOW-UP IN A RANDOMIZED TRIAL OF FENRETINIDE IN NON-MUSCLE INVASIVE BLADDER CANCER.
    Cancer Prev Res (Phila). 2016 Apr 4. pii: canprevres.0345.2015.
    Abstract     Related articles   

  403. ZHAO M, He XL, Teng XD
    Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview.
    Chin J Cancer Res. 2016;28:92-8.
    Abstract     Related articles   

  404. GOK S, Aydin OZ, Sural YS, Zorlu F, et al
    Bladder cancer diagnosis from bladder wash by Fourier transform infrared spectroscopy as a novel test for tumor recurrence.
    J Biophotonics. 2016 Apr 4. doi: 10.1002/jbio.201500322.
    Abstract     Related articles   

  405. TAKEUCHI H, Taoka R, Mmeje CO, Jinesh GG, et al
    CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.
    Urol Oncol. 2016 Mar 30. pii: S1078-1439(16)00081.
    Abstract     Related articles   

  406. MORIZAWA Y, Miyake M, Shimada K, Hori S, et al
    Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
    Urol Oncol. 2016 Mar 30. pii: S1078-1439(16)00045.
    Abstract     Related articles   

  407. MCBETH L, Nwaneri AC, Grabnar M, Demeter J, et al
    Glucocorticoid receptor beta increases migration of human bladder cancer cells.
    Oncotarget. 2016 Mar 27. doi: 10.18632/oncotarget.8430.
    Abstract     Related articles   

  408. LIU L, Liu Y, Zhang X, Chen M, et al
    Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer.
    Oncotarget. 2016 Feb 4. doi: 10.18632/oncotarget.7192.
    Abstract     Related articles   

  409. WU D, Niu X, Pan H, Zhou Y, et al
    MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.
    Mol Med Rep. 2016 Mar 28. doi: 10.3892/mmr.2016.5055.
    Abstract     Related articles   

  410. LI CW, Chen BS
    Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data.
    Dis Markers. 2016;2016:4149608.
    Abstract     Related articles   

  411. BAGI P, Nordsten CB, Kehlet H
    Cystectomy for bladder cancer in Denmark during the 2006-2013 period.
    Dan Med J. 2016;63.
    Abstract     Related articles   

  412. GANDAGLIA G, Karl A, Novara G, de Groote R, et al
    Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centers.
    Eur J Surg Oncol. 2016 Mar 19. pii: S0748-7983(16)00372.
    Abstract     Related articles   

  413. HEYES SM, Harrington A, Belan I, Bond MJ, et al
    Family focus on bladder cancer research.
    Aust Nurs Midwifery J. 2016;23:41.
    Abstract     Related articles   

  414. LIAO YX, Zeng JM, Zhou JJ, Yang GH, et al
    Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.
    Mol Med Rep. 2016 Apr 14. doi: 10.3892/mmr.2016.5127.
    Abstract     Related articles   

  415. JIANG G, Wu AD, Huang C, Gu J, et al
    Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis.
    Cancer Prev Res (Phila). 2016 Apr 14. pii: canprevres.0338.2015.
    Abstract     Related articles   

  416. OLIVEIRA PA, Gil da Costa RM, Vasconcelos Nobrega C, Arantes-Rodrigues R, et al
    Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery.
    Expert Opin Drug Discov. 2016.
    Abstract     Related articles   

  417. ZHANG Y, Xu F, Zhang FQ, Song L, et al
    Recent perspectives of bladder cancer diagnostics.
    Minerva Med. 2016.
    Abstract     Related articles   

  418. JIANG SJ, Ye LY, Meng FH
    Comparison of intravesical bacillus Calmette-Guerin and mitomycin C administration for non-muscle invasive bladder cancer: A meta-analysis and systematic review.
    Oncol Lett. 2016;11:2751-2756.
    Abstract     Related articles   

  419. PRELAJ A, Rebuzzi SE, Magliocca FM, Speranza I, et al
    Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report.
    Am J Case Rep. 2016;17:248-53.
    Abstract     Related articles   

  420. MATSUSHITA R, Yoshino H, Enokida H, Goto Y, et al
    Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Oncotarget. 2016 Apr 9. doi: 10.18632/oncotarget.8668.
    Abstract     Related articles   

  421. SONPAVDE G, Bellmunt J
    Bladder cancer: Angiogenesis as a therapeutic target in urothelial carcinoma.
    Nat Rev Urol. 2016 Apr 13. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  422. LIN YL, Wang YL, Fu XL, Li WP, et al
    Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.
    Oncotarget. 2016 Apr 7. doi: 10.18632/oncotarget.8635.
    Abstract     Related articles   

  423. PENCE S, Ozbek E, Ozan Tiryakioglu N, Ersoy Tunali N, et al
    Deregulation of seven CpG island-harboring miRNAs in bladder cancer: miR-155 and miR-23b as the most promising oncomiRs.
    Cell Mol Biol (Noisy-le-grand). 2016;62:25-30.
    Abstract     Related articles   

  424. SCHWARTZ LE, Khani F, Bishop JA, Vang R, et al
    Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
    Am J Surg Pathol. 2015.
    Abstract     Related articles   

  425. KAWASAKI T, Suzuki M, Sato A, Yashima-Abo A, et al
    Neural cell adhesion molecule (CD56)-positive B cell lymphoma of the urinary bladder.
    J Clin Pathol. 2016;69:89-92.
    Abstract     Related articles   

  426. CHEN CH, Wu YJ, Chen JJ
    Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles.
    Front Biosci (Landmark Ed). 2016;21:1211-1221.
    Abstract     Related articles   

  427. LUTKENHAUS LJ, Vestergaard A, Bel A, Hoyer M, et al
    A biological modeling based comparison of two strategies for adaptive radiotherapy of urinary bladder cancer.
    Acta Oncol. 2016.
    Abstract     Related articles   

  428. VAN DER HEIJDEN AG, Dewhirst MW
    Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  429. ZAITSU M, Nakamura F, Toyokawa S, Tonooka A, et al
    Risk of Alcohol Consumption in Bladder Cancer: Case-Control Study from a Nationwide Inpatient Database in Japan.
    Tohoku J Exp Med. 2016;239:9-15.
    Abstract     Related articles   

  430. VAN OSCH FH, Jochems SH, van Schooten FJ, Bryan RT, et al
    Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies.
    Int J Epidemiol. 2016.
    Abstract     Related articles   

  431. SNIDER JW 3RD, Datta NR, Vujaskovic Z
    Hyperthermia and radiotherapy in bladder cancer.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   


  432. Drug used for controlling blood sugar levels in type 2 diabetes linked to bladder cancer risk.
    Nurs Stand. 2016;30:14-5.
    Abstract     Related articles   

  433. CHEN JC, Li T, Ning XH, Peng SH, et al
    [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2016;96:1124-7.
    Abstract     Related articles   

  434. MERANDY K, Hardie T
    Indicators of Health Literacy In Bladder Cancer Survivors: A Secondary Analysis of the Integrative Health Interview Series (IHIS).
    Urol Nurs. 2016;36:37-43.
    Abstract     Related articles   

  435. TAKEUCHI A, Eto M, Tatsugami K, Shiota M, et al
    Antitumor activity of recombinant Bacille Calmette-Guerin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
    Int Immunopharmacol. 2016;35:327-331.
    Abstract     Related articles   

  436. SHANG Z, Li Y, Hsu I, Zhang M, et al
    Targeting estrogen/estrogen receptor alpha will enhance Bacillus Calmette-Guerin efficacy in bladder cancer.
    Oncotarget. 2016 Apr 15. doi: 10.18632/oncotarget.8756.
    Abstract     Related articles   

  437. POUESSEL D, Neuzillet Y, Mertens LS, van der Heijden MS, et al
    Tumor Heterogeneity of Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations in Invasive Bladder Cancer: Implications for Peri-Operative anti-FGFR3 Treatment.
    Ann Oncol. 2016.
    Abstract     Related articles   

  438. FENNER A
    Bladder cancer: CDODA-Me has anticancer activity.
    Nat Rev Urol. 2016 Apr 19. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  439. THOMA C
    Bladder Cancer: Noninvasive diagnosis and detection of recurrence.
    Nat Rev Urol. 2016 Apr 19. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  440. HUA Q, Lv X, Gu X, Chen Y, et al
    Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population.
    Mutagenesis. 2016.
    Abstract     Related articles   

  441. TIRYAKIOGLU NO, Tunali NE
    Association of AKR1C3 Polymorphisms with Bladder Cancer.
    Urol J. 2016;13:2615-21.
    Abstract     Related articles   

  442. HUI DS, Stoeckel DA, Kaufman EE, Jacobs DL, et al
    Massive Hemoptysis From an Aortobronchial Fistula Secondary to BCG-Related Mycotic Thoracic Aortic Aneurysm.
    Ann Thorac Surg. 2016;101:350-2.
    Abstract     Related articles   

  443. REIS LO, Taheri D, Chaux A, Guner G, et al
    Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
    Hum Pathol. 2016;47:20-5.
    Abstract     Related articles   

  444. RAYAMAJHI SJ, Mittal BR, Shukla J, Vatsa R, et al
    Recurrent Urinary Bladder Paraganglioma Detected on 68Ga DOTANOC PET/CT.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  445. TAKEUCHI H, Tanaka M, Tanaka A, Tsunemi A, et al
    Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness.
    Oncol Lett. 2016;11:3403-3408.
    Abstract     Related articles   

  446. KHAN R, Ibrahim H, Tulpule S, Iroka N, et al
    Bladder cancer in a young patient: Undiscovered risk factors.
    Oncol Lett. 2016;11:3202-3204.
    Abstract     Related articles   

  447. ZHOU XF, Ding ZS, Fang DB, Wang JF, et al
    [Selective bladder preservation in muscle-invasive bladder cancer by transurethral resection combined with intravesical instillation therapy: analysis of clinical effect in the elderly].
    Zhonghua Yi Xue Za Zhi. 2016;96:1278-80.
    Abstract     Related articles   

  448. BURGER M
    [Bladder-sparing therapy as an alternative to cystectomy : Commentary on organ-sparing therapy in bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  449. NIEDWOROK C, Shaleva A, Rubben H, Stenzl A, et al
    [Organ-sparing treatment of bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  450. TSUJI S, Chen X, Hancock B, Hernandez V, et al
    Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer.
    Mol Ther Oncolytics. 2016;3:16004.
    Abstract     Related articles   

  451. TAPAK L, Mahjub H, Sadeghifar M, Saidijam M, et al
    Predicting the Survival Time for Bladder Cancer Using an Additive Hazards Model in Microarray Data.
    Iran J Public Health. 2016;45:239-48.
    Abstract     Related articles   

  452. GE Q, Wang C, Chen Z, Li F, et al
    The suppressive effects of miR-1180-5p on the proliferation and tumorigenicity of bladder cancer cells.
    Histol Histopathol. 2016 Apr 26:11772.
    Abstract     Related articles   

  453. READ J, Symmons J, Palmer JM, Montgomery GW, et al
    Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.
    Fam Cancer. 2016.
    Abstract     Related articles   

  454. MCHAFFIE DR, Kruser TJ, Gaston K, Mahoney J, et al
    Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer.
    Urol Oncol. 2016 Apr 20. pii: S1078-1439(16)00093.
    Abstract     Related articles   

  455. QIE Y, Hu H, Tian D, Zhang Y, et al
    The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy.
    Onco Targets Ther. 2016;9:2019-25.
    Abstract     Related articles   

  456. HSIEH HY, Shen CH, Lin RI, Feng YM, et al
    Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3beta to suppress mTOR and beta-catenin signaling pathways.
    Cancer Lett. 2016;370:56-65.
    Abstract     Related articles   

  457. KIRBY MG , White ID, Butcher J, Challacombe B, et al
    Development of UK recommendations on treatment for post-surgical erectile dysfunction.
    Int J Clin Pract. 2013 Nov 4. doi: 10.1111/ijcp.12338.
    Abstract     Related articles   

  458. ORSOLIC N, Karac I, Sirovina D, Kukolj M, et al
    Chemotherapeutic potential of quercetin on human bladder cancer cells.
    J Environ Sci Health A Tox Hazard Subst Environ Eng. 2016.
    Abstract     Related articles   

  459. DAI X, Fang X, Ma Y, Xianyu J, et al
    Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
    Medicine (Baltimore). 2016;95:e3493.
    Abstract     Related articles   

  460. MITIN T
    Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.
    JAMA Oncol. 2016 May 5. doi: 10.1001/jamaoncol.2016.0152.
    Abstract     Related articles   

  461. CHEDGY EC, Black PC
    Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer.
    JAMA Oncol. 2016 May 5. doi: 10.1001/jamaoncol.2016.0149.
    Abstract     Related articles   

  462. PAN CW, Liu H, Zhao Y, Qian C, et al
    JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer.
    Oncotarget. 2016 Apr 27. doi: 10.18632/oncotarget.9046.
    Abstract     Related articles   

  463. NIVEAN M, Muttuvelu DV, Afzelius P, Berman DC, et al
    Paraneoplastic retinopathy associated with occult bladder cancer.
    Indian J Ophthalmol. 2016;64:248-50.
    Abstract     Related articles   

  464. TIWANA MS, Ni LH, Saini S, Verma SK, et al
    Radiation therapy outcomes in muscle invasive urinary bladder cancer: A single institution experience.
    Indian J Cancer. 2016;53:143-6.
    Abstract     Related articles   

  465. LIN JF, Lin YC, Yang SC, Tsai TF, et al
    Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
    Drug Des Devel Ther. 2016;10:1501-13.
    Abstract     Related articles   

  466. SEILER R
    Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing.
    Transl Androl Urol. 2016;5:271-3.
    Abstract     Related articles   

  467. ALANEE S, Ganai S, Gupta P, Holland B, et al
    Disparities in long-term radiographic follow-up after cystectomy for bladder cancer: Analysis of the SEER-Medicare database.
    Urol Ann. 2016;8:178-83.
    Abstract     Related articles   

  468. HU ZD
    Serum and urinary endocan levels for bladder cancer diagnosis.
    Ann Clin Biochem. 2016 May 1. pii: 0004563216645623.
    Abstract     Related articles   

  469. BARIS D, Waddell R, Beane Freeman LE, Schwenn M, et al
    Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
    J Natl Cancer Inst. 2016;108.
    Abstract     Related articles   

  470. REIS LO, Moro JC, Ribeiro LF, Voris BR, et al
    Are we following the guidelines on non-muscle invasive bladder cancer?
    Int Braz J Urol. 2016;42:22-8.
    Abstract     Related articles   

  471. LONGO TA, Gopalakrishna A, Tsivian M, Van Noord M, et al
    A systematic review of regional hyperthermia therapy in bladder cancer.
    Int J Hyperthermia. 2016.
    Abstract     Related articles   

  472. DAVIDSON MB
    Pioglitazone (Actos) and bladder cancer: legal system triumphs over the evidence.
    J Diabetes Complications. 2016 Apr 11. pii: S1056-8727(16)30103.
    Abstract     Related articles   

  473. SHI H, Li X, Zhang Q, Yang H, et al
    Discovery of urine biomarkers for bladder cancer via global metabolomics.
    Biomarkers. 2016.
    Abstract     Related articles   

  474. ZHANG M, Zhuang Q, Cui L
    MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.
    Biomed Pharmacother. 2016;80:268-75.
    Abstract     Related articles   

  475. ZHU Y, Dai B, Zhang H, Shi G, et al
    Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis.
    Cancer Lett. 2016 Apr 26. pii: S0304-3835(16)30266.
    Abstract     Related articles   

  476. DU J, Wang SH, Yang Q, Chen QQ, et al
    p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis.
    World J Surg Oncol. 2016;14:137.
    Abstract     Related articles   

  477. RAGHAVAN D
    Systemic Therapy for Invasive Bladder Cancer: The Value Proposition.
    Oncologist. 2016 Apr 28. pii: theoncologist.2016-0074.
    Abstract     Related articles   

  478. REDWAN B, Ziegeler S, Dickgreber N, Fischer S, et al
    Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation.
    J Thorac Cardiovasc Surg. 2015 Sep 24. pii: S0022-5223(15)01547.
    Abstract     Related articles   

  479. MAINWARING A, Stephenson BM, Carter AC
    Is a sublay prophylactic mesh a necessary prerequisite to prevent ileal conduit herniation?
    Scand J Urol. 2016;50:93-4.
    Abstract     Related articles   

  480. BOEGEMANN M, Krabbe LM
    Prognostic Implications of Immunohistochemical Biomarkers in Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer.
    Mini Rev Med Chem. 2016.
    Abstract     Related articles   

  481. SONG YL, Wang L, Ren JC, Xu ZH, et al
    CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  482. LIANG Y, Zhu J, Huang H, Xiang D, et al
    SESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancers.
    Autophagy. 2016.
    Abstract     Related articles   

  483. WESTHOVENS IM, Vanden Abeele ME, Messiaen PE, van der Hilst JCh, et al
    Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  484. LATOSINSKA A, Makridakis M, Frantzi M, Borras DM, et al
    Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.
    Sci Rep. 2016;6:25619.
    Abstract     Related articles   

  485. JIANG X, Du L, Duan W, Wang R, et al
    Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
    Oncotarget. 2016 May 4. doi: 10.18632/oncotarget.9166.
    Abstract     Related articles   

  486. LIU S, Wu Y, Yang T, Feng C, et al
    Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss.
    Oncotarget. 2016 May 4. doi: 10.18632/oncotarget.9158.
    Abstract     Related articles   

  487. THOMA C
    Bladder cancer: Better prediction of lymph node metastasis.
    Nat Rev Urol. 2016 May 10. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  488. SCHINKEL JK, Shao S, Zahm SH, McGlynn KA, et al
    Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.
    Cancer Epidemiol. 2016;42:154-158.
    Abstract     Related articles   

  489. HUMPHREYS C, Cooper AJ, Barbu E, Birch BR, et al
    Artemisinins as potential anticancer agents: uptake detection in erythrocytes using Fourier transform infrared spectroscopy and cytotoxicity against bladder cancer cells.
    J Clin Pathol. 2016 May 6. pii: jclinpath-2016-203721.
    Abstract     Related articles   

  490. MACKEL CE, Burke SM, Huhta T, Riesenburger R, et al
    Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer.
    Cureus. 2016;8:e545.
    Abstract     Related articles   

  491. DING G, Yu S, Cheng S, Li G, et al
    Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF.
    Am J Transl Res. 2016;8:578-87.
    Abstract     Related articles   

  492. SASAKI H, Yoshiike M, Nozawa S, Usuba W, et al
    Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
    Clin Genitourin Cancer. 2016 Apr 9. pii: S1558-7673(16)30078.
    Abstract     Related articles   

  493. WANG K, Tian Y, Xu H
    Improved Noninvasive Bladder Cancer Diagnosis using Urine Sediments and Novel DNA Methylation Biomarker Panels.
    Clin Lab. 2016;62:327-36.
    Abstract     Related articles   

  494. LI MY, Yang YL, Liu L, Wang L, et al
    Effects of social support, hope and resilience on quality of life among Chinese bladder cancer patients: a cross-sectional study.
    Health Qual Life Outcomes. 2016;14:73.
    Abstract     Related articles   

  495. ZHU G, Su H, Lu L, Guo H, et al
    Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in gansu province of China.
    Oncotarget. 2016 May 2. doi: 10.18632/oncotarget.9146.
    Abstract     Related articles   

  496. TRUTA A, Popon TA, Saraci G, Ghervan L, et al
    Novel non invasive diagnostic strategies in bladder cancer.
    Clujul Med. 2016;89:187-92.
    Abstract     Related articles   

  497. SOKOL WN JR
    Post Cystoscopy Anaphylaxis.
    J Allergy Clin Immunol Pract. 2016;4:189.
    Abstract     Related articles   

  498. LEDFORD DK
    Reply.
    J Allergy Clin Immunol Pract. 2016;4:189-90.
    Abstract     Related articles   

  499. WANG J, Manucha V
    Villous Adenoma of the Urinary Bladder: A Brief Review of the Literature.
    Arch Pathol Lab Med. 2016;140:91-3.
    Abstract     Related articles   

  500. YEH BW, Li WM, Li CC, Kang WY, et al
    Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor.
    Toxicol Appl Pharmacol. 2016;290:98-106.
    Abstract     Related articles   

  501. MASSON-LECOMTE A, Lopez de Maturana E, Goddard ME, Picornell A, et al
    Inflammatory-related genetic variants in non-muscle invasive bladder cancer prognosis. A multi-marker Bayesian assessment.
    Cancer Epidemiol Biomarkers Prev. 2016 May 6. pii: cebp.0894.2015.
    Abstract     Related articles   

  502. SWEIS RF, Spranger S, Bao R, Paner GP, et al
    Molecular Drivers of the Non-T Cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
    Cancer Immunol Res. 2016 May 17. pii: canimm.0274.2015.
    Abstract     Related articles   

  503. TAO L, Qiu J, Jiang M, Song W, et al
    Infiltrated T cells promote bladder cancer progression via increasing IL-1-->androgen receptor (AR)-->HIF-1alpha-->VEGFa signals.
    Mol Cancer Ther. 2016 May 11. pii: molcanther.0306.2015.
    Abstract     Related articles   

  504. SINGLA N, Haddad AQ, Passoni NM, Meissner M, et al
    Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.
    World J Urol. 2016.
    Abstract     Related articles   

  505. RABIE E, Faeghi F, Izadpanahi MH, Dayani MA, et al
    Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer.
    J Clin Diagn Res. 2016;10:TC01-5.
    Abstract     Related articles   

  506. PARK T, Lee S
    Clinical Experiences of Korean Medicine Treatment against Urinary Bladder Cancer in General Practice.
    Evid Based Complement Alternat Med. 2016;2016:3759069.
    Abstract     Related articles   

  507. KIM WT, Yun SJ, Yan C, Jeong P, et al
    Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
    Yonsei Med J. 2016;57:865-71.
    Abstract     Related articles   

  508. KIM HS, Ku JH, Kim SJ, Hong SJ, et al
    Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study.
    Yonsei Med J. 2016;57:855-64.
    Abstract     Related articles   

  509. SU Q, Peng M, Zhang Y, Xu W, et al
    Quercetin induces bladder cancer cells apoptosis by activation of AMPK signaling pathway.
    Am J Cancer Res. 2016;6:498-508.
    Abstract     Related articles   

  510. LI F, Yu Z, Chen P, Lin G, et al
    The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.
    Am J Cancer Res. 2016;6:331-40.
    Abstract     Related articles   

  511. ZHANG H, Lu C, Fang M, Yan W, et al
    HIF-1alpha activates hypoxia-induced PFKFB4 expression in human bladder cancer cells.
    Biochem Biophys Res Commun. 2016 May 12. pii: S0006-291X(16)30707.
    Abstract     Related articles   

  512. RADWAN RW, Evans MD, Davies M, Harris DA, et al
    Pelvic exenteration for advanced malignancy in elderly patients.
    Br J Surg. 2016;103:e115-9.
    Abstract     Related articles   

  513. LIU S, Chaudhry MR, Berrebi AA, Papadimitriou JC, et al
    Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation.
    Transplantation. 2016.
    Abstract     Related articles   

  514. TAN WS, Rodney S, Lamb B, Feneley M, et al
    Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia.
    Cancer Treat Rev. 2016;47:22-31.
    Abstract     Related articles   

  515. LEE YR, Lim JS, Shin JH, Choi S, et al
    Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer.
    Int Neurourol J. 2016;20.
    Abstract     Related articles   

  516. TRAN WT, Sannachi L, Papanicolau N, Tadayyon H, et al
    Quantitative ultrasound imaging of therapy response in bladder cancer in vivo.
    Oncoscience. 2016;3.
    Abstract     Related articles   

  517. ALAYEV A, Salamon RS, Schwartz NS, Berman AY, et al
    Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
    J Cell Physiol. 2016 May 25. doi: 10.1002/jcp.25443.
    Abstract     Related articles   

  518. QUAN L, Chattopadhyay K, Nelson HH, Chan KK, et al
    Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Oncotarget. 2016 May 19. doi: 10.18632/oncotarget.9475.
    Abstract     Related articles   

  519. LIU C, Shi B, Hao C, Wang Q, et al
    Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.
    Oncotarget. 2016 May 19. doi: 10.18632/oncotarget.9468.
    Abstract     Related articles   

  520. MILOWSKY MI, Rumble RB, Lee CT
    Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary.
    J Oncol Pract. 2016 May 24. pii: JOPR012898.
    Abstract     Related articles   

  521. KRISHNATREYA M, Kataki AC
    Randomized-Control Screening Trials to Lower Gall Bladder Cancer Mortality in High Risk Populations.
    Asian Pac J Cancer Prev. 2016;17:2325-7.
    Abstract     Related articles   

  522. AGRAWAL S, Mohan L, Mourya C, Neyaz Z, et al
    Radiological Downstaging with Neoadjuvant Therapy in Unresectable Gall Bladder Cancer Cases.
    Asian Pac J Cancer Prev. 2016;17:2137-40.
    Abstract     Related articles   

  523. CELIK O, Akand M, Keskin MZ, Ekin RG, et al
    Predictive Effect of Preoperative Anemia on Long-Term Survival Outcomes with Non-Muscle Invasive Bladder Cancer.
    Asian Pac J Cancer Prev. 2016;17:1755-8.
    Abstract     Related articles   

  524. YANG X, Jiang J, Yang X, Han J, et al
    Licochalcone A induces T24 bladder cancer cell apoptosis by increasing intracellular calcium levels.
    Mol Med Rep. 2016 May 24. doi: 10.3892/mmr.2016.5334.
    Abstract     Related articles   

  525. PICHLER R, Fritz J, Zavadil C, Schafer G, et al
    Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical bacillus calmette-guerin therapy in bladder cancer.
    Oncotarget. 2016 May 21. doi: 10.18632/oncotarget.9537.
    Abstract     Related articles   

  526. BURASCHI S, Xu SQ, Stefanello M, Moskalev I, et al
    Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.
    Oncotarget. 2016 May 23. doi: 10.18632/oncotarget.9556.
    Abstract     Related articles   

  527. EAPEN LJ, Jones E, Kassouf W, Lambert C, et al
    Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  528. SIEMENS DR
    Raising the bar for bladder cancer care.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  529. SWEENEY SK, Luo Y, O'Donnell MA, Assouline J, et al
    Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles.
    Cancer Nanotechnol. 2016;7:3.
    Abstract     Related articles   

  530. ZHANG M, Li H, Zou D, Gao J, et al
    Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile.
    Onco Targets Ther. 2016;9:2717-23.
    Abstract     Related articles   

  531. RAMASWAMY A, Ostwal V, Pande N, Sahu A, et al
    Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option.
    J Gastrointest Cancer. 2016.
    Abstract     Related articles   

  532. ZHAN Y, Lin J, Liu Y, Chen M, et al
    Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    J Exp Clin Cancer Res. 2016;35:83.
    Abstract     Related articles   

  533. ZHOU BF, Wei JH, Chen ZH, Dong P, et al
    Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.
    Oncotarget. 2016 May 17. doi: 10.18632/oncotarget.9406.
    Abstract     Related articles   

  534. GAN X, Lin X, He R, Lin X, et al
    Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis.
    Dis Markers. 2016;2016:5259602.
    Abstract     Related articles   

  535. OJHA R, Jha V, Singh SK
    Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells.
    Biochim Biophys Acta. 2016;1863:347-59.
    Abstract     Related articles   

  536. BAE SH, Seon HJ, Choi YD, Shim HJ, et al
    Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
    J Am Acad Dermatol. 2015 Nov 12. pii: S0190-9622(15)02255.
    Abstract     Related articles   

  537. STAERK K, Khandige S, Kolmos HJ, Moller-Jensen J, et al
    Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions.
    J Infect Dis. 2016;213:386-94.
    Abstract     Related articles   

  538. SHAFI H, Vakili Sadeghi M, Ghorbani H, Sharbatdaran M, et al
    A Case of Multiple Myeloma Following Bladder Cancer.
    Int J Hematol Oncol Stem Cell Res. 2016;10:111-4.
    Abstract     Related articles   

  539. SKINNER EC
    Treatment of Muscle-Invasive Bladder Cancer in Older Patients.
    Am Soc Clin Oncol Educ Book. 2016;35:e228-33.
    Abstract     Related articles   

  540. MITRA AP
    Molecular substratification of bladder cancer: moving towards individualized patient management.
    Ther Adv Urol. 2016;8:215-33.
    Abstract     Related articles   

  541. CHEN S, Chen X, Xie G, He Y, et al
    Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.
    Oncotarget. 2016 May 26. doi: 10.18632/oncotarget.9616.
    Abstract     Related articles   

  542. SANKHWAR M, Sankhwar SN, Bansal SK, Gupta G, et al
    Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sci Rep. 2016;6:27018.
    Abstract     Related articles   

  543. LU CS, Shieh GS, Wang CT, Su BH, et al
    Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.
    Oncotarget. 2016 May 26. doi: 10.18632/oncotarget.9602.
    Abstract     Related articles   

  544. FAHMY O, Khairul-Asri MG, Stenzl A, Gakis G, et al
    Systemic anti-CTLA-4 and intravesical Bacille-Calmette-Guerin therapy in non-muscle invasive bladder cancer: Is there a rationale of synergism?
    Med Hypotheses. 2016;92:57-8.
    Abstract     Related articles   

  545. LIU J, Xu R, Zhao X
    [Mechanisms for effect of osthole on inhibiting the growth and invasion of bladder cancer cells].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41:345-52.
    Abstract     Related articles   

  546. PINTO-LEITE R, Arantes-Rodrigues R, Sousa N, Oliveira PA, et al
    mTOR inhibitors in urinary bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  547. OKUBO T, Kawada M, Saikawa D, Yamamoto K, et al
    [Surgical Treatment for Refractory Metastatic Lung Tumors from Urachal Carcinoma after Chemotherapy].
    Kyobu Geka. 2016;69:210-3.
    Abstract     Related articles   

  548. KAWAHARA T, Kashiwagi E, Li Y, Zheng Y, et al
    Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
    Mol Carcinog. 2016;55:161-9.
    Abstract     Related articles   

  549. LI G, Song H, Wang J, Bao Y, et al
    Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer.
    Sci Rep. 2016;6:27586.
    Abstract     Related articles   

  550. ANG WX, Zhao Y, Kwang T, Wu C, et al
    Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy.
    Sci Rep. 2016;6:27455.
    Abstract     Related articles   

  551. THOMA C
    Bladder cancer: FOXP3Delta3 involved in chemotherapy resistance.
    Nat Rev Urol. 2016 Jun 7. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  552. DABI Y, Rouscoff Y, Anract J, Delongchamps NB, et al
    Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
    World J Urol. 2016.
    Abstract     Related articles   

  553. REXER H
    [Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO].
    Urologe A. 2016.
    Abstract     Related articles   

  554. SALMINEN AP, Jambor I, Syvanen KT, Bostrom PJ, et al
    Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer.
    Minerva Urol Nefrol. 2016;68:138-49.
    Abstract     Related articles   

  555. LAWRENTSCHUK N
    Bladder cancer: working towards better outcomes.
    Minerva Urol Nefrol. 2016;68:105.
    Abstract     Related articles   

  556. POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
    Stage of bladder cancer in Central Europe - Polish perspective.
    Neoplasma. 2016 Jun 7. doi: 10.4149/neo_2016.
    Abstract     Related articles   

  557. HE Y, Wu X, Cao Y, Hou Y, et al
    Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway.
    Neoplasma. 2016 Jun 7. doi: 10.4149/neo_2016.
    Abstract     Related articles   

  558. KADO T, Usui I, Tobe K
    [Pioglitazone and the risk of bladder cancer].
    Nihon Rinsho. 2016;74 Suppl 2:442-6.
    Abstract     Related articles   

  559. GUO J, Ren Y, Hou G, Wen B, et al
    A comprehensive investigation towards the indicative proteins of bladder cancer in urine: from surveying cell secretomes to verifying urine proteins.
    J Proteome Res. 2016.
    Abstract     Related articles   

  560. NOGUERA-ORTEGA E, Blanco-Cabra N, Rabanal RM, Sanchez-Chardi A, et al
    Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.
    Sci Rep. 2016;6:27232.
    Abstract     Related articles   

  561. GOLOVINA DA, Ermilova VD, Zavalishina LE, Andreeva YY, et al
    Loss of Cell Differentiation in HPV-Associated Bladder Cancer.
    Bull Exp Biol Med. 2016.
    Abstract     Related articles   

  562. ABDUL-MAKSOUD RS, Shalaby SM, Elsayed WS, Elkady S, et al
    Fibroblast growth factor receptor 1 and cytokeratin 20 expressions and their relation to prognostic variables in bladder cancer.
    Gene. 2016 May 31. pii: S0378-1119(16)30438-3. doi: 10.1016/j.gene.2016.
    Abstract     Related articles   

  563. JONES RR, Weyer PJ, Dellavalle CT, Inoue-Choi M, et al
    Nitrate from Drinking Water and Diet and Bladder Cancer among Postmenopausal Women in Iowa.
    Environ Health Perspect. 2016.
    Abstract     Related articles   

  564. UTTAM M, Pravin N, Anish B, Nandita K, et al
    Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?
    Int Braz J Urol. 2016;42:234-41.
    Abstract     Related articles   

  565. KAIMAKLIOTIS HZ, Monn MF, Cho JS, Pedrosa JA, et al
    Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.
    Future Oncol. 2016.
    Abstract     Related articles   

  566. FURUDOI A, Caumont C, Dutriaux C, Cappellen D, et al
    Primary digestive melanoma in association with tubular adenoma: a case report illustrating the distinction from metastatic colonic melanoma.
    Hum Pathol. 2016;48:167-71.
    Abstract     Related articles   

  567. YAN L, Salama ME, Lanciault C, Matsumura L, et al
    Polyomavirus large T antigen is prevalent in urothelial carcinoma post-kidney transplant.
    Hum Pathol. 2016;48:122-31.
    Abstract     Related articles   

  568. BRYANT CM, Dang LH, Stechmiller BK, Gilbert SM, et al
    Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.
    Am J Clin Oncol. 2016;39:69-75.
    Abstract     Related articles   

  569. CETRAZ M, Sen V, Schoch S, Streule K, et al
    Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Arch Toxicol. 2016.
    Abstract     Related articles   

  570. CHEETHAM PJ, Petrylak DP
    New Agents for the Treatment of Advanced Bladder Cancer.
    Oncology (Williston Park). 2016;30.
    Abstract     Related articles   

  571. ARAGON-CHING JB, Trump DL
    Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.
    Future Oncol. 2016.
    Abstract     Related articles   

  572. LEBENTRAU S, Lebentrau J, May M, Wick AK, et al
    [Results of a Questionnaire-Based Study on Guideline Adherence Regarding Adjuvant Treatment Recommendations for Patients with Non-Muscle-Invasive Bladder Cancer: Just a Disturbing Sidelight?]
    Aktuelle Urol. 2016.
    Abstract     Related articles   

  573. GOPALAKRISHNA A, Longo TA, Fantony JJ, Owusu R, et al
    The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient.
    BMC Urol. 2016;16:30.
    Abstract     Related articles   

  574. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupation and Risk of Bladder Cancer in Nordic Countries.
    J Occup Environ Med. 2016.
    Abstract     Related articles   

  575. BOLAT D, Gunlusoy B, Degirmenci T, Ceylan Y, et al
    Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study.
    Arch Esp Urol. 2016;69:225-233.
    Abstract     Related articles   

  576. ZERMANN H, Vahlensieck W, Hoffmann W
    [Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
    Urologe A. 2016.
    Abstract     Related articles   

  577. SIDERIS S, Aoun F, Zanaty M, Martinez NC, et al
    Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.
    Mol Clin Oncol. 2016;4:1063-1067.
    Abstract     Related articles   

  578. BIALECKI J, Nowak-Misiak M, Rapala K, Marczynski W, et al
    Spinal tuberculosis with severe neurological symptoms as a complication of intravesical BCG therapy for carcinoma of the bladder.
    Neurol Neurochir Pol. 2016;50:131-8.
    Abstract     Related articles   

  579. PENG M, Huang Y, Tao T, Peng CY, et al
    Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk.
    Sci Rep. 2016;6:28611.
    Abstract     Related articles   

  580. TAKEUCHI A, Shiota M, Tatsugami K, Yokomizo A, et al
    [BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives].
    Fukuoka Igaku Zasshi. 2016;107:8-11.
    Abstract     Related articles   

  581. YUKSEL OH, Akan S, Urkmez A, Yildirim C, et al
    Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence.
    Mol Clin Oncol. 2016;5:201-206.
    Abstract     Related articles   

  582. KAWAHARA T, Ide H, Kashiwagi E, El-Shishtawy KA, et al
    Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
    Urol Oncol. 2016 Jun 18. pii: S1078-1439(16)30086.
    Abstract     Related articles   


  583. First-Line Atezolizumab Effective in Bladder Cancer.
    Cancer Discov. 2016.
    Abstract     Related articles   

  584. OHSHIO I, Kawakami R, Tsukada Y, Nakajima K, et al
    ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin.
    Biochem Biophys Res Commun. 2016 Jun 18. pii: S0006-291X(16)31002.
    Abstract     Related articles   

  585. LI J, Zhuang C, Liu Y, Chen M, et al
    Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    J Exp Clin Cancer Res. 2016;35:99.
    Abstract     Related articles   

  586. GRUBA N, Wysocka M, Brzezinska M, Debowski D, et al
    Bladder cancer detection using a peptide substrate of the 20S proteasome.
    FEBS J. 2016 Jun 21. doi: 10.1111/febs.13786.
    Abstract     Related articles   

  587. KIM J
    Immune checkpoint blockade therapy for bladder cancer treatment.
    Investig Clin Urol. 2016;57 Suppl 1:S98-S105.
    Abstract     Related articles   

  588. KIM YJ, Kim WJ
    Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
    Investig Clin Urol. 2016;57 Suppl 1:S77-88.
    Abstract     Related articles   

  589. ENOKIDA H, Yoshino H, Matsushita R, Nakagawa M, et al
    The role of microRNAs in bladder cancer.
    Investig Clin Urol. 2016;57 Suppl 1:S60-76.
    Abstract     Related articles   

  590. YUN SJ, Kim SK, Kim WJ
    How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
    Investig Clin Urol. 2016;57 Suppl 1:S44-51.
    Abstract     Related articles   

  591. MIYAKE M, Fujimoto K, Hirao Y
    Active surveillance for nonmuscle invasive bladder cancer.
    Investig Clin Urol. 2016;57 Suppl 1:S4-S13.
    Abstract     Related articles   

  592. ERLICH A, Zlotta AR
    Treatment of bladder cancer in the elderly.
    Investig Clin Urol. 2016;57 Suppl 1:S26-35.
    Abstract     Related articles   

  593. PIYATHILAKE C
    Dietary factors associated with bladder cancer.
    Investig Clin Urol. 2016;57 Suppl 1:S14-25.
    Abstract     Related articles   

  594. KIM WJ
    Changing landscape of diagnosis and treatment of bladder cancer.
    Investig Clin Urol. 2016;57 Suppl 1:S1-3.
    Abstract     Related articles   

  595. NGUYEN DP, O'Malley P, Al Awamlh BA, Furrer MA, et al
    Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer.
    Clin Genitourin Cancer. 2016 May 27. pii: S1558-7673(16)30143.
    Abstract     Related articles   

  596. KANG M, Jeong CW, Kwak C, Kim HH, et al
    Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs.
    Oncotarget. 2016 Jun 14. doi: 10.18632/oncotarget.9991.
    Abstract     Related articles   

  597. CHEN MC, Hsu WL, Hwang PA, Chen YL, et al
    Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
    Oncotarget. 2016 Jun 13. doi: 10.18632/oncotarget.9958.
    Abstract     Related articles   

  598. XU ZC, Cai HZ, Li X, Xu WZ, et al
    ERCC1 C118T polymorphism has predictive value for platinum-based chemotherapy in patients with late-stage bladder cancer.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  599. YANG C, Zhang W, Wang L, Kazobinka G, et al
    Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.
    Lab Invest. 2016 Jun 20. doi: 10.1038/labinvest.2016.
    Abstract     Related articles   

  600. MUSAVI SHENAS SM, Mansoori B, Mohammadi A, Salehi S, et al
    SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line.
    Artif Cells Nanomed Biotechnol. 2016.
    Abstract     Related articles   

  601. KASHIWAGI E, Ide H, Inoue S, Kawahara T, et al
    Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer.
    Oncotarget. 2016 Jun 14. doi: 10.18632/oncotarget.9994.
    Abstract     Related articles   

  602. BROWER V
    Anti-PD-L1 inhibitor durvalumab in bladder cancer.
    Lancet Oncol. 2016 Jun 16. pii: S1470-2045(16)30242.
    Abstract     Related articles   

  603. PERES R, Furuya H, Pagano I, Shimizu Y, et al
    Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation.
    Oncotarget. 2016 Jun 15. doi: 10.18632/oncotarget.10097.
    Abstract     Related articles   

  604. CHEDGY EC, Douglas J, Wright JL, Seiler R, et al
    Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer.
    Urol Oncol. 2016 Jun 14. pii: S1078-1439(16)30064.
    Abstract     Related articles   

  605. FUKUMOTO K, Kikuchi E, Mikami S, Ogihara K, et al
    Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers.
    Cancer Sci. 2016 Jun 18. doi: 10.1111/cas.12990.
    Abstract     Related articles   

  606. AFSHARI-MOGHADDAM A, Soleimani M, Lashei A, Dehghani M, et al
    Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review.
    Life Sci. 2016 Jun 14. pii: S0024-3205(16)30369.
    Abstract     Related articles   

  607. GUNLUSOY B, Ceylan Y, Degirmenci T, Aydogdu O, et al
    The potential effect of age on the natural behavior of bladder cancer: Does urothelial cell carcinoma progress differently in various age groups?
    Kaohsiung J Med Sci. 2016;32:261-6.
    Abstract     Related articles   

  608. SCHOFFEL N, Domnitz F, Bruggmann D, Klingelhofer D, et al
    [A critical perspective on the global research activity in the field of bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  609. MIYAZAKI M, Yoshiiwa T, Ishihara T, Kawano M, et al
    Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer.
    Case Rep Orthop. 2016;2016:6741284.
    Abstract     Related articles   

  610. GIEDL J, Rogler A, Wild A, Riener MO, et al
    TERT Core Promotor Mutations in Early-Onset Bladder Cancer.
    J Cancer. 2016;7:915-20.
    Abstract     Related articles   

  611. DAL MORO F, Zattoni F
    T.A.B.: Proposed new system for graphic standardization (and sharing) of clinical histories of bladder cancer patients.
    Urologia. 2016 Jun 6:0. doi: 10.5301/uro.5000177.
    Abstract     Related articles   

  612. BUTI S, Ciccarese C, Iacovelli R, Bersanelli M, et al
    Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
    Future Oncol. 2016.
    Abstract     Related articles   

  613. BAIG M, Guarino M, Petrelli N
    Report on demographics of gall bladder cancer in Delaware and retrospective review of treatment strategies for gallbladder cancer in a large community cancer center.
    Surg Oncol. 2016;25:86-91.
    Abstract     Related articles   

  614. HERR HW
    COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
    Oncology (Williston Park). 2016;30.
    Abstract     Related articles   

  615. FELDMAN AS
    POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
    Oncology (Williston Park). 2016;30.
    Abstract     Related articles   

  616. KER CR, Lin KL, Long CY
    Intravesical endometriosis mimicking bladder cancer.
    Int Urogynecol J. 2016.
    Abstract     Related articles   

  617. SHEN Z, Xie L, Chen T, Tian D, et al
    Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study.
    Medicine (Baltimore). 2016;95:e2625.
    Abstract     Related articles   

  618. LI Q, Bagrodia A, Cha EK, Coleman JA, et al
    Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma.
    Curr Urol Rep. 2016;17:12.
    Abstract     Related articles   

  619. CERRUTO MA, D'Elia C, Siracusano S, Gedeshi X, et al
    Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit.
    Eur J Surg Oncol. 2016;42:343-60.
    Abstract     Related articles   

  620. BARRESI V, Ieni A, Cardia R, Licata L, et al
    HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.
    APMIS. 2016;124:188-93.
    Abstract     Related articles   

  621. RAY DB, Merrill GA, Brenner FJ, Lytle LS, et al
    T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Exp Cell Res. 2016;340:1-11.
    Abstract     Related articles   

  622. YONEMORI M, Seki N, Yoshino H, Matsushita R, et al
    Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 (MMP11) in bladder cancer.
    Cancer Sci. 2016 Jun 29. doi: 10.1111/cas.13002.
    Abstract     Related articles   

  623. OZ II, Altinbas NK, Serifoglu I, Oz EB, et al
    The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer.
    Pol J Radiol. 2016;81:281-7.
    Abstract     Related articles   

  624. CREZEE H, Inman BA
    The use of hyperthermia in the treatment of bladder cancer.
    Int J Hyperthermia. 2016;32:349-50.
    Abstract     Related articles   

  625. WEI Y, He R, Wu Y, Gan B, et al
    Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues.
    Tumour Biol. 2016.
    Abstract     Related articles   

  626. FENNER A
    Bladder cancer: Cisplatin response is modulated by AR activity.
    Nat Rev Urol. 2016 Jun 28. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  627. DONG Y, Wang A
    Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study.
    Oncol Lett. 2016;12:89-92.
    Abstract     Related articles   

  628. HE H, Han C, Hao L, Zang G, et al
    ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.
    Oncol Lett. 2016;12:83-88.
    Abstract     Related articles   

  629. CHUNG JM, Ha HK, Kim DH, Joo J, et al
    Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study.
    Clin Genitourin Cancer. 2016 May 30. pii: S1558-7673(16)30132.
    Abstract     Related articles   

  630. KAMAT AM, Hahn NM, Efstathiou JA, Lerner SP, et al
    Bladder cancer.
    Lancet. 2016 Jun 23. pii: S0140-6736(16)30512.
    Abstract     Related articles   

  631. BAKER H
    Familial risk in patients with carcinoma of unknown primary.
    Lancet Oncol. 2016;17:e48.
    Abstract     Related articles   

  632. KANAAN N, Hassoun Z, Raggi C, Jadoul M, et al
    Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
    Transplantation. 2016;100:416-21.
    Abstract     Related articles   

  633. CUI X, Kong C, Zhu Y, Zeng Y, et al
    miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-kappaB and sustains NF-kappaB activation by decreasing Cylindromatosis expression.
    Oncotarget. 2016 Jul 6. doi: 10.18632/oncotarget.10423.
    Abstract     Related articles   

  634. NAVAI N, Benedict WF, Zhang G, Abraham A, et al
    Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon alpha2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  635. FUJIMURA M, Sakamoto S, Sekita N, Takeuchi N, et al
    Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion.
    Springerplus. 2016;5:848.
    Abstract     Related articles   

  636. GOOSSENS ME, Isa F, Brinkman M, Mak D, et al
    International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics.
    Arch Public Health. 2016;74:30.
    Abstract     Related articles   

  637. CAO J, Xu R, Zhao X, Zhong Z, et al
    Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence.
    Sci Rep. 2016;6:29466.
    Abstract     Related articles   

  638. XIANGUO C, ZongYao H, Jun Z, Song F, et al
    Promoting progression and clinicopathological significance of NEAT1 over-expression in bladder cancer.
    Oncotarget. 2016 Jun 15. doi: 10.18632/oncotarget.10084.
    Abstract     Related articles   

  639. LOPES M, Nascimento LC, Zago MM
    Paradox of life among survivors of bladder cancer and treatments.
    Rev Esc Enferm USP. 2016;50:224-231.
    Abstract     Related articles   

  640. HUANG S, Kou L, Furuya H, Yu C, et al
    A nomogram derived by combination of demographic and biomarker data improves the non-invasive evaluation of patients at risk for bladder cancer.
    Cancer Epidemiol Biomarkers Prev. 2016 Jul 6. pii: cebp.0260.2016.
    Abstract     Related articles   

  641. VINALL RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, et al
    Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy.
    Genes Cancer. 2016;7.
    Abstract     Related articles   

  642. SCHMITZ-DRAGER C, Bonberg N, Pesch B, Todenhofer T, et al
    Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Urol Oncol. 2016 Jul 2. pii: S1078-1439(16)30118.
    Abstract     Related articles   

  643. DI MARTINO E, Tomlinson DC, Williams SV, Knowles MA, et al
    A place for precision medicine in bladder cancer: targeting the FGFRs.
    Future Oncol. 2016.
    Abstract     Related articles   

  644. FAHMY O, Khairul-Asri MG, Stenzl A, Gakis G, et al
    The current status of checkpoint inhibitors in metastatic bladder cancer.
    Clin Exp Metastasis. 2016.
    Abstract     Related articles   

  645. LIANG Y, Zhu F, Zhang H, Chen D, et al
    Conditional ablation of TGF-beta signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.
    Sci Rep. 2016;6:29479.
    Abstract     Related articles   

  646. ALBAYRAK S, Zengin K, Tanik S, Atar M, et al
    Can the neutrophil-to-lymphocyte ratio be used to predict recurrence and progression of non-muscle-invasive bladder cancer?
    Kaohsiung J Med Sci. 2016;32:327-33.
    Abstract     Related articles   

  647. SCHULTZ L, Spagnul SJ, Damm GR, da Cunha IW, et al
    Ulceration in bladder cancer associates with extravesical disease, independent of cell cycle, or hypoxia pathways status: Integrating gross morphology and expression profiles in cystectomies.
    Urol Oncol. 2016 Jul 1. pii: S1078-1439(16)30112.
    Abstract     Related articles   

  648. LERNER SP
    Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines.
    Nat Rev Urol. 2016 Jul 5. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  649. SANSEVERINO R, Napodano G, Campitelli A, Addesso M, et al
    Prognostic impact of ReTURB in high grade T1 primary bladder cancer.
    Arch Ital Urol Androl. 2016;88:81-5.
    Abstract     Related articles   

  650. KAMAT AM, Cookson M, Witjes JA, Stenzl A, et al
    The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis.
    Bl Cancer. 2016;2:273-278.
    Abstract     Related articles   

  651. BOSTROM PJ, Mirtti T, van Rhijn B, Fleshner NE, et al
    Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.
    Bl Cancer. 2016;2:263-272.
    Abstract     Related articles   

  652. KAYE DR, Canner JK, Kates M, Schoenberg MP, et al
    Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.
    Bl Cancer. 2016;2:225-234.
    Abstract     Related articles   

  653. STEINBERG RL, Thomas LJ, Mott SL, O'Donnell MA, et al
    Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.
    Bl Cancer. 2016;2:215-224.
    Abstract     Related articles   

  654. KAMAT AM, Agarwal P, Bivalacqua T, Chisolm S, et al
    Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank.
    Bl Cancer. 2016;2:203-213.
    Abstract     Related articles   

  655. LERNER SP, Bajorin DF, Dinney CP, Efstathiou JA, et al
    Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.
    Bl Cancer. 2016;2:165-202.
    Abstract     Related articles   

  656. MIRZA A, Choudhury A
    Bladder Preservation for Muscle Invasive Bladder Cancer.
    Bl Cancer. 2016;2:151-163.
    Abstract     Related articles   

  657. MOHAMED NE, Gilbert F, Lee CT, Sfakianos J, et al
    Pursuing Quality in the Application of Bladder Cancer Quality of Life Research.
    Bl Cancer. 2016;2:139-149.
    Abstract     Related articles   

  658. GODOY G, Gakis G, Smith CL, Fahmy O, et al
    Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.
    Bl Cancer. 2016;2:127-137.
    Abstract     Related articles   

  659. BOSTROM PJ, Thoms J, Sykes J, Ahmed O, et al
    Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.
    Bl Cancer. 2016;2:101-109.
    Abstract     Related articles   

  660. GROTENHUIS AJ, Dudek AM, Verhaegh GW, Aben KK, et al
    Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response.
    Bl Cancer. 2016;2:77-89.
    Abstract     Related articles   

  661. BHAT A, Mokou M, Zoidakis J, Jankowski V, et al
    BcCluster: A Bladder Cancer Database at the Molecular Level.
    Bl Cancer. 2016;2:65-76.
    Abstract     Related articles   


  662. Editorial concerning "Pelvic lymph node dissection may be limited on the contralateral side in strictly unilateral bladder cancer without compromising oncological radicality".
    Bl Cancer. 2016;2:61-62.
    Abstract     Related articles   

  663. KISS B, Paerli M, Schondorf D, Burkhard FC, et al
    Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality.
    Bl Cancer. 2016;2:53-59.
    Abstract     Related articles   

  664. BOORMANS JL, Zwarthoff EC
    Limited Funds for Bladder Cancer Research and What Can We Do About It.
    Bl Cancer. 2016;2:49-51.
    Abstract     Related articles   

  665. LERNER SP, McConkey DJ, Hoadley KA, Chan KS, et al
    Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting.
    Bl Cancer. 2016;2:37-47.
    Abstract     Related articles   

  666. POWER NE, Izawa J
    Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE).
    Bl Cancer. 2016;2:27-36.
    Abstract     Related articles   

  667. BIDNUR S, Savdie R, Black PC
    Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer.
    Bl Cancer. 2016;2:15-25.
    Abstract     Related articles   

  668. ZHU F, Ren Q
    [A case of Mullerian duct cyst torsion combined with bladder cancer].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41:653-6.
    Abstract     Related articles   

  669. WAN P, Huang Y, Wang Z, Wang H, et al
    [The establishment of 5637 bladder cancer cell line with stable overexpression of miR-449c].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32:760-3.
    Abstract     Related articles   

  670. KASSOUF W, Traboulsi SL, Schmitz-Drager B, Palou J, et al
    Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Urol Oncol. 2016 Jun 28. pii: S1078-1439(16)30109.
    Abstract     Related articles   

  671. LIN MH, Lee YH, Cheng HL, Chen HY, et al
    Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1).
    Molecules. 2016;21.
    Abstract     Related articles   

  672. AMANTINI C, Morelli MB, Nabissi M, Cardinali C, et al
    Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner.
    Oncotarget. 2016 Jun 29. doi: 10.18632/oncotarget.10326.
    Abstract     Related articles   

  673. KIM KH, Yoon HS, Yoon H, Chung WS, et al
    Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer.
    J Korean Med Sci. 2016;31:1100-4.
    Abstract     Related articles   

  674. BUISAN O, Orsola A, Areal J, Font A, et al
    Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2016 Jun 1. pii: S1558-7673(16)30130.
    Abstract     Related articles   

  675. XIE Q, Huang Z, Zhu Z, Zheng X, et al
    Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
    Anal Quant Cytopathol Histpathol. 2016;38:38-44.
    Abstract     Related articles   

  676. CUI L, Sun MM, Zhao ZH, Yang JP, et al
    BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
    J Biol Regul Homeost Agents. 2016;30:485-90.
    Abstract     Related articles   

  677. KUROZUMI A, Goto Y, Okato A, Ichikawa T, et al
    Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.
    J Hum Genet. 2016 Jun 30. doi: 10.1038/jhg.2016.
    Abstract     Related articles   

  678. PANDITH AA, Hussain A, Khan MS, Shah ZA, et al
    Oncogenic Activation of Fibroblast Growth Factor Receptor-3 and RAS Genes as Non-Overlapping Mutual Exclusive Events in Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2016;17:2787-93.
    Abstract     Related articles   

  679. WANG X, Wu G, Cao G, Chen X, et al
    MicroRNA335 inhibits bladder cancer cell growth and migration by targeting mitogenactivated protein kinase 1.
    Mol Med Rep. 2016 Jun 27. doi: 10.3892/mmr.2016.5448.
    Abstract     Related articles   

  680. MIRJALILI SM, Hashemipour S, Salehi S, Kazemifar AM, et al
    Thyroid metastasis of bladder transitional cell carcinoma.
    Malays J Pathol. 2016;38:65-70.
    Abstract     Related articles   

  681. AYEDI I, Abdelli I, Chaabouni H, Charfi S, et al
    [Neuroendocrine carcinoma of the bladder: A single centre retrospective study].
    Cancer Radiother. 2016;20:1-5.
    Abstract     Related articles   

  682. TORIYAMA S, Horinaka M, Yasuda S, Taniguchi T, et al
    A histone deacetylase inhibitor OBP-801 and celecoxib synergistically inhibit the cell growth with apoptosis via a DR5-dependent pathway in bladder cancer cells.
    Mol Cancer Ther. 2016 Jul 12. pii: molcanther.0010.2016.
    Abstract     Related articles   

  683. ZIBELMAN M, Plimack ER
    Systemic therapy for bladder cancer finally comes into a new age.
    Future Oncol. 2016.
    Abstract     Related articles   

  684. ISHAQ M, Ojha R, Sharma K, Sharma G, et al
    Functional inhibition of Hsp70 by Pifithrin-mu switches Gambogic acid induced caspase dependent cell death to caspase independent cell death in human bladder cancer cells.
    Biochim Biophys Acta. 2016 Jul 7. pii: S0167-4889(16)30180.
    Abstract     Related articles   

  685. CELIK O, Ekin G, Ipekci T, Budak S, et al
    Diagnosis and treatment in primary bladder small cell carcinoma: Literature review.
    Arch Ital Urol Androl. 2016;88:52-5.
    Abstract     Related articles   

  686. MINARDI D, Milanese G, Parri G, Lacetera V, et al
    Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
    Arch Ital Urol Androl. 2016;88:13-6.
    Abstract     Related articles   

  687. CHUNG AD, Schieda N, Flood TA, Cagiannos I, et al
    Suburothelial and extrinsic lesions of the urinary bladder: radiologic and pathologic features with emphasis on MR imaging.
    Abdom Imaging. 2015.
    Abstract     Related articles   

  688. CHANG N, Lee HW, Lim JE, Jeong DE, et al
    Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.
    Oncotarget. 2016 Jul 12. doi: 10.18632/oncotarget.10539.
    Abstract     Related articles   

  689. HE A, Chen Z, Mei H, Liu Y, et al
    Decreased expression of LncRNA MIR31HG in human bladder cancer.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  690. FAN Z, Huangfu X, Liu Z
    Effect of autophagy on cisplatin caused bladder cancer cell apoptosis.
    Panminerva Med. 2016.
    Abstract     Related articles   

  691. LENIS AT, Donin NM, Litwin MS, Saigal CS, et al
    Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guerin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2016 Jun 25. pii: S1558-7673(16)30175.
    Abstract     Related articles   

  692. SHIOTA M, Yokomizo A, Takeuchi A, Inokuchi J, et al
    Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  693. KATES M, Ball MW, Chappidi MR, Baras AS, et al
    Accuracy of urethral frozen section during radical cystectomy for bladder cancer.
    Urol Oncol. 2016 Jul 15. pii: S1078-1439(16)30131.
    Abstract     Related articles   

  694. HOJEIJ R, Domingos-Pereira S, Nkosi M, Gharbi D, et al
    Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
    Int J Mol Sci. 2016;17.
    Abstract     Related articles   

  695. LI S, Zhu Y, Liang Z, Wang X, et al
    Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Oncotarget. 2016 Jul 13. doi: 10.18632/oncotarget.10575.
    Abstract     Related articles   

  696. GROSSMAN HB, Lamm DL, Kamat AM, Keefe S, et al
    Innovation in Bladder Cancer Immunotherapy.
    J Immunother. 2016.
    Abstract     Related articles   

  697. JORDAN AR, Lokeshwar SD, Lopez LE, Hennig M, et al
    Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.
    Oncotarget. 2016 Jul 11. doi: 10.18632/oncotarget.10529.
    Abstract     Related articles   

  698. LERNER SP, Robertson AG
    Molecular Subtypes of Non-muscle Invasive Bladder Cancer.
    Cancer Cell. 2016;30:1-3.
    Abstract     Related articles   

  699. TANAKA K, Ikeda A, Miyakawa T, Komine M, et al
    [A Case of Inflammatory Myofibroblastic Tumor of Urinary Bladder].
    Hinyokika Kiyo. 2016;62:201-4.
    Abstract     Related articles   

  700. KONO Y, Terada N, Takashima Y, Hikami K, et al
    [Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty].
    Hinyokika Kiyo. 2016;62:33-7.
    Abstract     Related articles   

  701. LI J, Xu Y, Zhang Z, Zhang M, et al
    [Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32:232-5.
    Abstract     Related articles   

  702. CHEN W, Zhou J, Wu K, Huang J, et al
    Targeting XBP1-mediated beta-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.
    Oncotarget. 2016 Jul 27. doi: 10.18632/oncotarget.10863.
    Abstract     Related articles   

  703. NAKHLE J, Pierron V, Bauchet AL, Plas P, et al
    Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer.
    Oncoimmunology. 2016;5:e1145333.
    Abstract     Related articles   

  704. POSPISILOVA S, Pazourkova E, Horinek A, Brisuda A, et al
    MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
    Neoplasma. 2016;63.
    Abstract     Related articles   

  705. LIU J, Zhang WY, Kong ZH, Ding DG, et al
    Induction of cell cycle arrest and apoptosis by grape seed procyanidin extract in human bladder cancer BIU87 cells.
    Eur Rev Med Pharmacol Sci. 2016;20:3282-91.
    Abstract     Related articles   

  706. ZOLOT J
    Arsenic Levels in Drinking Water Linked to Bladder Cancer in New England.
    Am J Nurs. 2016;116:16.
    Abstract     Related articles   

  707. ZHU L, Ni C, Dong B, Zhang Y, et al
    A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer.
    Cancer Med. 2016 Jul 27. doi: 10.1002.
    Abstract     Related articles   

  708. YIN L, Liu S, Li C, Ding S, et al
    CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Tumour Biol. 2016.
    Abstract     Related articles   

  709. KAWAHARA T, Inoue S, Ide H, Kashiwagi E, et al
    ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
    Oncotarget. 2016 Jul 18. doi: 10.18632/oncotarget.10679.
    Abstract     Related articles   

  710. VILA-CABALLER M, Codolo G, Munari F, Malfanti A, et al
    A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.
    J Control Release. 2016;238:31-42.
    Abstract     Related articles   

  711. JOHN BA, Xu T, Ripp S, Wang HR, et al
    A Real-Time Non-invasive Auto-bioluminescent Urinary Bladder Cancer Xenograft Model.
    Mol Imaging Biol. 2016.
    Abstract     Related articles   

  712. SEO HK, Shin SP, Jung NR, Kwon WA, et al
    The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.
    Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10784.
    Abstract     Related articles   

  713. MCDONALD ML, Liss MA, Nseyo UU, Gal DB, et al
    Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival.
    Clin Genitourin Cancer. 2016 Jun 23. pii: S1558-7673(16)30160.
    Abstract     Related articles   

  714. ILIEV R, Kleinova R, Juracek J, Dolezel J, et al
    Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  715. MARUF M, Brancato SJ, Agarwal PK
    Nonmuscle invasive bladder cancer: a primer on immunotherapy.
    Cancer Biol Med. 2016;13:194-205.
    Abstract     Related articles   

  716. SOLOWAY MS
    Ct2 Bladder Cancer.
    Curr Urol Rep. 2016;17:66.
    Abstract     Related articles   

  717. ISKENDER B, Izgi K, Canatan H
    Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Tumour Biol. 2016.
    Abstract     Related articles   

  718. MIKHAILENKO DS, Kushlinskii NE
    [THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].
    Klin Lab Diagn. 2016;61:78-83.
    Abstract     Related articles   

  719. ANGHEL RM, Gales LN, Trifanescu OG
    Outcome of urinary bladder cancer after combined therapies.
    J Med Life. 2016;9:153-9.
    Abstract     Related articles   

  720. WANG M, Xiao X, Zeng F, Xie F, et al
    Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.
    Gene. 2016 Jul 19. pii: S0378-1119(16)30568-6. doi: 10.1016/j.gene.2016.
    Abstract     Related articles   

  721. MOHAMED NE, Pisipati S, Lee CT, Goltz HH, et al
    Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices.
    Urol Oncol. 2016 Jul 19. pii: S1078-1439(16)30127.
    Abstract     Related articles   

  722. PALMER S, Litvinova K, Dunaev A, Fleming S, et al
    Changes in autofluorescence based organoid model of muscle invasive urinary bladder cancer.
    Biomed Opt Express. 2016;7:1193-200.
    Abstract     Related articles   

  723. ZHENG LF, Sun WY
    Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer.
    Biomed Rep. 2016;5:159-164.
    Abstract     Related articles   

  724. HERR HW
    Cystoscopy and intravesical bacille Calmette-Guerin therapy in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria: An update.
    Arab J Urol. 2016;14:75-7.
    Abstract     Related articles   

  725. LONG Y, Wu Z, Yang X, Chen L, et al
    MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS.
    Mol Med Rep. 2016 Jul 20. doi: 10.3892/mmr.2016.5534.
    Abstract     Related articles   

  726. FENNER A
    Bladder cancer: Accuracy of urethral frozen section.
    Nat Rev Urol. 2016 Aug 2. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  727. SIDAWAY P
    Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.
    Nat Rev Urol. 2016 Aug 2. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  728. LIN TY, Li Y, Liu Q, Chen JL, et al
    Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer.
    Biomaterials. 2016;104:339-351.
    Abstract     Related articles   

  729. GAWLIK-RZEMIENIEWSKA N, Galilejczyk A, Krawczyk M, Bednarek I, et al
    Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells.
    Arch Med Sci. 2016;12:889-97.
    Abstract     Related articles   

  730. KUMARI S, Tewari S, Husain N, Agarwal A, et al
    Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
    Pathol Oncol Res. 2016.
    Abstract     Related articles   

  731. OJHA R, Singh SK, Bhattacharyya S
    JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells.
    Biochim Biophys Acta. 2016 Jul 27. pii: S0304-4165(16)30268.
    Abstract     Related articles   

  732. ZHOU Y, Song R, Zhang Z, Lu X, et al
    The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer.
    Anal Bioanal Chem. 2016.
    Abstract     Related articles   

  733. AKKALP AK, Onur O, Tetikkurt US, Tolga D, et al
    Prognostic Significance of Mitotic Activity in Noninvasive, Low-Grade, Papillary Urothelial Carcinoma.
    Anal Quant Cytopathol Histpathol. 2016;38:23-30.
    Abstract     Related articles   

  734. MONTORI VM
    Selecting the right drug treatment for adults with type 2 diabetes.
    BMJ. 2016;352:i1663.
    Abstract     Related articles   

  735. UEDA N, Kobayashi Y, Arai H, Honda M, et al
    [Intravesical Recurrence of Small Cell Carcinoma of the Ureter: A Case Report].
    Hinyokika Kiyo. 2016;62:93-7.
    Abstract     Related articles   

  736. YANAGISAWA M, Kawakami T, Suzuki K, Nakayama T, et al
    [Case of a Plasmacytoid Urothelial Carcinoma Identified Due to the Hardening of the Abdominal Wall].
    Hinyokika Kiyo. 2016;62:83-6.
    Abstract     Related articles   

  737. NITTA S, Suetomi T, Kojou K, Tanaka K, et al
    [Solitary Bladder Metastasis of Chromophobe Renal Cell Carcinoma: Report of a Case].
    Hinyokika Kiyo. 2016;62:63-7.
    Abstract     Related articles   

  738. KUBOTA M, Kanno T, Nishiyama R, Okada T, et al
    [A Case of Perirenal Non-Specific Lymphadenitis Resected by Laparoscopic Operation for the Possibility of Malignancy].
    Hinyokika Kiyo. 2016;62:57-61.
    Abstract     Related articles   

  739. OSMAN Y, Harraz AM
    A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors.
    Curr Urol Rep. 2016;17:21.
    Abstract     Related articles   

  740. KONRADSEN S, Mathisen T, Haro S
    [A man in his 60s with acute back pain and kidney failure].
    Tidsskr Nor Laegeforen. 2016;136:139-41.
    Abstract     Related articles   

  741. SHANG C, Guo Y, Zhang H, Xue YX, et al
    Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Cancer Chemother Pharmacol. 2016;77:507-13.
    Abstract     Related articles   

  742. JAKOBSEN M, Engvad B, Jensen T, Marcussen N, et al
    Incidental finding of multiple well-differentiated papillary mesotheliomas in peritoneum.
    APMIS. 2016;124:333-4.
    Abstract     Related articles   

  743. KIKUCHI E, Miyazaki J, Yuge K, Hagiwara M, et al
    Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience.
    Jpn J Clin Oncol. 2016;46:163-9.
    Abstract     Related articles   

  744. BROEDE A, Oll M, Maurer A, Siegert S, et al
    Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ss-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
    J Clin Pathol. 2016;69:307-12.
    Abstract     Related articles   

  745. KLINGA G, Sherif A
    A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy.
    Springerplus. 2016;5:1167.
    Abstract     Related articles   

  746. WAKAI K, Utsumi T, Oka R, Endo T, et al
    Clinical predictors for high-grade bladder cancer before first-time transurethral resection of the bladder tumor: a retrospective cohort study.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  747. BAUMANN BC, Bosch WR, Bahl A, Birtle AJ, et al
    Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.
    Int J Radiat Oncol Biol Phys. 2016;96:78-86.
    Abstract     Related articles   

  748. AHN JH, Jung SI, Yim SU, Kim SW, et al
    Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus.
    J Korean Med Sci. 2016;31:1464-71.
    Abstract     Related articles   

  749. ALMEIDA GL, Busato WF Jr, Ribas CM, Ribas JM Filho, et al
    External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1.
    Int Braz J Urol. 2016 Aug 10. doi: 10.1590/S1677-5538.IBJU.2015.0169.
    Abstract     Related articles   

  750. WANG Y, Xing QF, Liu XQ, Guo ZJ, et al
    MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.
    Am J Transl Res. 2016;8:3056-66.
    Abstract     Related articles   

  751. RATNER M
    Genentech's PD-L1 agent approved for bladder cancer.
    Nat Biotechnol. 2016;34:789-90.
    Abstract     Related articles   

  752. SATKUNASIVAM R, Wallis CJ, Nam RK, Desai M, et al
    Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer.
    Nat Rev Urol. 2016 Aug 9. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  753. POLAT M, Altunay Tuman B, Sahin A, Dogan U, et al
    Bilateral nevus comedonicus of the eyelids associated with bladder cancer and successful treatment with topical tretinoin.
    Dermatol Ther. 2016 Aug 9. doi: 10.1111/dth.12385.
    Abstract     Related articles   

  754. VAN KESSEL KE, de Haan LM, Fransen van de Putte EE, van Rhijn BW, et al
    Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer.
    Bl Cancer. 2016;2:351-360.
    Abstract     Related articles   

  755. DANNA BJ, Metcalfe MJ, Wood EL, Shah JB, et al
    Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments.
    Bl Cancer. 2016;2:329-340.
    Abstract     Related articles   

  756. CASEY MF, Wisnivesky J, Le VH, Sarpel U, et al
    The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer.
    Bl Cancer. 2016;2:319-327.
    Abstract     Related articles   

  757. D'COSTA JJ, Goldsmith JC, Wilson JS, Bryan RT, et al
    A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer.
    Bl Cancer. 2016;2:301-317.
    Abstract     Related articles   

  758. GAKIS G, Fahmy O
    Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer.
    Bl Cancer. 2016;2:293-300.
    Abstract     Related articles   

  759. DOUGLASS L, Schoenberg M
    The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer.
    Bl Cancer. 2016;2:285-292.
    Abstract     Related articles   

  760. LEIBOWITZ-AMIT R, Israel A, Gal M, Atenafu EA, et al
    Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2016 Aug 4. pii: S0936-6555(16)30185.
    Abstract     Related articles   

  761. GUIJARRO A, Hernandez V, Llorente C
    The anatomical limits and oncological benefit of lymphadenectomy in muscle invasive bladder cancer.
    Actas Urol Esp. 2016 Aug 3. pii: S0210-4806(16)30112.
    Abstract     Related articles   

  762. RETZ M, Gschwend JE, Maisch P
    [Short version of the German S3 guideline for bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  763. OSHIRO H, Czerniak BA, Sakamaki K, Tsuta K, et al
    Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.
    Medicine (Baltimore). 2016;95:e4500.
    Abstract     Related articles   

  764. MA C, Gu L, Yang M, Zhang Z, et al
    rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis.
    Medicine (Baltimore). 2016;95:e4417.
    Abstract     Related articles   

  765. ROTH B, Jayaratna I, Sundi D, Cheng T, et al
    Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.
    Oncotarget. 2016 Aug 2. doi: 10.18632/oncotarget.11009.
    Abstract     Related articles   

  766. VEERATTERAPILLAY R, Heer R, Johnson MI, Persad R, et al
    High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG Shortage.
    Curr Urol Rep. 2016;17:68.
    Abstract     Related articles   

  767. NAWAZ K, Webster RM
    The bladder cancer drug market.
    Nat Rev Drug Discov. 2016 Aug 5. doi: 10.1038/nrd.2016.
    Abstract     Related articles   

  768. HERMANS TJ, Fransen van de Putte EE, Fossion LM, Werkhoven EV, et al
    Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.
    Urol Oncol. 2016 Aug 1. pii: S1078-1439(16)30135.
    Abstract     Related articles   

  769. MLAKAR J, Volavsek M
    Influence of gross specimen sampling on the incidence of incidental prostatic carcinoma in cystoprostatectomy specimens of patients with bladder carcinoma.
    Pol J Pathol. 2016;67:8-12.
    Abstract     Related articles   

  770. NEUMANN PA, Mehdorn AS, Puehse G, Senninger N, et al
    Perineal herniation of an ileal neobladder following radical cystectomy and consecutive rectal resection for recurrent bladder carcinoma.
    Ann R Coll Surg Engl. 2016;98:e62-4.
    Abstract     Related articles   

  771. TSUI KH, Lin YH, Chung LC, Chuang ST, et al
    Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Cancer Lett. 2016;375:142-51.
    Abstract     Related articles   

  772. WALLIS CJ, Mahar AL, Choo R, Herschorn S, et al
    Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.
    BMJ. 2016;352:i851.
    Abstract     Related articles   

  773. EYLER CE, Zietman AL
    A (relatively) risky business: the link between prostatic radiotherapy and second malignancies.
    BMJ. 2016;352:i1073.
    Abstract     Related articles   

  774. AHN J, Kim KH, Park S, Ahn YH, et al
    Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.
    Oncotarget. 2016 Aug 11. doi: 10.18632/oncotarget.11207.
    Abstract     Related articles   

  775. SEKULA P, Pressler JB, Sauerbrei W, Goebell PJ, et al
    Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example.
    BMJ Open. 2016;6:e009972.
    Abstract     Related articles   

  776. ZHANG R, Wang L, Garrett SH, Sens DA, et al
    Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.
    Exp Toxicol Pathol. 2016 Aug 13. pii: S0940-2993(16)30103.
    Abstract     Related articles   

  777. LEE CJ, Davila D, Dua A, Keyashian B, et al
    Disseminated Mycotic Aneurysms Following Intravesical bacillus Calmette-Guerin Therapy for Bladder Cancer: Case Discussion and Systematic Treatment Algorithm.
    Ann Vasc Surg. 2016 Aug 12. pii: S0890-5096(16)30646.
    Abstract     Related articles   

  778. KORHONEN P, Heintjes EM, Williams R, Hoti F, et al
    Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.
    BMJ. 2016;354:i3903.
    Abstract     Related articles   

  779. KIM WT, Jeong P, Yan C, Kim YH, et al
    UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Oncotarget. 2016 Aug 12. doi: 10.18632/oncotarget.11277.
    Abstract     Related articles   

  780. RIOU O, Chauvet B, Lagrange JL, Martin P, et al
    [Radiotherapy of bladder cancer].
    Cancer Radiother. 2016 Aug 9. pii: S1278-3218(16)30134.
    Abstract     Related articles   

  781. GABIG TG, Waltzer WC, Whyard T, Romanov V, et al
    Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
    Biochem Biophys Res Commun. 2016 Aug 9. pii: S0006-291X(16)31301.
    Abstract     Related articles   

  782. KARL A, Grimm T, Jokisch F, Gaisa NT, et al
    [Non-muscle invasive bladder cancer : Current aspects of diagnostics, local therapy options and the update of the 2016 WHO classification].
    Urologe A. 2016.
    Abstract     Related articles   

  783. SERRETTA V, Gesolfo CS, Di Maida F, Caruana G, et al
    The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer.
    Urologia. 2016 Aug 11:0. doi: 10.5301/uro.5000189.
    Abstract     Related articles   

  784. HE A, Liu Y, Chen Z, Li J, et al
    Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    J Exp Clin Cancer Res. 2016;35:125.
    Abstract     Related articles   

  785. PATTISON JM, Posternak V, Cole MD
    Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.
    Mol Cancer Res. 2016 Aug 11. pii: molcanres.0123.2016.
    Abstract     Related articles   

  786. BARKAN GA
    Enough is enough: Adequacy of voided urine cytology.
    Cancer Cytopathol. 2016;124:163-6.
    Abstract     Related articles   

  787. VANDENBUSSCHE CJ, Rosenthal DL, Olson MT
    Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:174-80.
    Abstract     Related articles   

  788. GLASS RE, Coutsouvelis C, Sheikh-Fayyaz S, Chau K, et al
    Two-tiered subdivision of atypia on urine cytology can improve patient follow-up and optimize the utility of UroVysion.
    Cancer Cytopathol. 2016;124:188-95.
    Abstract     Related articles   

  789. LIANG Z, Wang X, Xie B, Zhu Y, et al
    Pesticide exposure and risk of bladder cancer: A meta-analysis.
    Oncotarget. 2016 Aug 19. doi: 10.18632/oncotarget.11397.
    Abstract     Related articles   

  790. JOU YC, Tsai YS, Lin CT, Tung CL, et al
    Foxp3 enhances HIF-1alpha target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation.
    Oncotarget. 2016 Aug 19. doi: 10.18632/oncotarget.11395.
    Abstract     Related articles   

  791. ZHANG R, Che X, Zhang J, Li Y, et al
    Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation.
    Oncotarget. 2016 Aug 20. doi: 10.18632/oncotarget.11440.
    Abstract     Related articles   

  792. XIU W, Ma J, Lei T, Zhang M, et al
    Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2/STAT3 pathway.
    Oncotarget. 2016 Aug 20. doi: 10.18632/oncotarget.11434.
    Abstract     Related articles   

  793. POUESSEL D, Bastuji-Garin S, Houede N, Vordos D, et al
    Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.
    Clin Genitourin Cancer. 2016 Jul 21. pii: S1558-7673(16)30213.
    Abstract     Related articles   

  794. ROLEVICH A, Minich A, Nabebina T, Polyakov S, et al
    Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer.
    Cent European J Urol. 2016;69:170-7.
    Abstract     Related articles   

  795. KOLODZIEJ A, Krajewski W, Matuszewski M, Tupikowski K, et al
    Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer.
    Cent European J Urol. 2016;69:150-6.
    Abstract     Related articles   

  796. UHLMAN MA, Bevill MD, Goodheart MJ, Brown JA, et al
    Bladder cancer will grow anywhere: report of a urothelial carcinoma drop metastasis to the vagina and literature review.
    Can J Urol. 2016;23:8379-81.
    Abstract     Related articles   

  797. BORKOWSKI T, Monika Dulewicz A, Borkowski A, Pietka D, et al
    Clinical value of digital image analysis in the diagnosis of urinary bladder cancer, particularly in aggressive tumors: a preliminary report.
    Pol J Pathol. 2016;67:122-9.
    Abstract     Related articles   

  798. LI F, Hong X, Hou L, Lin F, et al
    A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis.
    Oncotarget. 2016 Aug 17. doi: 10.18632/oncotarget.11343.
    Abstract     Related articles   

  799. PEIXOTO A, Fernandes E, Gaiteiro C, Lima L, et al
    Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.
    Oncotarget. 2016 Aug 12. doi: 10.18632/oncotarget.11257.
    Abstract     Related articles   

  800. MA C, Lu B, Diao C, Zhao K, et al
    Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Onco Targets Ther. 2016;9:4917-22.
    Abstract     Related articles   

  801. PATEL MN, Hemal AK
    Molecular Targeted Fluorescence-Guided Intraoperative Imaging of Bladder Cancer Nodal Drainage Using Indocyanine Green During Radical and Partial Cystectomy.
    Curr Urol Rep. 2016;17:74.
    Abstract     Related articles   

  802. HAO H, Su XH, Zheng W, Ge P, et al
    [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
    Beijing Da Xue Xue Bao. 2016;48:627-31.
    Abstract     Related articles   

  803. MURASAWA H, Koie T, Ohyama C, Yamamoto H, et al
    The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
    Int J Clin Oncol. 2016.
    Abstract     Related articles   

  804. SONPAVDE G
    Systemic Therapy for Urothelial Carcinoma: Is a Renaissance Around the Corner?
    Oncology (Williston Park). 2016;30:580-3.
    Abstract     Related articles   

  805. SOMDA SM, Florence D, Leconte E, Filleron T, et al
    Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach.
    Urol Oncol. 2016;34:244-5.
    Abstract     Related articles   

  806. ZHANG D, Su M, Liu C, Zhao H, et al
    Discussion on robot-assisted laparoscopic cystectomy and Ileal neobladder surgery preoperative care.
    Pak J Pharm Sci. 2016;29.
    Abstract     Related articles   

  807. RAMAN JD
    Prognostic markers for urologic cancers.
    Can J Urol. 2016;23:8155.
    Abstract     Related articles   

  808. WENJUAN C, Jianzhong L, Chong L, Yanjun G, et al
    The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis.
    Int Braz J Urol. 2016 Sep 1. doi: 10.1590/S1677-5538.IBJU.2015.0446.
    Abstract     Related articles   

  809. RETZ M, Maisch P, Gschwend JE
    [S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators].
    Urologe A. 2016;55:1188-91.
    Abstract     Related articles   

  810. WELINDER C, Jirstrom K, Lehn S, Nodin B, et al
    Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
    Heliyon. 2016;2:e00143.
    Abstract     Related articles   

  811. TORZSOK P, Bauer S, Forstner R, Sievert KD, et al
    Laparoscopic Radical Cystectomy and Ileal Neobladder for Muscle Invasive Bladder Cancer in Combination with One Stage Prophylactic Laparoscopic Sacrospinal Fixation to Avoid Future Pelvic Organ Prolapse.
    J Endourol Case Rep. 2016;2:59-61.
    Abstract     Related articles   

  812. DAGROSA LM, Ghali F, Gormley EA
    Renal Papillary Necrosis Appearing as Bladder Cancer on Imaging.
    J Endourol Case Rep. 2016;2:27-9.
    Abstract     Related articles   

  813. XIAO J, Lin HY, Zhu YY, Zhu YP, et al
    MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway.
    Onco Targets Ther. 2016;9:5181-93.
    Abstract     Related articles   

  814. CHEN F, Huang T, Ren Y, Wei J, et al
    Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis.
    BMC Urol. 2016;16:52.
    Abstract     Related articles   

  815. VAN RHIJN BW, Burger M
    Bladder cancer: Low adherence to guidelines in non-muscle-invasive disease.
    Nat Rev Urol. 2016 Aug 31. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  816. ZHUANG X, Lv M, Zhong Z, Zhang L, et al
    Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    J Exp Clin Cancer Res. 2016;35:130.
    Abstract     Related articles   

  817. CHENG Y, Zhang X, Li P, Yang C, et al
    MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.
    Onco Targets Ther. 2016;9:5091-9.
    Abstract     Related articles   

  818. HEIDARI F, Abbas Zade S, Mir Hosseini SH, Ghadian A, et al
    Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?
    Nephrourol Mon. 2016;8:e30261.
    Abstract     Related articles   

  819. MATIC M, Dragicevic B, Pekmezovic T, Suvakov S, et al
    Common Polymorphisms in GSTA1, GSTM1 and GSTT1 Are Associated with Susceptibility to Urinary Bladder Cancer in Individuals from Balkan Endemic Nephropathy Areas of Serbia.
    Tohoku J Exp Med. 2016;240:25-30.
    Abstract     Related articles   

  820. YANG LS, Shan BL, Shan LL, Chin P, et al
    A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer.
    Surg Oncol. 2016;25:281-97.
    Abstract     Related articles   

  821. ZHU YT, Pang SY, Luo Y, Chen W, et al
    A modified method by differential adhesion for enrichment of bladder cancer stem cells.
    Int Braz J Urol. 2016;42:817-24.
    Abstract     Related articles   

  822. FAVILLA V, Castelli T, Urzi D, Reale G, et al
    Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
    Int Braz J Urol. 2016;42:685-93.
    Abstract     Related articles   

  823. FENG L, Song J, Wu M, Tian Y, et al
    Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience.
    Int Braz J Urol. 2016;42:655-62.
    Abstract     Related articles   

  824. PARK BH, Lim JE, Jeon HG, Seo SI, et al
    Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Oncotarget. 2016 Aug 24. doi: 10.18632/oncotarget.11563.
    Abstract     Related articles   

  825. GERARDI MA, Jereczek-Fossa BA, Zerini D, Surgo A, et al
    Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience.
    Ecancermedicalscience. 2016;10:657.
    Abstract     Related articles   

  826. HERNANDEZ-FERNANDEZ C, Herranz-Amo F, Moralejo-Garate M, Subira-Rios D, et al
    Infiltrating bladder cancer: prognostic factors, follow-up and treatment of relapses.
    Actas Urol Esp. 2016 Aug 22. pii: S0210-4806(16)30119.
    Abstract     Related articles   

  827. JENSEN BT, Dalbagni G, Borre M, Love-Retinger N, et al
    Preoperative Nutritional Status and The Impact on Radical Cystectomy Recovery: An International Comparative Study.
    Urol Nurs. 2016;36:133-40.
    Abstract     Related articles   

  828. MARIC P, Milovic N, Bancevic V, Kosevic B, et al
    Pheochromocytoma of the urinary bladder--A case report.
    Vojnosanit Pregl. 2016;73:584-7.
    Abstract     Related articles   

  829. ALEMOZAFFAR M, Filson CP, Master VA
    The importance of surgical margins in renal cell and urothelial carcinomas.
    J Surg Oncol. 2016;113:316-22.
    Abstract     Related articles   

  830. AGGIO RB, de Lacy Costello B, White P, Khalid T, et al
    The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies.
    J Breath Res. 2016;10:017106.
    Abstract     Related articles   

  831. BAHN YE, Kim SH, Kim MJ, Kim CS, et al
    Detection of Urothelial Carcinoma: Comparison of Reduced-Dose Iterative Reconstruction with Standard-Dose Filtered Back Projection.
    Radiology. 2016;279:471-80.
    Abstract     Related articles   

  832. CHEN H, Liu L, Pambuccian SE, Barkan GA, et al
    Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion.
    Cancer Cytopathol. 2016;124:273-8.
    Abstract     Related articles   

  833. WITTIG K, Ruel N, Barlog J, Crocitto L, et al
    Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy.
    J Endourol. 2016;30:83-91.
    Abstract     Related articles   

  834. GANDAGLIA G, De Groote R, Geurts N, D'Hondt F, et al
    Oncologic Outcomes of Robot-Assisted Radical Cystectomy: Results of a High-Volume Robotic Center.
    J Endourol. 2016;30:75-82.
    Abstract     Related articles   

  835. SHAO F, Zou Y, Cai L, Wang X, et al
    Unexpected Detection of Urinary Bladder Cancer on Dual Phase 18F-NaF PET/CT in a Patient With Back Pain.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  836. HOFBAUER S, Kalogirou C, Roghmann F, Seitz AK, et al
    [Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics].
    Urologe A. 2016.
    Abstract     Related articles   

  837. ROLEVICH AI, Zhegalik AG, Mokhort AA, Minich AA, et al
    Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
    World J Urol. 2016.
    Abstract     Related articles   

  838. FALZONE L, Candido S, Salemi R, Basile MS, et al
    Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer.
    Oncotarget. 2016 Sep 1. doi: 10.18632/oncotarget.11805.
    Abstract     Related articles   

  839. CAO Y, Wang X, Xu C, Gao Z, et al
    4-HPR impairs bladder cancer cell migration and invasion by interfering with the Wnt5a/JNK and Wnt5a/MMP-2 signaling pathways.
    Oncol Lett. 2016;12:1833-1839.
    Abstract     Related articles   

  840. PICHLER R, De Zordo T, Fritz J, Kroiss A, et al
    Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Clin Genitourin Cancer. 2016 Aug 10. pii: S1558-7673(16)30243.
    Abstract     Related articles   

  841. ZHANG H, Wang F, Mao C, Zhang Z, et al
    Effect of Combined Treatment of Radiation and Tissue-specific Recombinant Oncolytic Adenovirus on bladder cancer cells.
    Int J Radiat Biol. 2016.
    Abstract     Related articles   

  842. ZOIDAKIS J
    Simple and Efficient Stratification of Invasive Bladder Cancer Patients.
    EBioMedicine. 2016 Aug 28. pii: S2352-3964(16)30397.
    Abstract     Related articles   

  843. KIM JH, Kwak Y, Song C, Roh EJ, et al
    Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line.
    Bioorg Med Chem Lett. 2016 Aug 24. pii: S0960-894X(16)30908.
    Abstract     Related articles   

  844. XYLINAS E, Hassler MR, Zhuang D, Krzywinski M, et al
    An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
    Biomolecules. 2016;6.
    Abstract     Related articles   

  845. WANG ZY, Zhang W, Yang JJ, Song DK, et al
    Association of thymosin beta4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
    Neoplasma. 2016;.
    Abstract     Related articles   

  846. LAN Y, Liu D, Lin M
    Comparison of the combination therapy of bacillus Calmette-Guerin and mitomycin C with the monotherapy for non-muscle-invasive bladder cancer: a meta-analysis.
    Neoplasma. 2016;.
    Abstract     Related articles   

  847. TRACZYK-BORSZYNSKA M, Borkowska E, Jablonowski Z, Jedrzejczyk A, et al
    Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis.
    Neoplasma. 2016;.
    Abstract     Related articles   

  848. COHEN AJ, Packiam V, Nottingham C, Steinberg G, et al
    Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Urol Oncol. 2016 Sep 1. pii: S1078-1439(16)30210.
    Abstract     Related articles   

  849. PAN J, Li X, Wu W, Xue M, et al
    Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
    Cancer Lett. 2016 Aug 31. pii: S0304-3835(16)30490.
    Abstract     Related articles   

  850. YOSHIDA T, Kinoshita H, Yoshida K, Mishima T, et al
    Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  851. MOSCHINI M, Luzzago S, Cazzaniga W, Cucchiara V, et al
    Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years.
    Clin Genitourin Cancer. 2016 Aug 8. pii: S1558-7673(16)30227.
    Abstract     Related articles   

  852. CHEN Z, Liu Y, He A, Li J, et al
    Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells.
    Sci Rep. 2016;6:30798.
    Abstract     Related articles   

  853. AMIR S, Mabjeesh NJ
    microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
    Histol Histopathol. 2016 Sep 2:11814.
    Abstract     Related articles   

  854. FU J, Nguyen L, Nguyen E, Lau N, et al
    An interesting case of profound hypoxemia.
    Exp Mol Pathol. 2016;100:321-4.
    Abstract     Related articles   

  855. WANG YY, Wu ZY, Wang GC, Liu K, et al
    LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
    Tumour Biol. 2016.
    Abstract     Related articles   

  856. YU Y, Li X, Liang C, Tang J, et al
    The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.
    Medicine (Baltimore). 2016;95:e4900.
    Abstract     Related articles   

  857. CHEN Z, Wu L, Lin Q, Shi J, et al
    Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Arch Iran Med. 2016;19:645-51.
    Abstract     Related articles   

  858. KEEHN A, Ludmir E, Taylor J, Rabbani F, et al
    Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.
    World J Urol. 2016.
    Abstract     Related articles   

  859. SHI J, Fu S, Wang L, Tao Y, et al
    Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro.
    Anticancer Drugs. 2016.
    Abstract     Related articles   

  860. KEY J, Dhawan D, Cooper CL, Knapp DW, et al
    Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Int J Nanomedicine. 2016;11:4141-55.
    Abstract     Related articles   

  861. STONE L
    Bladder cancer: Two molecular subtypes identified.
    Nat Rev Urol. 2016 Sep 13. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  862. GUAL FRAU J, Palou J, Rodriguez O, Parada R, et al
    Failure of Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder cancer: Definition and treatment options.
    Arch Esp Urol. 2016;69:423-33.
    Abstract     Related articles   

  863. KANG M, Ku JH
    Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance.
    Investig Clin Urol. 2016;57:307-8.
    Abstract     Related articles   

  864. IEDA T, Muto S, Shimizu F, Taguri M, et al
    Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia.
    EBioMedicine. 2016 Sep 2. pii: S2352-3964(16)30405.
    Abstract     Related articles   

  865. GAISA NT
    [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
    Pathologe. 2016.
    Abstract     Related articles   

  866. DADHANIA V, Zhang M, Zhang L, Bondaruk J, et al
    Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
    EBioMedicine. 2016 Aug 25. pii: S2352-3964(16)30391.
    Abstract     Related articles   

  867. KLAUTKE G
    [Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer].
    Strahlenther Onkol. 2016.
    Abstract     Related articles   

  868. ZHOU J, Dong D, Cheng R, Wang Y, et al
    Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
    Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11889.
    Abstract     Related articles   

  869. CRITELLI R, Fasanelli F, Oderda M, Polidoro S, et al
    Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
    Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11883.
    Abstract     Related articles   

  870. KEEHN A, Gartrell B, Schoenberg MP
    Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer.
    Future Oncol. 2016.
    Abstract     Related articles   

  871. WANG L, Zhou Z, Gong MZ, Pan DL, et al
    A Large Bladder Tumor Covered With a Thick "Shell" of Necrotic Material: Misdiagnosis of a Patient With Spina Bifida.
    Medicine (Baltimore). 2016;95:e3443.
    Abstract     Related articles   

  872. LUO Y, Zhang X, Mo M, Tan Z, et al
    High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Medicine (Baltimore). 2016;95:e3337.
    Abstract     Related articles   

  873. SAINT-JACQUES N, Lee JS, Brown P, Stafford J, et al
    Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.
    BMC Public Health. 2016;16:175.
    Abstract     Related articles   

  874. ZHENG CL, Han XH, Feng SN, Wang JZ, et al
    [Value of urine sediment analyzer in the screening of urinary tract infection in cancer patients].
    Zhonghua Zhong Liu Za Zhi. 2016;38:35-9.
    Abstract     Related articles   

  875. ARTHUR EG, Arthur GL, Keeler MR, Bryan JN, et al
    Risk of Osteosarcoma in Dogs After Open Fracture Fixation.
    Vet Surg. 2016;45:30-5.
    Abstract     Related articles   

  876. AGARWAL KK, Roy SG, Kumar R
    Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
    PET Clin. 2016;11:39-46.
    Abstract     Related articles   

  877. SHIMADA K, Fujii T, Tatsumi Y, Anai S, et al
    Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.
    Diagn Cytopathol. 2016;44:3-9.
    Abstract     Related articles   

  878. XIAO D, Zhang G, Liu Y, Yang Z, et al
    3D detection and extraction of bladder tumors via MR virtual cystoscopy.
    Int J Comput Assist Radiol Surg. 2016;11:89-97.
    Abstract     Related articles   

  879. BROOKS M, Mo Q, Krasnow R, Ho PL, et al
    Positive association of collagen type I with non-muscle invasive bladder cancer progression.
    Oncotarget. 2016 Sep 17. doi: 10.18632/oncotarget.12089.
    Abstract     Related articles   

  880. HAN MH, Lee DS, Jeong JW, Hong SH, et al
    Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
    Drug Dev Res. 2016 Sep 21. doi: 10.1002/ddr.21367.
    Abstract     Related articles   

  881. ROSHDY S, Senbel A, Khater A, Farouk O, et al
    Genital Sparing Cystectomy for Female Bladder Cancer and its Functional Outcome; a Seven Years' Experience with 24 Cases.
    Indian J Surg Oncol. 2016;7:307-11.
    Abstract     Related articles   

  882. KUPPACHI S, Holanda D, Eberlein M, Alexiev B, et al
    An unexpected surge in plasma BKPyV viral load heralds the development of BKPyV associated metastatic bladder cancer in a lung transplant recipient with BKPyV nephropathy.
    Am J Transplant. 2016 Sep 20. doi: 10.1111/ajt.14057.
    Abstract     Related articles   

  883. MBEUTCHA A, Shariat SF, Rieken M, Rink M, et al
    Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Sep 16. pii: S1078-1439(16)30065.
    Abstract     Related articles   

  884. ANDERSON-OTUNU O, Akhtar S
    Chronic Infections of the Urinary Tract and Bladder Cancer Risk: a Systematic Review.
    Asian Pac J Cancer Prev. 2016;17:3805-7.
    Abstract     Related articles   

  885. SOLAKHAN M, Demirpence O, Orhan N, Yildirim OA, et al
    Lack of Any Role of Systemic Inflammatory Responses in Predicting Muscle Invasion by Bladder Cancer.
    Asian Pac J Cancer Prev. 2016;17:3737-9.
    Abstract     Related articles   

  886. DONG BB, Yan JS, Yan YY, Xie TC, et al
    Downregulation of Pigment epithelium-derived factor is associated with increased epithelial-mesenchymal transition (EMT) in bladder cancer.
    Panminerva Med. 2016.
    Abstract     Related articles   

  887. PAN A, Zhang H, Li Y, Lin TY, et al
    Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.
    Nanotechnology. 2016;27:425103.
    Abstract     Related articles   

  888. BRANT A, Kates M, Chappidi MR, Patel HD, et al
    Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
    Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30214.
    Abstract     Related articles   

  889. WITJES JA, Dalbagni G, Karnes RJ, Shariat S, et al
    The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30114.
    Abstract     Related articles   

  890. PECHERY A, Fauconnet S, Bittard H, Lascombe I, et al
    Apoptotic effect of the selective PPARbeta/delta agonist GW501516 in invasive bladder cancer cells.
    Tumour Biol. 2016.
    Abstract     Related articles   

  891. KOPSIAFTIS S, Sullivan KL, Garg I, Taylor JA, et al
    AMPKalpha2 Regulates Bladder Cancer Growth Through SKP2-mediated Degradation of p27.
    Mol Cancer Res. 2016 Sep 16. pii: molcanres.0111.2016.
    Abstract     Related articles   

  892. PASSONI N, Gayed B, Kapur P, Sagalowsky AI, et al
    Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
    Urol Oncol. 2016 Sep 13. pii: S1078-1439(16)30066.
    Abstract     Related articles   

  893. LEBENTRAU S, May M, Weckermann D, Speck T, et al
    [Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution].
    Urologe A. 2016.
    Abstract     Related articles   

  894. REXER H, Merseburger A
    [Neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  895. WU TF, Hsu LT, Tsang BX, Huang LC, et al
    Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.
    BMC Complement Altern Med. 2016;16:96.
    Abstract     Related articles   

  896. RAGGI D, Miceli R, Sonpavde G, Giannatempo P, et al
    Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.
    Ann Oncol. 2016;27:49-61.
    Abstract     Related articles   

  897. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.
    Neoplasia. 2016;18:636-646.
    Abstract     Related articles   

  898. ZHAO J, Xu W, He M, Zhang Z, et al
    Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival.
    Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12315.
    Abstract     Related articles   

  899. KAELBERER JB, O'Donnell MA, Mitchell DL, Snow AN, et al
    Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival.
    Prostate Int. 2016;4:107-12.
    Abstract     Related articles   

  900. POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
    Patterns of care in patients with muscle-invasive bladder cancer - a retrospective cohort study.
    Contemp Oncol (Pozn). 2016;20:341-3.
    Abstract     Related articles   

  901. WANG G, Zhao MJ, Liu YQ, Liu XW, et al
    Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
    Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12324.
    Abstract     Related articles   

  902. HUANG J, Chen X, Lin TX
    [Strategies for diagnosis and treatment of bladder cancer in precise times].
    Zhonghua Wai Ke Za Zhi. 2016;54:734-737.
    Abstract     Related articles   

  903. FRANTZI M, Klimou Z, Makridakis M, Zoidakis J, et al
    Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
    Oncotarget. 2016 Sep 23. doi: 10.18632/oncotarget.12218.
    Abstract     Related articles   

  904. GIL D, Ciolczyk-Wierzbicka D, Dulinska-Litewka J, Laidler P, et al
    Integrin-linked kinase regulates cadherin switch in bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  905. JOSEPH N, Choudhury A
    Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96:614-6.
    Abstract     Related articles   

  906. VALLO S, Michaelis M, Gust KM, Black PC, et al
    Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.
    BMC Res Notes. 2016;9:454.
    Abstract     Related articles   

  907. SANCHEZ A, Wszolek MF, Drumm MR, Niemierko A, et al
    The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  908. OJERHOLM EJ, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  909. ROBERTS HJ, Krasnow RE, Drumm MR, Niemierko A, et al
    Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  910. ZAGHLOUL MS, Christodouleas JP, Smith A, Abdalla A, et al
    Adjuvant Sandwich Chemotherapy and Radiation Versus Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  911. BLOCK AM, Harkenrider MM, Henry E, Gaynor ER, et al
    Concurrent Chemotherapy Improves Overall Survival in Muscle-Invasive Bladder Cancer Patients Undergoing Radiation Therapy: An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  912. ZHONG J, Switchenko J, Jegadeesh N, Gillespie TW, et al
    Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  913. MOUW K, Braunstein LZ, Kim J, Polak P, et al
    Somatic ERCC2 Mutations Are Associated With a Distinct Mutational Signature in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  914. WILLERS H, Liu Q, Efstathiou JA, Gheorghiu L, et al
    PARP1 Inhibition Radiosensitizes A Subset Of Genotype-Defined Bladder Cancers Through Modulation Of Reactive Oxygen Species.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  915. KORPICS M, Block AM, Harkenrider MM, Welsh JS, et al
    The Impact of Radiation Therapy Dose on Survival in Patients with Muscle-Invasive Bladder Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  916. TUANQUIN LC, McDermott D, Mackley HB, Holder S, et al
    The Outcomes of Adjuvant Radiation Therapy in Postcystectomy Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  917. SOLANKI AA, Korpics M, Small C, Harkenrider MM, et al
    Variability of Radiation Oncologists' Chemoradiation Therapy Patterns of Care and the Impact of Multidisciplinary Clinics in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  918. FISCHER-VALUCK BW, Green OL, Mutic S, Gay HA, et al
    Vector Analysis of Bladder Cancer Patient Setup Utilizing a Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  919. FILONENKO EV, Kaprin AD, Alekseev BY, Apolikhin OI, et al
    5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
    Photodiagnosis Photodyn Ther. 2016 Sep 23. pii: S1572-1000(16)30054.
    Abstract     Related articles   

  920. STONE L
    Bladder cancer: Rho-sensitive pathway mediates metastasis.
    Nat Rev Urol. 2016 Sep 27. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  921. BALDIA PH, Maurer A, Heide T, Rose M, et al
    Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.
    Oncotarget. 2016 Sep 22. doi: 10.18632/oncotarget.12198.
    Abstract     Related articles   

  922. SORIA F, Moschini M, Haitel A, Wirth GJ, et al
    The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.
    Urol Oncol. 2016 Sep 21. pii: S1078-1439(16)30169.
    Abstract     Related articles   

  923. XIA L, Guzzo TJ
    Preoperative Anemia and Low Hemoglobin Level Are Associated With Worse Clinical Outcomes in Patients With Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis.
    Clin Genitourin Cancer. 2016 Aug 29. pii: S1558-7673(16)30251.
    Abstract     Related articles   

  924. CAO R, Meng Z, Liu T, Wang G, et al
    Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Oncotarget. 2016 Sep 20. doi: 10.18632/oncotarget.12146.
    Abstract     Related articles   

  925. JIN X, Zhang P, Luo L, Cheng H, et al
    Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.
    Int J Nanomedicine. 2016;11:4535-4544.
    Abstract     Related articles   

  926. CHEN DJ, Chen W, Jiang H, Yang H, et al
    Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
    Drug Des Devel Ther. 2016;10:2845-2853.
    Abstract     Related articles   

  927. DE PAOLI M, Gogalic S, Sauer U, Preininger C, et al
    Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.
    Dis Markers. 2016;2016:4591910.
    Abstract     Related articles   

  928. OGIHARA K, Kikuchi E, Yuge K, Yanai Y, et al
    The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  929. VLAHOU A, Black PC, Goebell PJ, Kamat AM, et al
    Taking the next step-Advancing bladder cancer management.
    Urol Oncol. 2016;34:435-6.
    Abstract     Related articles   

  930. JENSEN TK, Jensen NV, Jorgensen SM, Clark P, et al
    Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008-2012.
    Acta Oncol. 2016;55 Suppl 1:85-90.
    Abstract     Related articles   

  931. YADAV S, Banerjee I, Tomar V, Yadav SS, et al
    Pelvic paraganglioma: a rare and unusual clinical presentation of paraganglioma.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  932. CHUNG KT
    Carcinogenicity, allergenicity, and lupus-inducibility of arylamines.
    Front Biosci (Elite Ed). 2016;8:29-39.
    Abstract     Related articles   

  933. CAO Q, Wang N, Qi J, Gu Z, et al
    Long noncoding RNAGAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (CC motif) ligand 1 expression.
    Mol Med Rep. 2016;13:27-34.
    Abstract     Related articles   

  934. HUANG YC, Yu HS, Chai CY
    Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
    Exp Toxicol Pathol. 2016;68:61-8.
    Abstract     Related articles   

  935. GERSHMAN B, Moreira DM, Tollefson MK, Frank I, et al
    The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Urol Oncol. 2016;34:4.
    Abstract     Related articles   

  936. HAYASHI T, Yuasa T, Uehara S, Inoue Y, et al
    Clinical outcome of urachal cancer in Japanese patients.
    Int J Clin Oncol. 2016;21:133-8.
    Abstract     Related articles   

  937. LIU Y, Yang W, Zhao L, Liang Z, et al
    Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis.
    BMC Immunol. 2016;17:36.
    Abstract     Related articles   

  938. PALMER S, Litvinova K, Dunaev A, Yubo J, et al
    Optical redox ratio and endogenous porphyrins in the detection of urinary bladder cancer: A patient biopsy analysis.
    J Biophotonics. 2016 Oct 7. doi: 10.1002/jbio.201600162.
    Abstract     Related articles   

  939. PRASAIN JK, Rajbhandari R, Keeton AB, Piazza GA, et al
    Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells.
    Food Funct. 2016;7:4012-4019.
    Abstract     Related articles   

  940. YANG Y, Deng S, Zeng Q, Hu W, et al
    Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
    Dalton Trans. 2016.
    Abstract     Related articles   

  941. LI XZ, Han Y, Tian J, Ren X, et al
    Enhancement of dendritic cells with melanoma-associated antigen 3 for inducing cytotoxicity by cytotoxic T lymphocytes on bladder cancer BIU-87 cells.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  942. CHOI BH, Lee DH, Kim J, Kang JH, et al
    Controls of Nuclear Factor-Kappa B Signaling Activity by 5'-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells.
    Int Neurourol J. 2016;20:182-187.
    Abstract     Related articles   

  943. HIRASAWA Y, Nakashima J, Yunaiyama D, Sugihara T, et al
    Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  944. ZHOU J, Duan H, Xie Y, Ning Y, et al
    MiR-193a-5p Targets the Coding Region of AP-2alpha mRNA and Induces Cisplatin Resistance in Bladder Cancers.
    J Cancer. 2016;7:1740-1746.
    Abstract     Related articles   

  945. MATSUMOTO R, Tsuda M, Yoshida K, Tanino M, et al
    Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
    Sci Rep. 2016;6:34625.
    Abstract     Related articles   

  946. CLARK PE, Spiess PE, Agarwal N, Bangs R, et al
    NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
    J Natl Compr Canc Netw. 2016;14:1213-1224.
    Abstract     Related articles   

  947. JANG D, Lim CS, Shin YS, Ko YK, et al
    A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis.
    BMC Anesthesiol. 2016;16:16.
    Abstract     Related articles   

  948. FALTAS B, Goldenberg DM, Ocean AJ, Govindan SV, et al
    Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:e75-9.
    Abstract     Related articles   

  949. ADEJORO O, Alishahi A, Soubra A, Konety B, et al
    Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer.
    Clin Genitourin Cancer. 2016;14:38-47.
    Abstract     Related articles   

  950. PALAZZETTI A, Oderda M, Falcone M, Cassenti A, et al
    Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic Bladder.
    Clin Genitourin Cancer. 2016;14:e127-30.
    Abstract     Related articles   

  951. POKURI VK, Syed JR, Yang Z, Field EP, et al
    Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
    Clin Genitourin Cancer. 2016;14:e59-65.
    Abstract     Related articles   

  952. WYMER KM, Antic T, O'Donnell PH
    Case Report of a Rare Presentation of Urothelial Carcinoma With Gastric Metastasis.
    Clin Genitourin Cancer. 2016;14:e111-4.
    Abstract     Related articles   

  953. KIM YS, Lee SI, Park SH, Park S, et al
    A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:76-81.
    Abstract     Related articles   

  954. WINTERS BR, Bremjit PJ, Gore JL, Lin DW, et al
    Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients.
    J Endourol. 2016;30:212-7.
    Abstract     Related articles   

  955. ZARGAR-SHOSHTARI K, Sverrisson EF, Sharma P, Gupta S, et al
    Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
    Clin Genitourin Cancer. 2016;14:82-8.
    Abstract     Related articles   

  956. PINCIROLI P, Won H, Iyer G, Canevari S, et al
    Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:e81-90.
    Abstract     Related articles   

  957. WANG J, Chen X, Liu Y, Chen J, et al
    Cystic Angiomyolipomas in the Bladder: A Case Report With Imaging Findings and Review of the Literature.
    Clin Genitourin Cancer. 2016;14:e99-e102.
    Abstract     Related articles   

  958. KANG M, Jeong CW, Kwak C, Kim HH, et al
    The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016;23:335-42.
    Abstract     Related articles   

  959. UCER O, Albaz AC, Atag E, Karaoglu A, et al
    The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey.
    Urol J. 2016;13:2841-2844.
    Abstract     Related articles   

  960. YOSHIDA T, Kinoshita H, Fukui K, Matsuzaki T, et al
    Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  961. MAK KS, Smith AB, Eidelman A, Clayman R, et al
    Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Aug 24. pii: S0360-3016(16)33135.
    Abstract     Related articles   

  962. KUMONDAI M, Hosono H, Orikasa K, Arai Y, et al
    CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
    Biol Pharm Bull. 2016;39:1683-1686.
    Abstract     Related articles   

  963. RESHETNIKOVA G, Sidorenko VS, Whyard T, Lukin M, et al
    Genotoxic and cytotoxic effects of the environmental pollutant 3-nitrobenzanthrone on bladder cancer cells.
    Exp Cell Res. 2016 Oct 5. pii: S0014-4827(16)30318.
    Abstract     Related articles   

  964. LAURENT M, Brureau L, Demery ME, Flechon A, et al
    Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study.
    Urol Oncol. 2016 Oct 6. pii: S1078-1439(16)30211.
    Abstract     Related articles   

  965. MOSCHINI M, Luzzago S, Zaffuto E, Dell'Oglio P, et al
    The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience.
    Eur J Surg Oncol. 2016 Sep 28. pii: S0748-7983(16)30897.
    Abstract     Related articles   

  966. CAFFO O, Thompson C, De Santis M, Kragelj B, et al
    Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.
    Radiother Oncol. 2016 Oct 5. pii: S0167-8140(16)34304.
    Abstract     Related articles   

  967. ZHUO Y, Chen Q, Chen B, Zhan X, et al
    Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest.
    Int J Clin Pharmacol Ther. 2016.
    Abstract     Related articles   

  968. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of bladder cancer patients.
    Acta Biochim Pol. 2016.
    Abstract     Related articles   

  969. GOODISON S, Ogawa O, Matsui Y, Kobayashi T, et al
    A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
    J Transl Med. 2016;14:287.
    Abstract     Related articles   

  970. WAKABAYASHI Y, Iwaya M, Akita M, Takeuchi W, et al
    Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin.
    Intern Med. 2016;55:651-6.
    Abstract     Related articles   

  971. OHTAKA M, Kawahara T, Kumano Y, Maeda Y, et al
    Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
    J Med Case Rep. 2016;10:48.
    Abstract     Related articles   

  972. NAWAR NA, Olsen J, Jelic TM, He C, et al
    Primary Urinary Bladder Angiosarcoma with Osteoclast-Like Multinucleated Giant Cells: A Case Report and Literature Review.
    Am J Case Rep. 2016;17:143-9.
    Abstract     Related articles   

  973. PATRIARCA C, Hurle R, Moschini M, Freschi M, et al
    Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
    Diagn Pathol. 2016;11:6.
    Abstract     Related articles   

  974. FUKUMOTO K, Kikuchi E, Mikami S, Miyajima A, et al
    Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guerin.
    BMC Urol. 2016;16:5.
    Abstract     Related articles   

  975. CHEN Y, Hong C, Ning Y, Su X, et al
    Meta-analysis of studies with bivariate binary outcomes: a marginal beta-binomial model approach.
    Stat Med. 2016;35:21-40.
    Abstract     Related articles   

  976. WANG QH, Ji ZG, Li HZ, Fan H, et al
    Clinicopathologic Comparison of Urothelial Bladder Carcinoma in Young and Elder Patients.
    Pathol Oncol Res. 2016;22:67-70.
    Abstract     Related articles   

  977. WANG F, Wu D, He F, Fu H, et al
    Study on the significance of Cofilin 1 overexpression in human bladder cancer.
    Tumori. 2016 Oct 21:0. doi: 10.5301/tj.5000569.
    Abstract     Related articles   

  978. COLOMBO R, van Valenberg H, Moschini M, Witjes JA, et al
    Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
    Urologia. 2016;83.
    Abstract     Related articles   

  979. LIN F, Dong L, Wang W, Liu Y, et al
    An Efficient Light-Inducible P53 Expression System for Inhibiting Proliferation of Bladder Cancer Cell.
    Int J Biol Sci. 2016;12:1273-1278.
    Abstract     Related articles   

  980. PARK S, Fudhaili A, Oh SS, Lee KW, et al
    Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2.
    Phytomedicine. 2016;23:1462-1468.
    Abstract     Related articles   

  981. CHENG HP, Liu Q, Li Y, Li XD, et al
    The inhibitory effect of PDIA6 downregulation on bladder cancer cell proliferation and invasion.
    Oncol Res. 2016.
    Abstract     Related articles   

  982. DOGAN HS, Bozaci AC, Ozdemir B, Tonyali S, et al
    Ureteroneocystostomy in primary vesicoureteral reflux: critical retrospective analysis of factors affecting the postoperative urinary tract infection rates.
    Int Braz J Urol. 2014.
    Abstract     Related articles   

  983. CESARIO JM, Brito RB, Malta CS, Silva CS, et al
    A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2016.
    Abstract     Related articles   

  984. ZERMANN DH, Vahlensieck W, Hoffmann W
    [Erratum to: Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
    Urologe A. 2016.
    Abstract     Related articles   

  985. KRAL M, Michalek J, Skarda J, Tichy T, et al
    High-grade urothelial bladder cancer in children: A case report and critical analysis of the literature.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016.
    Abstract     Related articles   

  986. ANDREU Z, Oshiro RO, Redruello A, Lopez-Martin S, et al
    Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
    Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431.
    Abstract     Related articles   

  987. MEEKS JJ, Carneiro BA, Pai SG, Oberlin DT, et al
    Genomic characterization of high-risk non-muscle invasive bladder cancer.
    Oncotarget. 2016 Oct 14. doi: 10.18632/oncotarget.12661.
    Abstract     Related articles   

  988. PEREIRA PM, Silva S, Bispo M, da Rocha Zuzarte M, et al
    Preclinical study on mitochondria-targeted photodynamic therapy using a galactodendritic chlorin for bladder cancer.
    Bioconjug Chem. 2016.
    Abstract     Related articles   

  989. ZHAO M, Yu S, Zhang M
    Differential expression of multidrug resistancerelated proteins in adriamycinresistant (pumc91/ADM) and parental (pumc91) human bladder cancer cell lines.
    Mol Med Rep. 2016 Oct 5. doi: 10.3892/mmr.2016.5806.
    Abstract     Related articles   

  990. KAMIYA N, Suzuki H, Suyama T, Kobayashi M, et al
    Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Int J Clin Oncol. 2016.
    Abstract     Related articles   

  991. ZHI Y, Pan J, Shen W, He P, et al
    Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
    Cell Physiol Biochem. 2016;39:1787-1794.
    Abstract     Related articles   

  992. MORALES-BARRERA R, Suarez C, de Castro AM, Racca F, et al
    Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
    Cancer Treat Rev. 2016;50:208-216.
    Abstract     Related articles   

  993. ROSENBLATT R, Johansson M, Alamdari F, Sidiki A, et al
    Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.
    World J Urol. 2016.
    Abstract     Related articles   

  994. CHEN M, Rothman N, Ye Y, Gu J, et al
    Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development.
    Genes Cancer. 2016;7.
    Abstract     Related articles   

  995. TAKAOKA EI, Miyazaki J, Ishikawa H, Kawai K, et al
    Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  996. HEIDEGGER I, Tulchiner G, Schafer G, Horninger W, et al
    Long term disease free survival with multimodal therapy in small cell bladder cancer.
    Eur J Med Res. 2016;21:40.
    Abstract     Related articles   

  997. DURAN I, Hagen C, Arranz JA, Apellaniz-Ruiz M, et al
    SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.
    Pharmacogenomics. 2016;17:463-71.
    Abstract     Related articles   

  998. BERNARDES FILHO F, de Melo AS, Pires AR, Lupi O, et al
    Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
    An Bras Dermatol. 2016;91:73-9.
    Abstract     Related articles   

  999. BAZRAFSHANI MR, Nowshadi PA, Shirian S, Daneshbod Y, et al
    Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.
    Cancer Med. 2016;5:145-52.
    Abstract     Related articles   

  1000. GEYNISMAN DM, Handorf E, Wong YN, Doyle J, et al
    Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.
    Cancer Med. 2016;5:192-9.
    Abstract     Related articles   

  1001. PARK S, Cho MS, Kim KH
    A case report of urothelial carcinoma with combined micropapillary and plasmacytoid morphology in the urinary bladder.
    Diagn Cytopathol. 2016;44:124-7.
    Abstract     Related articles   

  1002. YOUNES I, Frachet V, Rinaudo M, Jellouli K, et al
    Cytotoxicity of chitosans with different acetylation degrees and molecular weights on bladder carcinoma cells.
    Int J Biol Macromol. 2016;84:200-7.
    Abstract     Related articles   

  1003. DUAN W, Du L, Jiang X, Wang R, et al
    Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12880.
    Abstract     Related articles   

  1004. HONG X, Li T, Ling F, Yang D, et al
    Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis.
    Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12907.
    Abstract     Related articles   

  1005. HONG Z, Wu J, Li Q, Zhang S, et al
    Meta-analysis reveals no significant association between ERCC6 polymorphisms and bladder cancer risk.
    Int J Biol Markers. 2016 Oct 22:0. doi: 10.5301/jbm.5000236.
    Abstract     Related articles   

  1006. HAU AM, Leivo MZ, Gilder AS, Hu JJ, et al
    mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
    Cell Signal. 2016;29:96-106.
    Abstract     Related articles   

  1007. ZHUO C, Li X, Zhuang H, Tian S, et al
    Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis.
    Oncotarget. 2016 Oct 24. doi: 10.18632/oncotarget.12856.
    Abstract     Related articles   

  1008. SARGOS P, Baumann BC, Eapen LJ, Bahl A, et al
    Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
    Transl Androl Urol. 2016;5:702-710.
    Abstract     Related articles   

  1009. KLAILE Y, Schlack K, Boegemann M, Steinestel J, et al
    Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
    Transl Androl Urol. 2016;5:692-701.
    Abstract     Related articles   

  1010. SORIA F, Moschini M, Korn S, Shariat SF, et al
    How to optimally manage elderly bladder cancer patients?
    Transl Androl Urol. 2016;5:683-691.
    Abstract     Related articles   

  1011. MARKS P, Soave A, Shariat SF, Fajkovic H, et al
    Female with bladder cancer: what and why is there a difference?
    Transl Androl Urol. 2016;5:668-682.
    Abstract     Related articles   

  1012. SMOLENSKY D, Rathore K, Cekanova M
    Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.
    Drug Des Devel Ther. 2016;10:3305-3322.
    Abstract     Related articles   

  1013. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
    BMC Genomics. 2016;17:829.
    Abstract     Related articles   

  1014. ZHANG Y, Nolan M, Yamada H, Watanabe M, et al
    Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells.
    Biochem Biophys Res Commun. 2016 Oct 19. pii: S0006-291X(16)31741.
    Abstract     Related articles   

  1015. ALFANO M, Nebuloni M, Allevi R, Zerbi P, et al
    Linearized texture of three-dimensional extracellular matrix is mandatory for bladder cancer cell invasion.
    Sci Rep. 2016;6:36128.
    Abstract     Related articles   

  1016. WANG G, Cao R, Wang Y, Qian G, et al
    Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway.
    Sci Rep. 2016;6:35783.
    Abstract     Related articles   

  1017. ARRUDA RP, Mariano MB, Pereira CF, Lima GC, et al
    Laparoscopic Cystoprostatectomy for Bladder Cancer in a Male patient combined with open ileal conduit urinary diversion.
    Int Braz J Urol. 2016 Oct 25. doi: 10.1590/S1677-5538.IBJU.2014.0632.
    Abstract     Related articles   

  1018. QI D, Li J, Que B, Su J, et al
    Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.
    Cancer Cell Int. 2016;16:81.
    Abstract     Related articles   

  1019. SINGH P, Black P
    Emerging role of checkpoint inhibition in localized bladder cancer.
    Urol Oncol. 2016 Oct 21. pii: S1078-1439(16)30272.
    Abstract     Related articles   

  1020. ROSENKRANTZ AB, Friedman KP, Ponzo F, Raad RA, et al
    Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  1021. QIAN K, Wang G, Cao R, Liu T, et al
    Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways.
    Molecules. 2016;21.
    Abstract     Related articles   

  1022. STARKOV KE, Bunimovich-Mendrazitsky S
    Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy.
    Math Biosci Eng. 2016;13:1059-1075.
    Abstract     Related articles   

  1023. SADEE C, Kashdan E
    A model of thermotherapy treatment for bladder cancer.
    Math Biosci Eng. 2016;13:1169-1183.
    Abstract     Related articles   

  1024. SKOWRON KB, Pitroda SP, Namm JP, Balogun O, et al
    Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.
    Sci Rep. 2016;6:35854.
    Abstract     Related articles   

  1025. NOSSIER AI, Mohammed OS, Fakhr El-Deen RR, Zaghloul AS, et al
    Gelatin-modified gold nanoparticles for direct detection of urinary total gelatinase activity: Diagnostic value in bladder cancer.
    Talanta. 2016;161:511-519.
    Abstract     Related articles   

  1026. FERREIRA-TEIXEIRA M, Paiva-Oliveira D, Parada B, Alves V, et al
    Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    BMC Med. 2016;14:163.
    Abstract     Related articles   

  1027. HUANG HH, Kuo SM, Wu YJ, Su JH, et al
    Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation.
    Int J Nanomedicine. 2016;11:1237-51.
    Abstract     Related articles   

  1028. BACON N, Souza CH, Franz S
    Total cysto-prostatectomy: Technique description and results in 2 dogs.
    Can Vet J. 2016;57:141-6.
    Abstract     Related articles   

  1029. SOKOLOV A, Paull EO, Stuart JM
    ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.
    Pac Symp Biocomput. 2016;21:405-16.
    Abstract     Related articles   

  1030. ZHANG Y, Wang X, Hoffman RM, Seki N, et al
    Real Time Metastatic Route Tracking of Orthotopic PC-3-GFP Human Prostate Cancer Using Intravital Imaging.
    J Cell Biochem. 2016;117:1027-32.
    Abstract     Related articles   

  1031. PIETRUSINSKI M, Kepczynski, Jedrzejczyk A, Borkowska E, et al
    Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  1032. GARCIA J, Santome L, Anido U, Fernandez-Calvo O, et al
    Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).
    Curr Oncol Rep. 2016;18:72.
    Abstract     Related articles   

  1033. SCARPA ES, Emanuelli M, Frati A, Pozzi V, et al
    Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells.
    Food Funct. 2016.
    Abstract     Related articles   

  1034. JIN X, Ma J, Liang X, Tang K, et al
    Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway.
    Biomaterials. 2016;113:93-104.
    Abstract     Related articles   

  1035. DONG D, Jiang W, Lei J, Chen L, et al
    Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
    Oncotarget. 2016 Oct 28. doi: 10.18632/oncotarget.12976.
    Abstract     Related articles   

  1036. MANDAIR GS, Han AL, Keller ET, Morris MD, et al
    Raman microscopy of bladder cancer cells expressing green fluorescent protein.
    J Biomed Opt. 2016;21:115001.
    Abstract     Related articles   

  1037. SUI W, Matulay JT, Onyeji IC, Theofanides MC, et al
    Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.
    World J Urol. 2016.
    Abstract     Related articles   

  1038. MORALES A
    Administration of Mycobacterium phlei cell wall-nucleic acid complex in the immediate postoperative period for the treatment of non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  1039. ZLOTTA AR
    What's new in bladder cancer research?
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  1040. MATULEWICZ RS, Frainey BT, Oberlin DT, Meeks JJ, et al
    High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy.
    J Natl Compr Canc Netw. 2016;14:1403-1411.
    Abstract     Related articles   

  1041. LEE S, Jang J, Jeon H, Lee J, et al
    Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.
    J Microbiol. 2016;54:782-788.
    Abstract     Related articles   

  1042. KU JH, Kim WJ, Lerner SP, Chun F, et al
    Diagnostic and Prognostic Markers in Bladder Cancer.
    Dis Markers. 2016;2016:2425091.
    Abstract     Related articles   

  1043. KIM B, Kim G, Song B, Lee C, et al
    HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
    Dis Markers. 2016;2016:8463731.
    Abstract     Related articles   

  1044. CONCONI D, Sala E, Bovo G, Strada G, et al
    Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.
    Int J Mol Sci. 2016;17:271.
    Abstract     Related articles   

  1045. KHAN M, O'Kane D, Du Plessis J, Hoag N, et al
    Primary malignant melanoma of the urinary bladder and ureter.
    Can J Urol. 2016;23:8171-5.
    Abstract     Related articles   

  1046. PATNE SC, Katiyar R, Chaudhary D, Trivedi S, et al
    Dysuria and fever in a young woman diagnosed as having inflammatory myofibroblastic tumour of the urinary bladder.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  1047. CUI Y, Chen H, Liu L, Chen J, et al
    Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.
    J Laparoendosc Adv Surg Tech A. 2016;26:196-202.
    Abstract     Related articles   

  1048. PINKERNEIL M, Hoffmann MJ, Deenen R, Kohrer K, et al
    Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
    Mol Cancer Ther. 2016;15:299-312.
    Abstract     Related articles   

  1049. CHANG HY, Chang TC, Huang WY, Lee CT, et al
    RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer Drugs.
    Mol Cancer Ther. 2016;15:276-86.
    Abstract     Related articles   

  1050. ERDMANN E, Harding S, Lam H, Perez A, et al
    10-Year Observational Follow-Up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.
    Diabetes Obes Metab. 2015 Nov 23. doi: 10.1111/dom.12608.
    Abstract     Related articles   

  1051. WANG B, Li X, Ming S, Ma X, et al
    Combined Extraperitoneal and Transperitoneal Laparoscopic Extended Partial Cystectomy for the Treatment of Urachal Carcinoma.
    J Endourol. 2016;30:280-5.
    Abstract     Related articles   

  1052. LI X, Gao Y, Zhou H, Xu W, et al
    The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-kappa B1 gene and the risk of urinary cancer.
    Cancer Biomark. 2016;16:11-7.
    Abstract     Related articles   

  1053. DI TRAPANI E, Sanchez-Salas R, Gandaglia G, Rocchini L, et al
    A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
    World J Urol. 2016;34:207-13.
    Abstract     Related articles   

  1054. SORIA F, Milla P, Fiorito C, Pisano F, et al
    Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.
    World J Urol. 2016;34:189-95.
    Abstract     Related articles   

  1055. WANG H, Ke C, Ma X, Zhao Q, et al
    MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3beta and activating Wnt signaling in bladder cancer cells.
    Tumour Biol. 2016.
    Abstract     Related articles   

  1056. HU H, Chen Y, Cheng S, Li G, et al
    Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
    Wien Klin Wochenschr. 2016.
    Abstract     Related articles   

  1057. QUIRT JS, Siemens DR, Zaza K, Mackillop WJ, et al
    Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study.
    Clin Oncol (R Coll Radiol). 2016 Nov 6. pii: S0936-6555(16)30319.
    Abstract     Related articles   

  1058. TSUJIMURA N, Yamada NO, Kuranaga Y, Kumazaki M, et al
    A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.
    Int J Mol Sci. 2016;17.
    Abstract     Related articles   

  1059. RIETHDORF S, Pantel K
    Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.
    Ann Transl Med. 2016;4:379.
    Abstract     Related articles   

  1060. TANIGUCHI Y, Nishikawa H, Karashima T, Yoshinaga Y, et al
    Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.
    Joint Bone Spine. 2016 Nov 4. pii: S1297-319X(16)30169.
    Abstract     Related articles   

  1061. SIDAWAY P
    Bladder cancer: Autologous NK cells active against high-risk cancer.
    Nat Rev Urol. 2016 Nov 8. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  1062. TAGLIABUE L, Russo G, Lucignani G
    18F-FDG PET/CT in Bladder Cancer.
    Clin Nucl Med. 2016;41:e522-e524.
    Abstract     Related articles   

  1063. GUI-ZHONG L, Li-Bo M
    Bladder cancer in individuals with spinal cord injuries: a meta-analysis.
    Spinal Cord. 2016 Nov 8. doi: 10.1038/sc.2016.
    Abstract     Related articles   

  1064. WEI L, Chintala S, Ciamporcero E, Ramakrishnan S, et al
    Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
    Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13062.
    Abstract     Related articles   

  1065. KANG W, Cui Z, Chen Q, Zhang D, et al
    Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.
    Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13054.
    Abstract     Related articles   

  1066. OHTAKE S, Kawahara T, Kasahara R, Ito H, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
    Biomed Res Int. 2016;2016:9846823.
    Abstract     Related articles   

  1067. HANSEN E, Larsson H, Norgaard M, Thind P, et al
    The Danish Bladder Cancer Database.
    Clin Epidemiol. 2016;8:439-443.
    Abstract     Related articles   

  1068. DI MASO M, Bosetti C, Taborelli M, Montella M, et al
    Dietary water intake and bladder cancer risk: An Italian case-control study.
    Cancer Epidemiol. 2016;45:151-156.
    Abstract     Related articles   

  1069. CHEN YJ, Wang HF, Liang M, Zou RC, et al
    Upregulation of miR-3658 in bladder cancer and tumor progression.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  1070. RADY EA, Hassanein WA, Elhaddad TA
    The power Lomax distribution with an application to bladder cancer data.
    Springerplus. 2016;5:1838.
    Abstract     Related articles   

  1071. ZHOU TC, Sankin AI, Porcelli SA, Perlin DS, et al
    A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.
    Urol Oncol. 2016 Nov 2. pii: S1078-1439(16)30309.
    Abstract     Related articles   

  1072. BOULANGER M, Tual S, Lemarchand C, Guizard AV, et al
    Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort.
    Int Arch Occup Environ Health. 2016.
    Abstract     Related articles   

  1073. ZHOU M, Wang S, Hu L, Liu F, et al
    miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.
    BMC Urol. 2016;16:64.
    Abstract     Related articles   

  1074. VERRILLI AM, Hohenhaus AE, Le Roux AB, Donovan TA, et al
    What Is Your Diagnosis?: Primary pulmonary neoplasia.
    J Am Vet Med Assoc. 2016;248:493-6.
    Abstract     Related articles   

  1075. PAPADIMITRIOU JC, Randhawa P, Rinaldo CH, Drachenberg CB, et al
    BK Polyomavirus Infection and Renourinary Tumorigenesis.
    Am J Transplant. 2016;16:398-406.
    Abstract     Related articles   

  1076. SAMARATUNGA H, Delahunt B, Egevad L, Adamson M, et al
    Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
    Histopathology. 2016;68:533-40.
    Abstract     Related articles   

  1077. HUANG K, Chen G, Li Y, Liu JK, et al
    [Expression of PAK1 in bladder cancer and its influence on invasion of bladder cancer cells].
    Zhonghua Yi Xue Za Zhi. 2016;96:3227-3231.
    Abstract     Related articles   

  1078. PANDYA S, Sutaria J
    1809: FOOTDROP AS A HARBINGER OF METASTATIC BLADDER CANCER.
    Crit Care Med. 2016;44.
    Abstract     Related articles   

  1079. OCHOA AE, Choi W, Su X, Siefker-Radtke A, et al
    Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Oncotarget. 2016 Nov 10. doi: 10.18632/oncotarget.13284.
    Abstract     Related articles   

  1080. STEINBERG GD
    Bladder cancer: Assessing the conundrum of microscopic haematuria.
    Nat Rev Urol. 2016 Nov 15. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  1081. ITAM S, Elhage O, Khan MS
    Large leiomyoma of the bladder masquerading as an enlarged prostate gland.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  1082. KIM KH, Kabir E, Jahan SA
    The use of personal hair dye and its implications for human health.
    Environ Int. 2016;89-90:222-7.
    Abstract     Related articles   

  1083. BUISSON Y
    [Congres de la Societe de pathologie exotique : parasitoses, mycoses et cancer 18 novembre 2015, Institut Pasteur, Paris].
    Bull Soc Pathol Exot. 2016;109:46-50.
    Abstract     Related articles   

  1084. YOSHIKAWA H, Nolan MW, Lewis DW, Larue SM, et al
    RETROSPECTIVE EVALUATION OF INTERFRACTION URETERAL MOVEMENT IN DOGS UNDERGOING RADIATION THERAPY TO ELUCIDATE APPROPRIATE SETUP MARGINS.
    Vet Radiol Ultrasound. 2016;57:170-9.
    Abstract     Related articles   

  1085. CECI C, Tentori L, Atzori MG, Lacal PM, et al
    Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
    Nutrients. 2016;8.
    Abstract     Related articles   

  1086. ZHANG Z, Zhang G, Kong C
    Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells.
    J Cell Mol Med. 2016 Nov 23. doi: 10.1111/jcmm.13018.
    Abstract     Related articles   

  1087. DONG L, Lin F, Wu W, Huang W, et al
    Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell.
    J Cancer. 2016;7:2132-2138.
    Abstract     Related articles   

  1088. FUNT SA, Rosenberg JE
    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
    Nat Rev Clin Oncol. 2016 Nov 22. doi: 10.1038/nrclinonc.2016.
    Abstract     Related articles   

  1089. VAN HOOREN L, Sandin LC, Moskalev I, Ellmark P, et al
    Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
    Eur J Immunol. 2016 Nov 22. doi: 10.1002/eji.201646583.
    Abstract     Related articles   

  1090. HOSSEINI SA, Zanganeh S, Akbarnejad E, Salehi F, et al
    Microfluidic device for label-free quantitation and distinction of bladder cancer cells from the blood cells using micro machined silicon based electrical approach; suitable in urinalysis assays.
    J Pharm Biomed Anal. 2016;134:36-42.
    Abstract     Related articles   


  1091. Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
    Int J Radiat Oncol Biol Phys. 2016;96:1129.
    Abstract     Related articles   

  1092. URQUIDI V, Netherton M, Gomes-Giacoia E, Serie DJ, et al
    A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Oncotarget. 2016 Nov 16. doi: 10.18632/oncotarget.13382.
    Abstract     Related articles   

  1093. WANG H, Niu L, Jiang S, Zhai J, et al
    Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
    Oncotarget. 2016 Nov 15. doi: 10.18632/oncotarget.13363.
    Abstract     Related articles   

  1094. CHEN X, Gu P, Xie R, Han J, et al
    Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
    J Cell Mol Med. 2016 Nov 10. doi: 10.1111/jcmm.12999.
    Abstract     Related articles   

  1095. TOKAS T, Avgeris M, Alamanis C, Scorilas A, et al
    Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
    J Cancer Res Clin Oncol. 2016.
    Abstract     Related articles   

  1096. YU C, Hequn C, Longfei L, Long W, et al
    GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
    Oncotarget. 2016 Nov 29. doi: 10.18632/oncotarget.13702.
    Abstract     Related articles   

  1097. SORIA F, Moschini M, Abufaraj M, Wirth GJ, et al
    Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Nov 28. pii: S1078-1439(16)30362.
    Abstract     Related articles   

  1098. WANG X, Liang Z, Xu X, Li J, et al
    miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Cell Death Dis. 2016;7:e2503.
    Abstract     Related articles   

  1099. NAN YH, Wang J, Wang Y, Sun PH, et al
    MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
    Am J Transl Res. 2016;8:4892-4901.
    Abstract     Related articles   

  1100. HUANG B, Zhai W, Hu G, Huang C, et al
    MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
    Am J Transl Res. 2016;8:4705-4715.
    Abstract     Related articles   

  1101. NOUHAUD FX, Rigaud J, Saint F, Colombel M, et al
    Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer.
    Anticancer Drugs. 2016.
    Abstract     Related articles   

  1102. HOU L, Hong X, Dai M, Chen P, et al
    Association of smoking status with prognosis in bladder cancer: A meta-analysis.
    Oncotarget. 2016 Nov 25. doi: 10.18632/oncotarget.13606.
    Abstract     Related articles   

  1103. DING C, Wu K, Wang W, Guan Z, et al
    Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13578.
    Abstract     Related articles   

  1104. MENDEZ WM JR, Eftim S, Cohen J, Warren I, et al
    Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
    J Expo Sci Environ Epidemiol. 2016 Nov 30. doi: 10.1038/jes.2016.
    Abstract     Related articles   

  1105. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2016.
    Abstract     Related articles   

  1106. VU VAN D, Heberling U, Wirth MP, Fuessel S, et al
    Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.
    Oncol Lett. 2016;12:3143-3152.
    Abstract     Related articles   

  1107. ARAFAT W, Darwish A, Naoum GE, Sameh W, et al
    Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients.
    Ecancermedicalscience. 2016;10:682.
    Abstract     Related articles   

  1108. SRIVASTAVA AK, Singh PK, Singh D, Dalela D, et al
    Clinical utility of urinary soluble Fas in screening for bladder cancer.
    Asia Pac J Clin Oncol. 2016;12:e215-21.
    Abstract     Related articles   

  1109. YAMASHITA H, Amponsa VO, Warrick JI, Zheng Z, et al
    On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.
    Nat Rev Urol. 2016 Nov 29. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  1110. KANIGEL WINNER KR, Costello JC
    A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.
    Pac Symp Biocomput. 2016;22:611-622.
    Abstract     Related articles   

  1111. KOJIMA T, Kawai K, Miyazaki J, Nishiyama H, et al
    Biomarkers for precision medicine in bladder cancer.
    Int J Clin Oncol. 2016.
    Abstract     Related articles   

  1112. ZHANG N, Jiang G, Liu X, Na R, et al
    Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies.
    Biomed Res Int. 2016;2016:9859021.
    Abstract     Related articles   

  1113. KATO T, Yasuda K, Iida H, Watanabe A, et al
    Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: A case report.
    Oncol Lett. 2016;12:4214-4218.
    Abstract     Related articles   

  1114. EGLOFF SA, Du L, Loomans HA, Starchenko A, et al
    Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13546.
    Abstract     Related articles   

  1115. XIANG W, Wu X, Huang C, Wang M, et al
    PTTG1 regulated by miR-146-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Oncotarget. 2016 Nov 22. doi: 10.18632/oncotarget.13507.
    Abstract     Related articles   

  1116. ZHANG X, Yang X, Yang C, Li P, et al
    Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13571.
    Abstract     Related articles   

  1117. HAHN NM
    New treatments for bladder cancer.
    Clin Adv Hematol Oncol. 2016;14:884-887.
    Abstract     Related articles   

  1118. WARRICK JI, Walter V, Yamashita H, Chung E, et al
    FOXA1, GATA3 and PPAR Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
    Sci Rep. 2016;6:38531.
    Abstract     Related articles   

  1119. SELINSKI S, Burger H, Blaszkewicz M, Otto T, et al
    Occupational risk factors for relapse-free survival in bladder cancer patients.
    J Toxicol Environ Health A. 2016;79.
    Abstract     Related articles   

  1120. YU GQ, Dou ZL, Jia ZH
    5bromo3(3hydroxyprop1ynyl)2Hpyran2one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
    Mol Med Rep. 2016 Dec 6. doi: 10.3892/mmr.2016.5991.
    Abstract     Related articles   

  1121. AKAZA H
    Bladder cancer: Advancing NMIBC treatment beyond current BCG formulations.
    Nat Rev Urol. 2016 Dec 6. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  1122. CHIU HF, Chen BK, Yang CY
    Parity, Age at First Birth, and Risk of Death from Bladder Cancer: A Population-Based Cohort Study in Taiwan.
    Int J Environ Res Public Health. 2016;13.
    Abstract     Related articles   

  1123. KOPSIAFTIS S, Hegde P, Taylor JA 3rd, Claffey KP, et al
    AMPKalpha Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
    Transl Oncol. 2016;9:606-616.
    Abstract     Related articles   

  1124. LI HT, Duymich CE, Weisenberger DJ, Liang G, et al
    Genetic and Epigenetic Alterations in Bladder Cancer.
    Int Neurourol J. 2016;20.
    Abstract     Related articles   

  1125. MARTINI A, Villari D, Nicita G
    Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis.
    Int J Surg. 2016 Nov 29. pii: S1743-9191(16)31148.
    Abstract     Related articles   

  1126. TERRERI S, Durso M, Colonna V, Romanelli A, et al
    New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer.
    Genes (Basel). 2016;7.
    Abstract     Related articles   

  1127. HONG Z, Li H, Li L, Wang W, et al
    Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  1128. KOIE T, Ohyama C, Yamamoto H, Imai A, et al
    The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  1129. SAHU D, Gupta S, Hau AM, Nakashima K, et al
    Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase.
    Am J Pathol. 2016 Dec 9. pii: S0002-9440(16)30407.
    Abstract     Related articles   

  1130. YANG R, Liu M, Liang H, Guo S, et al
    miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Mol Cancer. 2016;15:82.
    Abstract     Related articles   

  1131. ANGHEL RM, Gales LN, Trifanescu OG
    Outcome of urinary bladder cancer after combined therapies.
    J Med Life. 2016;9:95-100.
    Abstract     Related articles   

  1132. ZHOU Y, Chan CF, Kwong DW, Law GL, et al
    alphavbeta3-Isoform specific erbium complexes highly specific for bladder cancer imaging and photodynamic therapy.
    Chem Commun (Camb). 2016.
    Abstract     Related articles   

  1133. HEIDEGGER I, Oberaigner W, Horninger W, Pichler R, et al
    High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
    Urol Oncol. 2016 Dec 9. pii: S1078-1439(16)30370.
    Abstract     Related articles   

  1134. HUGEN CM, Duddalwar V, Daneshmand S
    Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.
    Curr Urol Rep. 2016;17:62.
    Abstract     Related articles   

  1135. WINNENBURG R, Shah NH
    Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.
    BMC Bioinformatics. 2016;17:250.
    Abstract     Related articles   

  1136. LIM S, Koh MJ, Jeong HJ, Cho NH, et al
    Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
    Yonsei Med J. 2016;57:831-9.
    Abstract     Related articles   

  1137. ARTCIBASOVA AV, Korzinkin MB, Sorokin MI, Shegay PV, et al
    MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.
    Cell Cycle. 2016;15:689-98.
    Abstract     Related articles   

  1138. LIU S, Zou L, Mao S, Zhang L, et al
    The safety and efficacy of bladder cryoablation in a beagle model by using a novel balloon cryoprobe.
    Cryobiology. 2016;72:157-60.
    Abstract     Related articles   

  1139. UESHIMA H, Myint KZ, Otake H
    Detection of large perforating artery by ultrasound prescan before obturator nerve block.
    J Clin Anesth. 2016;29:14.
    Abstract     Related articles   

  1140. ROMAN-JIMENEZ G, Crevoisier RD, Leseur J, Devillers A, et al
    Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.
    Comput Biol Med. 2016;71:77-85.
    Abstract     Related articles   

  1141. NECCHI A, Lo Vullo S, Mariani L, Raggi D, et al
    An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
    Invest New Drugs. 2016;34:236-42.
    Abstract     Related articles   

  1142. KUBOTA H, Takahashi S, Monzawa S, Yuasa N, et al
    Pictorial review of orthotopic neobladder reconstruction: indication, normal postsurgical anatomy, and complications.
    Abdom Radiol (NY). 2016;41:356-67.
    Abstract     Related articles   

  1143. MORGAN MS, Antonelli JA, Lotan Y, Shakir N, et al
    Use of an Electronic Medical Record to Assess Patient-Reported Morbidity Following Ureteroscopy.
    J Endourol. 2016;30 Suppl 1:S46-51.
    Abstract     Related articles   

  1144. NADEEM H, Jayakrishnan TT, Rajeev R, Johnston FM, et al
    Cost Differential of Chemotherapy for Solid Tumors.
    J Oncol Pract. 2016;12:e299-307.
    Abstract     Related articles   

  1145. PANER GP, Lopez-Beltran A, Sirohi D, Amin MB, et al
    Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Adv Anat Pathol. 2016;23:71-83.
    Abstract     Related articles   

  1146. ZENG X, Xu Z, Gu J, Huang H, et al
    Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
    Mol Cancer Ther. 2016;15:512-22.
    Abstract     Related articles   

  1147. BALL MW, Nathan R, Gerayli F
    Long-Term Response After Surgery and Adjuvant Chemoradiation for T4 Mucinous Adenocarcinoma of the Bladder: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2016;14:e225-7.
    Abstract     Related articles   

  1148. RETZ M, Gschwend JE, Schmid SC
    [Update 2016 - Immunotherapy for urothelial carcinoma].
    Urologe A. 2016;55:246-52.
    Abstract     Related articles   

  1149. BIENTINESI R, Ragonese M, Pinto F, Bassi PF, et al
    Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.
    Clin Genitourin Cancer. 2016;14:e199-201.
    Abstract     Related articles   

  1150. VALLONTHAIEL AG, Kaur K, Jain D, Singh G, et al
    Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy.
    Clin Genitourin Cancer. 2016;14:e183-6.
    Abstract     Related articles   

  1151. DE SANTIS M, Wiechno PJ, Bellmunt J, Lucas C, et al
    Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1).
    Ann Oncol. 2016;27:449-54.
    Abstract     Related articles   

  1152. GOLDBERG H, Baniel J, Mano R, Rotlevy G, et al
    Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison.
    Urol Oncol. 2016;34:121.
    Abstract     Related articles   

  1153. CAPOGROSSO P, Capitanio U, Ventimiglia E, Boeri L, et al
    Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality?
    J Endourol. 2016;30:400-5.
    Abstract     Related articles   

  1154. KIYOSHIMA K, Akitake M, Shiota M, Takeuchi A, et al
    Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2016;36:799-802.
    Abstract     Related articles   

  1155. YOSHIOKA H, Shimbo T, Yoshida K, Yoshikawa N, et al
    Treatment Results of Radiotherapy Combined with Balloon-occluded Arterial Infusion Chemotherapy for Invasive Bladder Cancer.
    Anticancer Res. 2016;36:731-6.
    Abstract     Related articles   

  1156. KILARI D, Iczkowski KA, Pandya C, Robin AJ, et al
    Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.
    Anticancer Res. 2016;36:495-501.
    Abstract     Related articles   

  1157. LENORMAND C, Couteau J, Nouhaud FX, Maillet G, et al
    Predictive Value of NRAMP1 and HGPX1 Gene Polymorphism for Maintenance BCG Response in Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2016;36:1737-43.
    Abstract     Related articles   

  1158. ELLINGER J, Schneider AC, Bachmann A, Kristiansen G, et al
    Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients.
    Anticancer Res. 2016;36:3961-4.
    Abstract     Related articles   

  1159. NAKAGAWA YU, Nagaya H, Miyata T, Wada Y, et al
    Piperazine-based Alpha-1 AR Blocker, Naftopidil, Selectively Suppresses Malignant Human Bladder Cells via Induction of Apoptosis.
    Anticancer Res. 2016;36:1563-70.
    Abstract     Related articles   

  1160. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients.
    Anticancer Res. 2016;36:4763-9.
    Abstract     Related articles   

  1161. CHANG WS, Liao CH, Tsai CW, Hu PS, et al
    Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
    Anticancer Res. 2016;36:4509-14.
    Abstract     Related articles   

  1162. SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
    Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy.
    Anticancer Res. 2016;36:5519-5525.
    Abstract     Related articles   

  1163. KRIEGMAIR MC, Balk M, Wirtz R, Steidler A, et al
    Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.
    Anticancer Res. 2016;36:5205-5213.
    Abstract     Related articles   

  1164. SKINNER EC
    Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
    BJU Int. 2015;116:678-9.
    Abstract     Related articles   

  1165. TAN WS, Sridhar A, Goldstraw M, Zacharakis E, et al
    Robot-assisted intracorporeal pyramid neobladder.
    BJU Int. 2015;116:771-9.
    Abstract     Related articles   

  1166. AL HUSSEIN AL AWAMLH B, Wang LC, Nguyen DP, Rieken M, et al
    Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?
    BJU Int. 2015;116:805-14.
    Abstract     Related articles   

  1167. KOUPPARIS A, Villeda-Sandoval C, Weale N, El-Mahdy M, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol.
    BJU Int. 2015;116:924-31.
    Abstract     Related articles   

  1168. IZQUIERDO L, Peri L, Leon P, Ramirez-Backhaus M, et al
    The role of cystectomy in elderly patients - a multicentre analysis.
    BJU Int. 2015;116 Suppl 3:73-9.
    Abstract     Related articles   

  1169. ODDENS JR, Sylvester RJ, Brausi MA, Kirkels WJ, et al
    Increasing age is not associated with toxicity leading to discontinuation of treatment in urothelial non muscle invasive bladder cancer patients randomized to receive 3 years of maintenance bacillus Calmette-Guerin: Results from EORTC GU Group study 3
    BJU Int. 2016 Mar 6. doi: 10.1111/bju.13474.
    Abstract     Related articles   

  1170. YADAV S, Tomar V, Yadav SS, Priyadarshi S, et al
    Role of oral PentosanPolysulphate in reduction of local side effects of BCG in Non muscle invasive Bladder Cancer patients: a pilot study.
    BJU Int. 2016 Mar 24. doi: 10.1111/bju.13489.
    Abstract     Related articles   

  1171. HURLE R, Pasini L, Lazzeri M, Colombo P, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project.
    BJU Int. 2016 May 21. doi: 10.1111/bju.13536.
    Abstract     Related articles   

  1172. SAMMON JD, Abdollah F, Klett DE, Pucheril D, et al
    The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy.
    BJU Int. 2016;117:211-2.
    Abstract     Related articles   

  1173. AZIZ A, Shariat SF, Roghmann F, Brookman-May S, et al
    Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    BJU Int. 2016;117:272-9.
    Abstract     Related articles   

  1174. ZEHNDER P, Moltzahn F, Mitra AP, Cai J, et al
    Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes.
    BJU Int. 2016;117:253-9.
    Abstract     Related articles   

  1175. CUMBERBATCH MG, Shellard BW, Catto JW
    The contemporary landscape of occupational bladder cancer within the United Kingdom: A meta-analysis of risks over the last 80 years.
    BJU Int. 2016 Jun 22. doi: 10.1111/bju.13561.
    Abstract     Related articles   

  1176. LOTAN Y
    Analysis of genetics to identify susceptibility to secondary malignancies in patients with bladder cancer.
    BJU Int. 2016;118:12-3.
    Abstract     Related articles   

  1177. MOSTAFID AH
    Time to re-evaluate and refine re-transurethral resection in bladder cancer?
    BJU Int. 2016;118:9-10.
    Abstract     Related articles   

  1178. SATKUNASIVAM R, Hu B, Metcalfe C, Ghodoussipour SB, et al
    Utility and significance of ureteric frozen section analysis during radical cystectomy.
    BJU Int. 2016;117:463-8.
    Abstract     Related articles   

  1179. ROLLE L, Falcone M, Ceruti C, Timpano M, et al
    A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the "Sliding Technique" for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
    BJU Int. 2015 Nov 11. doi: 10.1111/bju.13370.
    Abstract     Related articles   

  1180. VARTOLOMEI MD, Kiss B, Vidal A, Burkhard F, et al
    Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
    BJU Int. 2016;117:618-28.
    Abstract     Related articles   

  1181. ONISHI T, Sugino Y, Shibahara T, Masui S, et al
    Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle invasive bladder cancer.
    BJU Int. 2016 Jul 22. doi: 10.1111/bju.13599.
    Abstract     Related articles   

  1182. KAMAT AM, Willis DL, Dickstein RJ, Anderson R, et al
    Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guerin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies.
    BJU Int. 2016;117:754-60.
    Abstract     Related articles   

  1183. CHEN EC, Papa N, Lawrentschuk N, Bolton D, et al
    Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience.
    BJU Int. 2016;117 Suppl 4:50-3.
    Abstract     Related articles   

  1184. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    Abstract     Related articles   

  1185. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    Abstract     Related articles   

  1186. WANG W, Chen H, Liu Z, Qu P, et al
    Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Br J Cancer. 2016;114:305-13.
    Abstract     Related articles   

  1187. MIYAMOTO K, Seki N, Matsushita R, Yonemori M, et al
    Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
    Br J Cancer. 2016 Jun 16. doi: 10.1038/bjc.2016.
    Abstract     Related articles   

  1188. IRLAM-JONES JJ, Eustace A, Denley H, Choudhury A, et al
    Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer.
    Br J Cancer. 2016 Jul 21. doi: 10.1038/bjc.2016.
    Abstract     Related articles   

  1189. SAPRE N, Macintyre G, Clarkson M, Naeem H, et al
    A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
    Br J Cancer. 2016;114:454-62.
    Abstract     Related articles   

  1190. PARDINI B, Viberti C, Naccarati A, Allione A, et al
    Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
    Br J Cancer. 2016 Dec 13. doi: 10.1038/bjc.2016.
    Abstract     Related articles   

  1191. CHOU R, Selph SS, Buckley DI, Gustafson KS, et al
    Treatment of muscle-invasive bladder cancer: A systematic review.
    Cancer. 2016 Jan 15. doi: 10.1002/cncr.29843.
    Abstract     Related articles   

  1192. ROSE TL, Deal AM, Nielsen ME, Smith AB, et al
    Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.
    Cancer. 2016 May 25. doi: 10.1002/cncr.30029.
    Abstract     Related articles   

  1193. HARSHMAN LC
    Mind the gap: What is driving the survival disparity between the sexes in bladder cancer?
    Cancer. 2016 May 25. doi: 10.1002/cncr.30027.
    Abstract     Related articles   

  1194. ROSS JS, Wang K, Khaira D, Ali SM, et al
    Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Cancer. 2016;122:702-11.
    Abstract     Related articles   

  1195. TULLY CM, Apolo AB, Zabor EC, Regazzi AM, et al
    The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
    Cancer. 2016;122:712-21.
    Abstract     Related articles   

  1196. PRINTZ C
    Arsenic in private well water may contribute to bladder cancer risk.
    Cancer. 2016;122:2291.
    Abstract     Related articles   

  1197. DESAI NB, Scott SN, Zabor EC, Cha EK, et al
    Genomic characterization of response to chemoradiation in urothelial bladder cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30219.
    Abstract     Related articles   

  1198. OJERHOLM E, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30422.
    Abstract     Related articles   

  1199. REMY E, Rebouissou S, Chaouiya C, Zinovyev A, et al
    A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.
    Cancer Res. 2015;75:4042-52.
    Abstract     Related articles   

  1200. WANG M, Li Z, Chu H, Lv Q, et al
    Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.
    Cancer Res. 2016.
    Abstract     Related articles   


  1201. Correction: ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton.
    Cancer Res. 2016;76:4592.
    Abstract     Related articles   

  1202. MASAOKA H, Ito H, Soga N, Hosono S, et al
    Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: Gene-environment interaction.
    Carcinogenesis. 2016.
    Abstract     Related articles   

  1203. HAYASHI T, Gust KM, Wyatt AW, Goriki A, et al
    NOT ALL NOTCH IS CREATED EQUAL: THE ONCOGENIC ROLE OF NOTCH2 IN BLADDER CANCER AND ITS IMPLICATIONS FOR TARGETED THERAPY.
    Clin Cancer Res. 2016 Jan 14. pii: clincanres.2360.2015.
    Abstract     Related articles   

  1204. DRONCA RS, Dong H
    Immunomodulatory antibody therapy of cancer: the closer, the better.
    Clin Cancer Res. 2015;21:944-6.
    Abstract     Related articles   

  1205. MANGSBO SM, Broos S, Fletcher E, Veitonmaki N, et al
    The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
    Clin Cancer Res. 2015;21:1115-26.
    Abstract     Related articles   

  1206. FRANTZI M, Van Kessel KE, Zwarthoff EC, Marquez M, et al
    Development and validation of urine-based peptide biomarker panels for detecting bladder cancer in a multi-center study.
    Clin Cancer Res. 2016 Mar 29. pii: clincanres.2715.2015.
    Abstract     Related articles   

  1207. ZHANG H, Prado K, Zhang KX, Peek EM, et al
    Biased Expression of the FOXP3Delta3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.
    Clin Cancer Res. 2016 May 17. pii: clincanres.2581.2015.
    Abstract     Related articles   

  1208. DERRE L, Cesson V, Lucca I, Cerantola Y, et al
    Intravesical Bacillus Calmette Guerin combined with a cancer-vaccine increases local T-cell responses in non-muscle-invasive bladder cancer patients.
    Clin Cancer Res. 2016 Aug 12. pii: clincanres.1189.2016.
    Abstract     Related articles   

  1209. INMAN BA, Longo TA, Ramalingam S, Harrison MR, et al
    Atezolizumab: a PD-L1 blocking antibody for bladder cancer.
    Clin Cancer Res. 2016 Nov 30. pii: clincanres.1417.2016.
    Abstract     Related articles   

  1210. GRUBMUELLER B, Seitz C, Shariat SF
    The treatment of muscle-invasive bladder cancer in geriatric patients.
    Curr Opin Urol. 2016.
    Abstract     Related articles   

  1211. CHOPRA S, Abreu AL, Gill IS
    Robotic urinary diversion: the range of options.
    Curr Opin Urol. 2016;26:107-13.
    Abstract     Related articles   

  1212. LIEM EI, de Reijke TM
    Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
    Curr Opin Urol. 2016.
    Abstract     Related articles   

  1213. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Lemmens V, et al
    Perioperative treatment and radical cystectomy for bladder cancer - a population based trend analysis of 10,338 patients in the Netherlands.
    Eur J Cancer. 2015;54:18-26.
    Abstract     Related articles   

  1214. POUESSEL D, Chevret S, Rolland F, Gravis G, et al
    Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Eur J Cancer. 2015;54:69-74.
    Abstract     Related articles   

  1215. RIBAL MJ, Mengual L, Lozano JJ, Ingelmo-Torres M, et al
    Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
    Eur J Cancer. 2016;54:131-138.
    Abstract     Related articles   

  1216. WESTHOFF E, Maria de Oliveira-Neumayer J, Aben KK, Vrieling A, et al
    Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview.
    Eur J Cancer. 2016;60:136-145.
    Abstract     Related articles   

  1217. VAN DER HEIJDEN AG, Mengual L, Lozano JJ, Ingelmo-Torres M, et al
    A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016;64:127-136.
    Abstract     Related articles   

  1218. GOOSSENS ME, Zeegers MP, van Poppel H, Joniau S, et al
    Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
    Eur J Cancer. 2016;69:9-18.
    Abstract     Related articles   

  1219. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, et al
    Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Eur J Cancer. 2016;69:1-8.
    Abstract     Related articles   

  1220. VAN DER HEIJDEN AG, Mengual L
    Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32449.
    Abstract     Related articles   

  1221. ORSOLA A, Mullane SA, Bellmunt J
    Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernandez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32448.
    Abstract     Related articles   

  1222. HERR HW
    Reply from Author re: Peter C. Black. Narrowing the cystoscopy gap. Eur Urol 2015;67:609-10: A better transurethral resection--proved or not!
    Eur Urol. 2015;67:610-1.
    Abstract     Related articles   

  1223. BLACK PC
    Narrowing the cystoscopy gap.
    Eur Urol. 2015;67:609-10.
    Abstract     Related articles   

  1224. VAN DER HEIJDEN MS, van Rhijn BW
    The molecular background of urothelial cancer: ready for action?
    Eur Urol. 2015;67:202-3.
    Abstract     Related articles   

  1225. KIM PH, Cha EK, Sfakianos JP, Iyer G, et al
    Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.
    Eur Urol. 2015;67:198-201.
    Abstract     Related articles   

  1226. HERR HW
    Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
    Eur Urol. 2015;67:605-8.
    Abstract     Related articles   

  1227. BIRKENKAMP-DEMTRODER K, Nordentoft I, Christensen E, Hoyer S, et al
    Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Eur Urol. 2016 Jan 20. pii: S0302-2838(16)00058.
    Abstract     Related articles   

  1228. ARENDS TJ, Nativ O, Maffezzini M, de Cobelli O, et al
    Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Eur Urol. 2016 Jan 20. pii: S0302-2838(16)00057.
    Abstract     Related articles   

  1229. OHLMANN CH, Stockle M
    Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3
    Eur Urol. 2015;68:1104-5.
    Abstract     Related articles   

  1230. WILLIAMS SB, Kamat AM
    Re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patien
    Eur Urol. 2016 Feb 10. pii: S0302-2838(16)00173.
    Abstract     Related articles   

  1231. SYLVESTER R, Gontero P, Oddens J
    Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Surv
    Eur Urol. 2016 Feb 10. pii: S0302-2838(16)00175.
    Abstract     Related articles   

  1232. ROUPRET M
    Re: Finasteride Reduces the Risk of Bladder Cancer in a Large Prospective Screening Study.
    Eur Urol. 2016;69:537.
    Abstract     Related articles   

  1233. MMEJE CO, Guo CC, Shah JB, Navai N, et al
    Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guerin Therapy: Implication for Clinical Trial Design.
    Eur Urol. 2016 Feb 24. pii: S0302-2838(16)00209.
    Abstract     Related articles   

  1234. RENTSCH CA, Muller DC, Ruiz C, Bubendorf L, et al
    Moving Towards Minimally Invasive Genomically Based Diagnosis and Monitoring of Bladder Cancer.
    Eur Urol. 2016 Mar 4. pii: S0302-2838(16)00240.
    Abstract     Related articles   

  1235. GUO CC, Dadhania V, Zhang L, Majewski T, et al
    Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
    Eur Urol. 2016 Mar 14. pii: S0302-2838(16)00246.
    Abstract     Related articles   

  1236. GRAY PJ, Efstathiou JA, Shipley WU
    Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control Study.
    Eur Urol. 2016;69:757-8.
    Abstract     Related articles   

  1237. PALMA N, Morris JC, Ali SM, Ross JS, et al
    Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
    Eur Urol. 2015;68:168-70.
    Abstract     Related articles   

  1238. SOAVE A, Rink M
    Words of Wisdom. Re: Vinflunine in Routine Clinical Practice for the Treatment of Advanced or Metastatic Urothelial Cell Carcinoma--Data from a Prospective, Multicenter Experience.
    Eur Urol. 2016;69:373-4.
    Abstract     Related articles   

  1239. NAITO S, Algaba F, Babjuk M, Bryan RT, et al
    The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Mus
    Eur Urol. 2016 Apr 22. pii: S0302-2838(16)30031.
    Abstract     Related articles   

  1240. CUMBERBATCH MG, Catto JW
    Micropapillary Variant Bladder Cancer: A Bad Apple or a New Fruit?
    Eur Urol. 2016 Apr 29. pii: S0302-2838(16)30066.
    Abstract     Related articles   

  1241. MCKIERNAN J
    Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer: One Size Does Not Fit All.
    Eur Urol. 2016 May 4. pii: S0302-2838(16)30033.
    Abstract     Related articles   

  1242. YOSSEPOWITCH O
    Re: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.
    Eur Urol. 2016;70:204.
    Abstract     Related articles   

  1243. HERMANS TJ, Mertens LS, van Rhijn BW
    Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
    Eur Urol. 2016;69:1156-7.
    Abstract     Related articles   

  1244. WITJES JA
    Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
    Eur Urol. 2016;69:963.
    Abstract     Related articles   

  1245. YANG Z, Li C, Liu H, Zhang X, et al
    Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells.
    Eur Urol. 2016 Jul 4. pii: S0302-2838(16)30343.
    Abstract     Related articles   

  1246. ALFRED WITJES J, Lebret T, Comperat EM, Cowan NC, et al
    Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
    Eur Urol. 2016 Jun 30. pii: S0302-2838(16)30290.
    Abstract     Related articles   

  1247. ANTONI S, Ferlay J, Soerjomataram I, Znaor A, et al
    Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
    Eur Urol. 2016 Jun 28. pii: S0302-2838(16)30280.
    Abstract     Related articles   

  1248. ARENDS TJ, Witjes JA
    Reply to Slawomir Poletajew, Piotr Radziszewski, Juan Palou Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Baci
    Eur Urol. 2016 Jul 14. pii: S0302-2838(16)30395.
    Abstract     Related articles   

  1249. POLETAJEW S, Radziszewski P, Palou J
    Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and Hi
    Eur Urol. 2016 Jul 11. pii: S0302-2838(16)30394.
    Abstract     Related articles   

  1250. BABJUK M
    Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment?
    Eur Urol. 2016 Jul 11. pii: S0302-2838(16)30392.
    Abstract     Related articles   

  1251. SEISEN T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, et al
    Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephrourecterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Eur Urol. 2016 Jul 28. pii: S0302-2838(16)30419.
    Abstract     Related articles   

  1252. SHIBING Y, Qiang W
    Re: Morgan Roupret, Marko Babjuk, Eva Comperat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Eur Urol. 2016;69:e49-50.
    Abstract     Related articles   

  1253. ROUPRET M
    Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Roupret, Marko Babjuk, Eva Comperat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Eur Urol. 2016;69:e51-2.
    Abstract     Related articles   

  1254. LONGO T, McGinley KF, Freedman JA, Etienne W, et al
    Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.
    Eur Urol. 2016 Aug 9. pii: S0302-2838(16)30463.
    Abstract     Related articles   

  1255. KAMAT AM, Urbauer DL
    Reply from Authors re: Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff. Predicting Response to Intravesical Bacillus Calmette-Guerin Immunotherapy: Are We Moving Forward? Eur Urol 2016;69:201-2: The Goal: Individualized Bacillus Calmette-Guerin Therapy.
    Eur Urol. 2016;69:203.
    Abstract     Related articles   

  1256. WITJES JA
    The Final Answer to the Question of Whether We Should Use a Single Postoperative Instillation of Chemotherapy After Resection of pTa and pT1 Bladder Tumors.
    Eur Urol. 2016;69:245-6.
    Abstract     Related articles   

  1257. ZUIVERLOON TC, Zwarthoff EC
    Predicting Response to Intravesical Bacillus Calmette-Guerin Immunotherapy: Are We Moving Forward?
    Eur Urol. 2016;69:201-2.
    Abstract     Related articles   

  1258. LUO HL, Chen YT, Cheng YT, Chiang PH, et al
    Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Can
    Eur Urol. 2016 Sep 26. pii: S0302-2838(16)30663.
    Abstract     Related articles   

  1259. SEISEN T, Babjuk M, Roupret M
    Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for
    Eur Urol. 2016 Sep 22. pii: S0302-2838(16)30662.
    Abstract     Related articles   

  1260. SATKUNASIVAM R, Santomauro M, Chopra S, Plotner E, et al
    Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life.
    Eur Urol. 2016;69:247-53.
    Abstract     Related articles   

  1261. KAMAT AM, Briggman J, Urbauer DL, Svatek R, et al
    Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin.
    Eur Urol. 2016;69:197-200.
    Abstract     Related articles   

  1262. SYLVESTER RJ, Oosterlinck W, Holmang S, Sydes MR, et al
    Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carci
    Eur Urol. 2016;69:231-44.
    Abstract     Related articles   

  1263. NECCHI A, Giardiello D, Mariani L
    Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer.
    Eur Urol. 2016 Oct 6. pii: S0302-2838(16)30684.
    Abstract     Related articles   

  1264. LIEDBERG F, Jancke G, Sorenby A, Kannisto P, et al
    Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
    Eur Urol. 2016 Oct 19. pii: S0302-2838(16)30713.
    Abstract     Related articles   

  1265. PICKARD R
    Is Robot-assisted Cystectomy Better than Open?--Nearing an Answer after a Decade of Use.
    Eur Urol. 2016;69:622-3.
    Abstract     Related articles   

  1266. HAMILTON-REEVES JM, Bechtel MD, Hand LK, Schleper A, et al
    Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical Trial.
    Eur Urol. 2016;69:389-92.
    Abstract     Related articles   

  1267. RODRIGUES D, Jeronimo C, Henrique R, Belo L, et al
    Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30016.
    Abstract     Related articles   

  1268. ZHANG X, Zhang Y, Liu X, Liu T, et al
    Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30230.
    Abstract     Related articles   

  1269. KISELYOV A, Bunimovich-Mendrazitsky S, Startsev V
    Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.
    Int J Cancer. 2016;138:2562-9.
    Abstract     Related articles   

  1270. XIE X, Pan J, Wei L, Wu S, et al
    Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
    Int J Oncol. 2016 Jan 25. doi: 10.3892/ijo.2016.3357.
    Abstract     Related articles   

  1271. ZHANG Y, Liu W, He W, Zhang Y, et al
    Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
    Int J Oncol. 2016 Mar 3. doi: 10.3892/ijo.2016.3415.
    Abstract     Related articles   

  1272. LI QQ, Hao JJ, Zhang Z, Hsu I, et al
    Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3478.
    Abstract     Related articles   

  1273. CHOI EO, Park C, Hwang HJ, Hong SH, et al
    Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
    Int J Oncol. 2016;49:1009-18.
    Abstract     Related articles   

  1274. KAMEYAMA K, Horie K, Mizutani K, Kato T, et al
    Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.
    Int J Oncol. 2016 Nov 24. doi: 10.3892/ijo.2016.3781.
    Abstract     Related articles   

  1275. WANG JP, Jiao Y, Wang CY, Xu ZB, et al
    Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3791.
    Abstract     Related articles   

  1276. CHEN L, Wang G, Luo Y, Wang Y, et al
    Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3788.
    Abstract     Related articles   

  1277. KRABBE LM, Lotan Y
    Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Jan 14. doi: 10.1111/iju.13052.
    Abstract     Related articles   

  1278. GAUTHIER H, Culine S
    Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:495.
    Abstract     Related articles   

  1279. MUTO S, Abe H, Noguchi T, Sugiura S, et al
    Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:490-4.
    Abstract     Related articles   

  1280. KANG M, Lee S, Jeong SJ, Hong SK, et al
    Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.
    Int J Urol. 2015;22:389-93.
    Abstract     Related articles   

  1281. WASHIO M
    Editorial Comment to Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Feb 18. doi: 10.1111/iju.13064.
    Abstract     Related articles   

  1282. KAUSHIK D, Frank I, Boorjian SA, Cheville JC, et al
    Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Int J Urol. 2015;22:549-54.
    Abstract     Related articles   

  1283. MATSUZAKI K, Fujita K, Ujike T, Uemura M, et al
    Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 Apr 8. doi: 10.1111/iju.13100.
    Abstract     Related articles   

  1284. INAMOTO T, Azuma H
    Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 6. doi: 10.1111/iju.13115.
    Abstract     Related articles   

  1285. FUJITA K, Matsuzaki K
    Response to Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 30. doi: 10.1111/iju.13132.
    Abstract     Related articles   

  1286. KUBOTA Y, Nakaigawa N
    Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
    Int J Urol. 2016 Jul 3. doi: 10.1111/iju.13141.
    Abstract     Related articles   

  1287. NAKAI Y, Anai S, Tanaka N, Chihara Y, et al
    Insignificant role of bacillus Calmette-Guerin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13167.
    Abstract     Related articles   

  1288. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13164.
    Abstract     Related articles   

  1289. YUASA T
    Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 31. doi: 10.1111/iju.13178.
    Abstract     Related articles   

  1290. GOLABEK T, Bukowczan J
    Editorial Comment to Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Int J Urol. 2016;23:240.
    Abstract     Related articles   

  1291. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016 Sep 7. doi: 10.1111/iju.13220.
    Abstract     Related articles   

  1292. CONTRERAS-SANZ A, Roberts ME, Seiler R, Black PC, et al
    Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Int J Urol. 2016 Sep 6. doi: 10.1111/iju.13193.
    Abstract     Related articles   

  1293. HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
    Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
    Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
    Abstract     Related articles   

  1294. REIS LO
    Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016;23:963.
    Abstract     Related articles   

  1295. VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
    Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
    Abstract     Related articles   

  1296. BESIROGLU H
    Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
    Abstract     Related articles   

  1297. SATO Y, Kondo T, Takagi T, Junpei I, et al
    Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1298. WANG L, Zhou M, Feng C, Gao P, et al
    Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1299. XIE J, Zhang XB, Wen J, Zhang YS, et al
    Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1300. ZHANG J, Shi Z, Nan Y, Li M, et al
    Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1301. ANDER H, Donmez MI, Yitgin Y, Tefik T, et al
    Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up.
    Int Urol Nephrol. 2015;47:771-4.
    Abstract     Related articles   

  1302. LI CE, Chien CS, Chuang YC, Chang YI, et al
    Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1303. MAURICE MJ, Kim SP, Abouassaly R
    Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1304. LI HM, Azhati B, Rexiati M, Wang WG, et al
    Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1305. MAY M, Protzel C, Vetterlein MW, Gierth M, et al
    Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  1306. GALSKY MD, Stensland KD, Moshier E, Sfakianos JP, et al
    Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.
    J Clin Oncol. 2016 Jan 19. pii: JCO641076.
    Abstract     Related articles   

  1307. SONPAVDE G, Gordetsky JB, Lockhart ME, Nix JW, et al
    Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
    J Clin Oncol. 2016 Jan 19. pii: JCO654442.
    Abstract     Related articles   

  1308. PAL SK, Agarwal N, Grivas P, Choueiri T, et al
    Adjuvant Chemotherapy for Bladder Cancer: Using Population-Based Data to Fill a Void of Prospective Evidence.
    J Clin Oncol. 2016 Jan 19. pii: JCO654368.
    Abstract     Related articles   

  1309. KAMAT AM, Sylvester RJ, Bohle A, Palou J, et al
    Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.
    J Clin Oncol. 2016 Jan 25. pii: JCO644070.
    Abstract     Related articles   

  1310. MILOWSKY MI, Rumble RB, Booth CM, Gilligan T, et al
    Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    J Clin Oncol. 2016 Mar 21. pii: JCO659797.
    Abstract     Related articles   

  1311. GALSKY MD, Stensland K, Sfakianos JP, Mehrazin R, et al
    Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement.
    J Clin Oncol. 2016 Jun 6. pii: JCO675033.
    Abstract     Related articles   

  1312. MASSARD C, Gordon MS, Sharma S, Rafii S, et al
    Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.
    J Clin Oncol. 2016 Jun 6. pii: JCO679761.
    Abstract     Related articles   

  1313. HU YW
    Real-World Role of Adjuvant Chemotherapy in Bladder Cancer.
    J Clin Oncol. 2016 Jul 11. pii: JCO675884.
    Abstract     Related articles   

  1314. RUGGERI EM, Fabbri MA, Nelli F
    Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?
    J Clin Oncol. 2016 Jul 11. pii: JCO675132.
    Abstract     Related articles   

  1315. EAPEN LJ, MacRae RM
    Management Considerations After Cystectomy for Bladder Cancer.
    J Clin Oncol. 2016 Jul 18. pii: JCO679423.
    Abstract     Related articles   

  1316. DRAKE CG, Bivalacqua TJ, Hahn NM
    Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select.
    J Clin Oncol. 2016 Jul 25. pii: JCO684696.
    Abstract     Related articles   

  1317. PAL SK, Agarwal N, Boorjian SA, Hahn NM, et al
    National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
    J Clin Oncol. 2016 Jul 25. pii: JCO681429.
    Abstract     Related articles   

  1318. BANERJEE I, Giri V, Tomar V
    Re: The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A. Meyer, R. Ghandour, A. Bergman, C. Castaneda, M. Wosnitzer, G. Hruby, M. Benson and J. McKiernan J Urol 2014; 192: 696-70
    J Urol. 2015;193:2152.
    Abstract     Related articles   

  1319. MAMTANI R, Yang YX, Scott FI, Lewis JD, et al
    Association between itraconazole, a hedgehog-inhibitor, and bladder cancer.
    J Urol. 2016 Jan 23. pii: S0022-5347(16)00128-2. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1320. VON RUNDSTEDT FC, Kimal R, Ma J, Arnold J, et al
    Integrative pathway analysis of metabolic signature in bladder cancer - a linkage to the Cancer Genome Atlas Project and prediction of survival.
    J Urol. 2016 Jan 21. pii: S0022-5347(16)00072-0. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1321. KLATTE T, Seitz C, Rink M, Roupret M, et al
    ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy.
    J Urol. 2015;194:1456-62.
    Abstract     Related articles   

  1322. GAN C, Amery S, Chatterton K, Khan MS, et al
    Sequential BCG / Electromotive drug administration Mitomycin C (EMDA-MMC) as the standard intravesical regimen in high risk non muscle invasive bladder cancer (HR-NMIBC) - two year outcomes.
    J Urol. 2016 Feb 1. pii: S0022-5347(16)00226-3. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1323. LEITNER CV, Ederer IA, de Martino M, Hofbauer SL, et al
    Dynamic prognostication using conditional recurrence and progression estimates for patients with non-muscle invasive bladder cancer.
    J Urol. 2016 Jan 30. pii: S0022-5347(16)00225-1. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1324. TAYLOR JA 3RD
    Editorial Comment.
    J Urol. 2015;194:1208.
    Abstract     Related articles   

  1325. LUCHEY AM, Lin HY, Yue B, Agarwal G, et al
    Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
    J Urol. 2015 Jun 5. pii: S0022-5347(15)04113-0. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1326. XU W, Daneshmand S, Bazargani ST, Cai J, et al
    Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway.
    J Urol. 2015;194:1209-13.
    Abstract     Related articles   

  1327. CHANG SS
    Re: Conditional Survival after Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time.
    J Urol. 2016;195:610-1.
    Abstract     Related articles   

  1328. BHATTAR R, Priyadarshi S, Tomar V, Yadav SS, et al
    Re: Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer: M. L. Blute, Jr., T. J. Rushmer, F. Shi, B. J. Fuller, E. J. Abel, D. F. Jarrard and T. M. Downs J
    J Urol. 2016 Feb 11. pii: S0022-5347(16)00010-0. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1329. MATIN SF, Sfakianos JP, Espiritu PN, Coleman JA, et al
    Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    J Urol. 2015;194:1567-74.
    Abstract     Related articles   

  1330. WEIN AJ
    Re: The Microbiome of the Urinary Tract--A Role Beyond Infection.
    J Urol. 2015;194:1643-4.
    Abstract     Related articles   

  1331. WANG DS
    Re: Health-Related Quality of Life after Radical Cystectomy and Neobladder Reconstruction in Women: Impact of Voiding and Continence Status.
    J Urol. 2015;194:1585.
    Abstract     Related articles   

  1332. WANG DS
    Re: Impact of Surgeon Volume on the Morbidity and Costs of Radical Cystectomy in the USA: A Contemporary Population-Based Analysis.
    J Urol. 2015;194:1585-6.
    Abstract     Related articles   

  1333. LAGUNA MP
    Re: Risk Stratification for Bladder Recurrence of Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy.
    J Urol. 2015;194:1582-3.
    Abstract     Related articles   

  1334. STEINBERG G
    Blue Light Cystoscopy Should Be Used Routinely for Bladder Cancer Detection.
    J Urol. 2016 Mar 16. pii: S0022-5347(16)03458-3. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1335. CASTLE EP
    Blue Light Cystoscopy Should Be Used Routinely for Bladder Cancer Detection.
    J Urol. 2016 Mar 16. pii: S0022-5347(16)03459-5. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1336. SEILER R, Lam LL, Erho N, Takhar M, et al
    Prediction of lymph node metastasis in bladder cancer patients using whole transcriptome gene expression signatures.
    J Urol. 2016 Apr 19. pii: S0022-5347(16)30204-X. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1337. SHARMA P, Henriksen CH, Zargar-Shoshtari K, Xin R, et al
    Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical Cystectomy.
    J Urol. 2016;195:47-52.
    Abstract     Related articles   

  1338. NOGUERA-ORTEGA E, Rabanal RM, Secanella-Fandos S, Torrents E, et al
    gamma Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria.
    J Urol. 2016;195:198-205.
    Abstract     Related articles   

  1339. LANGLE YV, Belgorosky D, Prack McCormick B, Sahores A, et al
    FGFR3 Down-Regulation is Involved in bacillus Calmette-Guerin Induced Bladder Tumor Growth Inhibition.
    J Urol. 2016;195:188-97.
    Abstract     Related articles   

  1340. GREGG JR, Emeruwa C, Wong J, Barocas DA, et al
    Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women.
    J Urol. 2016 May 6. pii: S0022-5347(16)30355-X. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1341. CHANG SS
    Re: Variation in Performance of Candidate Surgical Quality Measures for Muscle-Invasive Bladder Cancer by Hospital Type.
    J Urol. 2016;195:1721-2.
    Abstract     Related articles   

  1342. CHANG SS
    Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-Invasive Bladder Cancer: A Sign of Changing Tides.
    J Urol. 2016;195:1721.
    Abstract     Related articles   

  1343. CHANG SS
    Re: Cost-Effectiveness of Neoadjuvant Chemotherapy before Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    J Urol. 2016;195:1720-2.
    Abstract     Related articles   

  1344. CHANG SS
    Re: Prognostic Factors and Risk Groups in T1G3 Non-Muscle-Invasive Bladder Cancer Patients Initially Treated with bacillus Calmette-Guerin: Results of a Retrospective Multicenter Study of 2451 Patients.
    J Urol. 2016;195:1382.
    Abstract     Related articles   

  1345. CADEDDU JA
    Re: Recurrence Patterns after Open and Robot-Assisted Radical Cystectomy for Bladder Cancer.
    J Urol. 2016;195:1379-80.
    Abstract     Related articles   

  1346. MOSSANEN M, Macleod LC, Chu A, Wright JL, et al
    Comparative effectiveness of a patient centered pathology report for bladder cancer care.
    J Urol. 2016 May 19. pii: S0022-5347(16)30455-4. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1347. LARA J, Brunson A, Keegan TH, Malogolowkin M, et al
    Determinants of survival in adolescents and young adults with urothelial bladder cancer: results from the California Cancer Registry.
    J Urol. 2016 May 18. pii: S0022-5347(16)30454-2. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1348. WANG DS
    Re: Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial.
    J Urol. 2016;195:65.
    Abstract     Related articles   

  1349. WANG DS
    Re: Perioperative Complications and 90-Day Mortality of Radical Cystectomy in the Elderly (75+): A Retrospective, Multicentre Study.
    J Urol. 2016;195:65.
    Abstract     Related articles   

  1350. CHANG SS
    Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial.
    J Urol. 2016;195:63-4.
    Abstract     Related articles   

  1351. HOMMA Y, Nakagawa T
    Optimal Dose and Duration of bacillus Calmette-Guerin Therapy for Urothelial Carcinoma of the Bladder.
    J Urol. 2016;195:9-10.
    Abstract     Related articles   

  1352. LERNER SP
    Editorial Comment.
    J Urol. 2016;195:59.
    Abstract     Related articles   

  1353. ZHANG S, Zhong G, He W, Yu H, et al
    LncRNA Up-regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    J Urol. 2016 Jun 4. pii: S0022-5347(16)30559-6. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1354. SCHAEFFER EM
    Re: Multiparametric MRI Findings of Granulomatous Prostatitis after Intravesical bacillus Calmette-Guerin Therapy in a Patient Undergoing Active Surveillance.
    J Urol. 2016;195:371.
    Abstract     Related articles   

  1355. CHANG SS
    Re: Adjuvant Cisplatin-Based Combined Chemotherapy for Lymph Node (LN)-Positive Urothelial Carcinoma of the Bladder (UCB) after Radical Cystectomy (RC): A Retrospective International Study of >1500 Patients.
    J Urol. 2016;195:300.
    Abstract     Related articles   

  1356. CHANG SS
    Re: Multiparametric 3-T MRI for Differentiating Low- versus High-Grade and Category T1 versus T2 Bladder Urothelial Carcinoma.
    J Urol. 2016;195:299-300.
    Abstract     Related articles   

  1357. CHANG SS
    Re: Endoscopic Molecular Imaging of Human Bladder Cancer Using a CD47 Antibody.
    J Urol. 2016;195.
    Abstract     Related articles   

  1358. ATALA A
    Re: Mutations in TERT Promoter and FGFR3 and Telomere Length in Bladder Cancer.
    J Urol. 2016;195.
    Abstract     Related articles   

  1359. GRIEBLING TL
    Re: Use of Preoperative Performance Status and Hemoglobin Concentration to Predict Overall Survival for Patients Aged >/=75 Years after Radical Cystectomy for Treatment of Bladder Cancer.
    J Urol. 2016;195.
    Abstract     Related articles   

  1360. GRIEBLING TL
    Re: Does Radical Cystectomy Outperform Other Bladder Preservative Treatments in Elderly Patients with Advanced Bladder Cancer?
    J Urol. 2016;195.
    Abstract     Related articles   

  1361. GRIEBLING TL
    Re: Different Patterns in the Prognostic Value of Age for Bladder Cancer-Specific Survival Depending on Tumor Stages.
    J Urol. 2016;195.
    Abstract     Related articles   

  1362. OZGUR BC, Yuceturk CN
    Re: Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer: M. L. Blute, Jr., T. J. Rushmer, F. Shi, B. J. Fuller, E. J. Abel, D. F. Jarrard and T. M. Downs J
    J Urol. 2016 Jun 10. pii: S0022-5347(16)30357-3. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1363. CHANG SS
    Re: Factors Influencing the Length of Stay after Radical Cystectomy: Implications for Cancer Care and Perioperative Management.
    J Urol. 2016;195:610.
    Abstract     Related articles   

  1364. KATTAN MW
    Editorial Comment.
    J Urol. 2016;195:289.
    Abstract     Related articles   

  1365. BARTSCH G JR, Mitra AP, Mitra SA, Almal AA, et al
    Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
    J Urol. 2016;195:493-8.
    Abstract     Related articles   

  1366. OING C, Rink M, Oechsle K, Seidel C, et al
    Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.
    J Urol. 2016;195:254-63.
    Abstract     Related articles   

  1367. SONPAVDE G, Pond GR, Rosenberg JE, Bajorin DF, et al
    Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma.
    J Urol. 2016;195:277-82.
    Abstract     Related articles   

  1368. CHANG SS, Boorjian SA, Chou R, Clark PE, et al
    Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
    J Urol. 2016 Jun 15. pii: S0022-5347(16)30629-2. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1369. BIRENDRA R, Kekre NS
    Re: A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer: J. C. Park, N. M. Gandhi, M. A. Carducci, M. A. Eisenberger, A. S. Baras, G. J. Netto, J. J. Li
    J Urol. 2016 Jul 6. pii: S0022-5347(16)30545-6. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1370. PENSON DF
    Re: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.
    J Urol. 2016;196:352-4.
    Abstract     Related articles   

  1371. CHANG SS
    Re: Whole-Exome Sequencing of Muscle-Invasive Bladder Cancer Identifies Recurrent Mutations of UNC5C and Prognostic Importance of DNA Repair Gene Mutations on Survival.
    J Urol. 2016;196:351-2.
    Abstract     Related articles   

  1372. SHIOTA M, Kiyoshima K, Yokomizo A, Takeuchi A, et al
    Suppressed recurrent bladder cancer after androgen suppression with androgen-deprivation therapy or 5alpha-reductase inhibitor.
    J Urol. 2016 Aug 6. pii: S0022-5347(16)30971-5. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1373. ATALA A
    Re: Regulation of UHRF1 by Dual-Strand Tumor-Suppressor MicroRNA-145 (miR-145-5p and miR-145-3p): Inhibition of Bladder Cancer Cell Aggressiveness.
    J Urol. 2016;196:1314.
    Abstract     Related articles   

  1374. CHANG SS
    Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder Cancer.
    J Urol. 2016;196:1045.
    Abstract     Related articles   

  1375. CHANG SS
    Re: Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: One-Year Results of a Multicentre Prospective Cohort Study.
    J Urol. 2016;196:1045-6.
    Abstract     Related articles   

  1376. CHANG SS
    Re: Gene Expression Test for the Non-Invasive Diagnosis of Bladder Cancer: A Prospective, Blinded, International and Multicenter Validation Study.
    J Urol. 2016;196:1044-6.
    Abstract     Related articles   

  1377. CHOU R, Selph S, Buckley DI, Fu R, et al
    Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: Systematic review and meta-analysis.
    J Urol. 2016 Oct 22. pii: S0022-5347(16)31585-3. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1378. CHANG SS
    Re: Long-Term Follow-up of TaG1 Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2017;197:52-54.
    Abstract     Related articles   

  1379. WANG DS
    Re: Long-Term Changes in Renal Function Outcomes following Radical Cystectomy and Urinary Diversion.
    J Urol. 2016;195:1511.
    Abstract     Related articles   

  1380. MOREY AF
    Re: Outcomes of the Endoscopic Treatment of Bladder Neck Contractures in the Orthotopic Neobladder.
    J Urol. 2016;195:1508-9.
    Abstract     Related articles   

  1381. CHANG SS
    Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience.
    J Urol. 2016;195:1381-2.
    Abstract     Related articles   

  1382. VENKATRAMANI V, Parekh DJ
    Editorial Comment.
    J Urol. 2016;195:1375.
    Abstract     Related articles   

  1383. KRISHNAN N, Liu X, Lavieri MS, Hu M, et al
    A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy.
    J Urol. 2016;195:1362-7.
    Abstract     Related articles   

  1384. ZHAO D, Besser AH, Wander SA, Sun J, et al
    Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Oncogene. 2015;34:5447-59.
    Abstract     Related articles   

  1385. KING MA, Ganley IG, Flemington V
    Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells.
    Oncogene. 2016 Feb 8. doi: 10.1038/onc.2015.
    Abstract     Related articles   

  1386. CIAMPORCERO E, Shen H, Ramakrishnan S, Yu Ku S, et al
    YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
    Oncogene. 2016;35:1541-53.
    Abstract     Related articles   

  1387. ZHANG H, Ye YL, Li MX, Ye SB, et al
    CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    Abstract     Related articles   

  1388. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    Abstract     Related articles   

  1389. SUN Y, Guan Z, Liang L, Cheng Y, et al
    HIF-1alpha/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4536.
    Abstract     Related articles   

  1390. CHEN F, Chen X, Yang D, Che X, et al
    Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4794.
    Abstract     Related articles   

  1391. CHUNG YH, Kim D
    RIP kinase-mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin-treated bladder cancer cells.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4895.
    Abstract     Related articles   

  1392. HU KY, Wang G, Liu PF, Cao YW, et al
    Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4884.
    Abstract     Related articles   

  1393. HUANG J, Wang B, Hui K, Zeng J, et al
    miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4940.
    Abstract     Related articles   

  1394. YIN X, Xu C, Zheng X, Yuan H, et al
    SnoN suppresses TGF-beta-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1gamma-dependent manner.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4939.
    Abstract     Related articles   

  1395. SHIN SS, Park SS, Hwang B, Kim WT, et al
    MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling, cell cycle regulators, and Ets-1-mediated MMP-2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5015.
    Abstract     Related articles   

  1396. SHIN SS, Park SS, Hwang B, Moon B, et al
    MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5052.
    Abstract     Related articles   

  1397. WANG J, Zhao X, Shi J, Pan Y, et al
    miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5040.
    Abstract     Related articles   

  1398. KOBAYASHI K, Matsumoto H, Matsuyama H, Fujii N, et al
    Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Oncol Rep. 2016 Sep 1. doi: 10.3892/or.2016.5061.
    Abstract     Related articles   

  1399. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    Abstract     Related articles   

  1400. NEUZILLET Y, Colin P, Comperat E, Dubosq F, et al
    [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
    Prog Urol. 2016 Jan 8. pii: S1166-7087(15)00736.
    Abstract     Related articles   

  1401. VARINOT J, Furudoi A, Roupret M, Comperat E, et al
    [Update on molecular classifications and new histological classification of bladder cancer].
    Prog Urol. 2016 Sep 20. pii: S1166-7087(16)30419.
    Abstract     Related articles   

  1402. IRANI J
    [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Prog Urol. 2016 Oct 3. pii: S1166-7087(16)30564.
    Abstract     Related articles   

  1403. DABI Y, Rouscoff Y, Delongchamps NB, Sibony M, et al
    [Negative prognostic impact of female gender on oncological outcomes following radical cystectomy].
    Prog Urol. 2016;26:83-8.
    Abstract     Related articles   

  1404. ROUPRET M, Neuzillet Y, Masson-Lecomte A, Colin P, et al
    [CCAFU french national guidelines 2016-2018 on bladder cancer].
    Prog Urol. 2016;27 Suppl 1:S67-S91.
    Abstract     Related articles   

  1405. GAKIS G, Rink M, Fritsche HM, Graefen M, et al
    Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2016.
    Abstract     Related articles   

  1406. NOVOTNY V, Froehner M, Ollig J, Koch R, et al
    Impact of Adjuvant Intravesical Bacillus Calmette-Guerin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Urol Int. 2016.
    Abstract     Related articles   

  1407. VILASECA A, Huguet J, Perez M, Camacho D, et al
    The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer.
    Urol Int. 2016.
    Abstract     Related articles   

  1408. ZAKARIA AS, Santos F, Kassouf W, Tanguay S, et al
    Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec.
    Urol Int. 2016.
    Abstract     Related articles   

  1409. FAHMY O, Scharpf M, Schubert T, Feyerabend S, et al
    Ten Years of Complete Remission of Pulmonary Metastasis after Post-Cystectomy Palliative Cisplatin-Gemcitabine Chemotherapy with Gefitinib for Muscle Invasive Bladder Cancer: A Case Report.
    Urol Int. 2016.
    Abstract     Related articles   

  1410. CHEN Y, Yang Y, Liu L, Wang S, et al
    Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2016;96:142-7.
    Abstract     Related articles   

  1411. WANG Y, Wang T, Han Y, Wu H, et al
    Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.
    Urol Int. 2015;94:464-71.
    Abstract     Related articles   

  1412. GARDE H, Ciappara M, Galante I, Fuentes Ferrer M, et al
    Radical cystectomy in octogenarian patients: a difficult decision to take.
    Urol Int. 2015;94:390-3.
    Abstract     Related articles   

  1413. ESWARA JR, Heney NM, Wu CL, McDougal WS, et al
    Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
    Urol Int. 2015;94:401-5.
    Abstract     Related articles   

  1414. BERGER I, Wehrberger C, Ponholzer A, Wolfgang M, et al
    Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older.
    Urol Int. 2015;94:394-400.
    Abstract     Related articles   

  1415. SIKIC D, Wach S, Taubert H, Richterstetter M, et al
    How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience.
    Urol Int. 2016.
    Abstract     Related articles   

  1416. BURGE F, Kockelbergh R
    Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes.
    Urol Int. 2016.
    Abstract     Related articles   

  1417. D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
    90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
    Urol Int. 2016.
    Abstract     Related articles   

  1418. NYAME YA, Nandanan N, Greene DJ, Krishnamurthi V, et al
    Robotic Anterior Pelvic Exenteration for Bladder Cancer in Patient with Previous Kidney-Pancreas Transplant.
    Urology. 2015 Dec 29. pii: S0090-4295(15)01185.
    Abstract     Related articles   

  1419. GRECO KA, Franzen CA, Foreman KE, Flanigan RC, et al
    PLK-1 Silencing in Bladder Cancer by siRNA Delivered with Exosomes.
    Urology. 2016 Feb 11. pii: S0090-4295(16)00110.
    Abstract     Related articles   

  1420. CHEDGY EC, Black PC
    "Pioglitazone: No Longer a Worry for Bladder Cancer?"
    Urology. 2016 Feb 15. pii: S0090-4295(16)00075.
    Abstract     Related articles   

  1421. LUCHEY AM, Manimala NJ, Dickinson S, Dhillon J, et al
    Change in Management Based on Pathologic Second Opinion among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice.
    Urology. 2016 Mar 31. pii: S0090-4295(16)30049.
    Abstract     Related articles   

  1422. NYAME YA, Zargar H, Ramirez D, Ganesan V, et al
    Robotic-Assisted Laparoscopic Bilateral Nerve Sparing and Apex Preserving Cystoprostatectomy in Young Men with Bladder Cancer.
    Urology. 2016 Apr 28. pii: S0090-4295(16)30127.
    Abstract     Related articles   

  1423. MINKOWITZ SY, Wadee R, Adam A
    The first report of Urothelial (Clear Cell Variant) bladder cancer in a child.
    Urology. 2016 May 17. pii: S0090-4295(16)30203.
    Abstract     Related articles   

  1424. MATIN SF, Melquist J, Karam JA
    Author reply.
    Urology. 2016;87:222-3.
    Abstract     Related articles   

  1425. OWEN RC, White WM
    Editorial comment.
    Urology. 2016;87:222.
    Abstract     Related articles   

  1426. MELQUIST JJ, Redrow G, Delacroix S, Park A, et al
    Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma.
    Urology. 2016;87:216-23.
    Abstract     Related articles   

  1427. CROZIER J, Hennessey D, Sengupta S, Bolton D, et al
    A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer.
    Urology. 2016 Jun 29. pii: S0090-4295(16)30329.
    Abstract     Related articles   

  1428. ADEJORO O, Alishahi A, Konety B
    Association of Comorbidity, Age and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Urology. 2016 Jul 7. pii: S0090-4295(16)30303.
    Abstract     Related articles   

  1429. FENG TS, Rusnack S, Kaminski J, Fleshner P, et al
    Appendicovesical Fistula Following Transurethral Resection of Bladder Tumor With Mitomycin C.
    Urology. 2016;89:e1-2.
    Abstract     Related articles   

  1430. HURLE R, Lazzeri M, Colombo P, Buffi N, et al
    "En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study.
    Urology. 2016;90:126-30.
    Abstract     Related articles   

  1431. SCHROECK FR, Pattison EA, Denhalter DW, Patterson OV, et al
    Early Stage Bladder Cancer - Do Pathology Reports Tell Us What We Need to Know?
    Urology. 2016 Aug 30. pii: S0090-4295(16)30544.
    Abstract     Related articles   

  1432. SHIVAPPA N, Hebert JR, Rosato V, Rossi M, et al
    Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-Control Study.
    Urology. 2016 Sep 29. pii: S0090-4295(16)30637.
    Abstract     Related articles   

  1433. KIM M, Jeong CW, Kwak C, Kim HH, et al
    Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.
    BMC Cancer. 2015;15:149.
    Abstract     Related articles   

  1434. YEH HH, Tseng YF, Hsu YC, Lan SH, et al
    Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
    BMC Cancer. 2015;15:172.
    Abstract     Related articles   

  1435. DORES GM, Qubaiah O, Mody A, Ghabach B, et al
    A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010.
    BMC Cancer. 2015;15:185.
    Abstract     Related articles   

  1436. LIU W, Qi L, Lv H, Zu X, et al
    MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
    BMC Cancer. 2015;15:92.
    Abstract     Related articles   

  1437. RETZ M, de Geeter P, Goebell PJ, Matz U, et al
    Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
    BMC Cancer. 2015;15:455.
    Abstract     Related articles   

  1438. KAWAHARA T, Furuya K, Nakamura M, Sakamaki K, et al
    Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    BMC Cancer. 2016;16:185.
    Abstract     Related articles   

  1439. LOPEZ DE MATURANA E, Picornell A, Masson-Lecomte A, Kogevinas M, et al
    Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.
    BMC Cancer. 2016;16:351.
    Abstract     Related articles   

  1440. GARCIA PV, Seiva FR, Carniato AP, de Mello Junior W, et al
    Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.
    BMC Cancer. 2016;16:422.
    Abstract     Related articles   

  1441. LI X, Wang H, Wang J, Chen Y, et al
    Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    BMC Cancer. 2016;16:578.
    Abstract     Related articles   

  1442. OLDENBURG D, Ru Y, Weinhaus B, Cash S, et al
    CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    BMC Cancer. 2016;16:713.
    Abstract     Related articles   

  1443. ROPERCH JP, Grandchamp B, Desgrandchamps F, Mongiat-Artus P, et al
    Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    BMC Cancer. 2016;16:704.
    Abstract     Related articles   

  1444. ANANTHARAMAN A, Friedlander T, Lu D, Krupa R, et al
    Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
    BMC Cancer. 2016;16:744.
    Abstract     Related articles   

  1445. BENHAMOU S, Bonastre J, Groussard K, Radvanyi F, et al
    A prospective multicenter study on bladder cancer: the COBLAnCE cohort.
    BMC Cancer. 2016;16:837.
    Abstract     Related articles   

  1446. KONG C, Zhan B, Piao C, Zhang Z, et al
    Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
    BMC Cancer. 2016;16:892.
    Abstract     Related articles   

  1447. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    Abstract     Related articles   

  1448. BERRONDO C, Flax J, Kucherov V, Siebert A, et al
    Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes.
    PLoS One. 2016;11:e0147236.
    Abstract     Related articles   

  1449. WANG S, Zhang H, Scharadin TM, Zimmermann M, et al
    Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.
    PLoS One. 2016;11:e0146256.
    Abstract     Related articles   

  1450. LI Y, Yu G, Li Q, Wang W, et al
    Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
    PLoS One. 2015;10:e0124959.
    Abstract     Related articles   

  1451. SHANG W, Ning Y, Xu X, Li M, et al
    Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    PLoS One. 2015;10:e0126016.
    Abstract     Related articles   

  1452. GEVAERT T, Moles Lopez X, Sagaert X, Libbrecht L, et al
    Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
    PLoS One. 2015;10:e0127020.
    Abstract     Related articles   

  1453. ARDELT PU, Ebbing J, Adams F, Reiss C, et al
    An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder.
    PLoS One. 2015;10:e0118646.
    Abstract     Related articles   

  1454. JOHNSON DT, Hooker E, Luong R, Yu EJ, et al
    Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    PLoS One. 2016;11:e0148851.
    Abstract     Related articles   

  1455. HATAKEYAMA S, Koie T, Narita T, Hosogoe S, et al
    Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
    PLoS One. 2016;11:e0149544.
    Abstract     Related articles   

  1456. WARD DG, Baxter L, Gordon NS, Ott S, et al
    Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer.
    PLoS One. 2016;11:e0149756.
    Abstract     Related articles   

  1457. LORENZATTI HILES G, Bucheit A, Rubin JR, Hayward A, et al
    ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
    PLoS One. 2016;11:e0150138.
    Abstract     Related articles   

  1458. MASSARI F, Bria E, Ciccarese C, Munari E, et al
    Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.
    PLoS One. 2015;10:e0127908.
    Abstract     Related articles   

  1459. HATAKEYAMA S, Koie T, Narita T, Hosogoe S, et al
    Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
    PLoS One. 2016;11:e0151742.
    Abstract     Related articles   

  1460. WU S, Xu R, Wan Q, Zhu X, et al
    Assessment of the potential diagnostic role of anaplastic lymphoma kinase for inflammatory myofibroblastic tumours: a meta-analysis.
    PLoS One. 2015;10:e0125087.
    Abstract     Related articles   

  1461. GUANCIAL EA, Kilari D, Xiao GQ, Abu-Farsakh SH, et al
    Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    PLoS One. 2016;11:e0155503.
    Abstract     Related articles   

  1462. CHEN MF, Lin PY, Wu CF, Chen WC, et al
    Correction: IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer.
    PLoS One. 2016;11:e0155774.
    Abstract     Related articles   

  1463. WANG S, Lei T, Zhang M
    The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
    PLoS One. 2016;11:e0157759.
    Abstract     Related articles   

  1464. JOUNG JY, Lim J, Oh CM, Jung KW, et al
    Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
    PLoS One. 2015;10:e0140693.
    Abstract     Related articles   

  1465. TIAN Y, Ma Z, Chen Z, Li M, et al
    Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0158891.
    Abstract     Related articles   

  1466. WU J, Huang Q, Meng D, Huang M, et al
    A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer.
    PLoS One. 2016;11:e0159115.
    Abstract     Related articles   

  1467. CHATZIHARALAMBOUS D, Lygirou V, Latosinska A, Stravodimos K, et al
    Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.
    PLoS One. 2016;11:e0149471.
    Abstract     Related articles   

  1468. MILLER A, Burson H, Soling A, Roughan J, et al
    Welfare Assessment following Heterotopic or Orthotopic Inoculation of Bladder Cancer in C57BL/6 Mice.
    PLoS One. 2016;11:e0158390.
    Abstract     Related articles   

  1469. DUAN F, Yu Y, Guan R, Xu Z, et al
    Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways.
    PLoS One. 2016;11:e0161886.
    Abstract     Related articles   

  1470. GARCIA MM, Gottschalk AR, Brajtbord J, Konety BR, et al
    Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.
    PLoS One. 2016;11:e0164558.
    Abstract     Related articles   

  1471. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    Abstract     Related articles   

  1472. KIM D, Choi Y, Ireland J, Foreman O, et al
    Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.
    PLoS One. 2016;11:e0165856.
    Abstract     Related articles   

  1473. LIMA L, Gaiteiro C, Peixoto A, Soares J, et al
    Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies.
    PLoS One. 2016;11:e0166120.
    Abstract     Related articles   

  1474. LONG X, Zu X, Li Y, He W, et al
    Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.
    PLoS One. 2016;11:e0166884.
    Abstract     Related articles   

  1475. DAI L, Ma C, Zhang Z, Zeng S, et al
    DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0167228.
    Abstract     Related articles   

  1476. KANEMOTO K, Fukuta K, Kawai N, Tozawa K, et al
    Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
    PLoS One. 2016;11:e0167374.
    Abstract     Related articles   

  1477. WU Z, Wang C, Zhang Z, Liu W, et al
    High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population.
    PLoS One. 2016;11:e0168351.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;